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Kv2.1 and TASK-1 channels are two main contributors of K+ currents in pulmonary 
artery smooth muscle cells (PASMC). Dysregulation of these channels has been 
implicated in the pathogenesis of pulmonary hypertension (PH). This thesis aims to 
delve deeper into the implications of the regulation of Kv2.1 by Kv9.3 in PH. Another 
subject of interest would be whether NADPH oxidase type 4 (Nox4), one of the major 
reactive oxygen species (ROS) producers in the PASMC, modulates Kv2.1, Kv9.3, 
and TASK-1 channels. The effects of several redox agents are also investigated as 
potential modulators of Kv2.1, Kv9.3, and TASK-1. In addition, this thesis also 
examined the effect of a Kv2Ðchannel blocker, stromatoxin, on Kv2.1 and Kv9.3. 
Finally, since amphoterin-induced gene and open reading frame (AMIGO) proteins 
have recently been shown as novel Kv2.1-interacting partners, their effects on Kv2.1 
and/or Kv9.3 are also explored in this study.  
Experimental approach 
Whole-cell patch clamp electrophysiology was used to measure currents of the ion 
channels expressed in modified tsA-201 cells, in the absence and presence of Nox4 
AMIGO and other regulatory molecules. Immunohistochemistry was deployed to 
visualize the distribution of Kv2.1 and Kv9.3 proteins in the rat lungs and hearts. 
Key results and Conclusions 
This study supports the findings that Kv9.3 regulates Kv2.1 by increasing the current 
amplitude, shifting the activation threshold to a more negative voltage range, and 
prolonging the slow component of time constant of deactivation. These effects could 
be beneficial in PH as this would mean cells could be brought back to its resting 
membrane potential faster and the transduction of the next action potential can be 
delayed. Kv2.1 and Kv9.3 have also been detected at the endothelium and PASMC in 
rat lungs and hearts, further substantiating the claim that these channels are potential 
players in regulating PH. AMIGO1 and AMIGO2 proteins are confirmed as 
regulators of Kv2.1 and Kv9.3 proteins. Nox4 does not regulate Kv2.1, Kv9.3, and 
TASK-1 channels expressed in tsA-201 cells. While hydrogen peroxide (H2O2) does 
not have any effect on Kv2.1 and Kv9.3, it abolished the current reduction effect of 
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AMIGO2 on Kv2.1/Kv9.3. Other redox agents used in this study such as dithiothreitol 
(DTT), 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB), and chloramine T (Ch-T) are not 
modulators of these channels expressed in tsA-201 cells. The lack of effect from 
Nox4 and these redox agents could suggest that the redox regulation of different Nox 
subunit/Kv channels combination varies for different cell types due to the different 
regulatory proteins present in different heterologous expression systems. As with the 
case of H2O2 and AMIGO2, it is likely that the regulatory proteins, which could 
facilitate the hypoxia-sensing properties of Nox4 and the effects of the redox agents 
on the ion channels, are missing in our heterologous expression system, compared 
with other host cells.  
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Chapter 1: Introduction 
 
1.1 Pulmonary Hypertension  
1.1.1 Classification of PH 
	
Pulmonary hypertension (PH) is a complex cardiopulmonary disorder that can be 
caused by several factors. The characteristics of this disorder include progressive 
sustained increase in mean pulmonary arterial pressure (mPAP), leading to right-sided 
heart failure and death. PH can occur due to precapillary (arterial) or postcapillary 
(venous) pathomechanisms (Guignabert et al, 2015). In 2013, the World Health 
Organization classified PH into five groups, which are pulmonary arterial 
hypertension, pulmonary hypertension due to left heart disease, pulmonary 
hypertension due to lung diseases and hypoxia, chronic thromboembolic pulmonary 
hypertension, and pulmonary hypertension with unclear and multifactorial 
mechanisms (Goldberg et al., 2017). The first group, pulmonary arterial hypertension 
(PAH) is further divided into idiopathic, hereditary, drug- and toxin-induced, and 
associated forms namely connective tissue diseases, human immunodeficiency virus 
(HIV) infection, portal hypertension, congenital heart diseases, and schistosomiasis 
(Goldberg et al, 2017). European Society of Cardiology guidelines defined pulmonary 
arterial hypertension as having an mPAP of ≥ 25 mm Hg at rest, with a normal 
pulmonary artery wedge pressure ≤ 15 mm Hg, and pulmonary vascular resistance > 3 
Woods unit. Unlike Group 2 PH, pulmonary arterial hypertension is precapillary PH 
because obstruction to flow happens at the precapillary level (Goldberg et al., 2017).  
 
1.1.2 Pathogenic mechanisms of Pulmonary Hypertension 
	
There are two main pathogenic mechanisms of PH, which are hypoxic pulmonary 
vasoconstriction and pulmonary vascular remodelling (Kuhr et al., 2012). 
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1.1.2.1 Hypoxic pulmonary vasoconstriction 
 
Although hypoxic pulmonary vasoconstriction is implicated in PH, it is actually an 
important physiological response where resistance pulmonary blood vessels constrict 
to divert blood from poorly ventilated regions of the lung to regions with a higher O2 
tension to improve gas exchange during hypoxia (low oxygen availability) (Archer et 
al., 1998). However, long-term hypoxia causing sustained hypoxic pulmonary 
vasoconstriction could lead to PH especially in chronic obstructive pulmonary 
diseases (e.g. chronic bronchitis, emphysema) and in people living at high altitudes 
(Kuhr et al., 2012; Morrell et al., 2009; Ward and McMurtry, 2009). This study 
concerns the properties of K+ channels which have a role in setting the resting 
membrane potentials (RMP) in the PASMC, which in turn regulate the Ca2+ signalling 
pathways to control the pulmonary vascular tone (Ko et al., 2010; Kuhr et al., 2012).  
 
1.1.2.2 Pulmonary vascular remodelling  
 
Pulmonary vascular remodelling  is a process where structural changes occurring in 
the pulmonary arteries leads to hypertrophy and/or luminal obstruction (Huang et al., 
2010; Kuhr et al., 2012). Pulmonary vascular remodelling leads to the onset of PH 
because the increment in the thickness and tissue mass of the pulmonary arterial walls 
causes an increase in pulmonary vascular resistance due to narrowing or obstruction 
of vessel lumen. The increase in tissue mass occurs because of uncontrolled cell 
proliferation.  
Multiple factors contribute to the disruption of this vascular apoptosis-proliferation 
homeostasis process such as alteration of ROS stalk between cells within the vascular 
wall, compromised functions of inflammatory cells, inhibition of apoptosis pathways 
and excessive activation of signalling pathways promoting cell proliferation, survival, 
and migration, and imbalance of systemic hormones, local growth factors, cytokines, 
transcription factors, and germline mutations (Guignabert et al., 2015). Several cell 
types within the vascular wall such as PASMC, pulmonary artery endothelial cells 
(PAEC), myofibroblasts, and pericytes, can alter structurally and functionally during 
vascular remodelling (Guignabert et al., 2015; Kuhr et al., 2012). Meanwhile, 
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deposition of inflammatory cells, platelet, and, progenitor cells causes thrombotic 
lesions which increases the pulmonary vascular resistance and obstructs blood flow in 
small arteries and arterioles (Kuhr et al., 2012).  
The pulmonary vascular remodeling process happens in five stages, beginning with 
the innermost tunica intima layer and ending at the outermost tunica adventitia layer 
(Figure 1.1). Intimal thickening occurs due to endothelial cells von Willebrand factor, 
a blood glycoprotein responsible for blood coagulation and fibrinolysis, which 
eventually lead to accumulation of collagen and proliferation of myofibroblasts. 
Medial thickening is characterized by medial hypertrophy and neomuscularization. 
Medial hypertrophy refers to the thickening and growth of PASMC. 
Neomuscularization is associated with the differentiation of fibroblasts and pericytes 
within non-muscular arteries such as distal alveolar duct and wall pulmonary arteries 
into smooth muscle cells that subsequently proliferate ( Rabinovitch, 2008, Kuhr et 
al., 2012).  
The loss of small precapillary arteries, probably due to vessel occlusion, could also be 
attributed to endothelial cell alteration and/or pericytes differentiation. In the fourth 
stage of the remodeling process, it is thought that gradual thickening of the wall of 
more proximal intra-acinar and pre-acinar muscular arteries coupled with obliteration 
that happened during neointimal formation may be responsible for increased 
proliferation and migration of cells that are likely to be SMC. These cells are 
hypothesized to be a specialized subpopulation of SMC or may have originated as 
stem cells or fibrocytes or may even have originated as endothelial cells. Cell culture 
studies have shown that endothelial cells release factors such as FGF2 which stimulate 
SMC proliferation. In idiopathic PAH patients, there is a noticeable Tie2 receptor 
upregulation and activation in endothelial cells which is associated with increased 
serotonin release. This further leads to serotonin-mediated SMC proliferation.  
Later stage of the disease is characterized by the development of plexiform lesion. It 
is hypothesized that clonal expansion of apoptosis-resistant endothelial cells or 
circulating endothelial progenitor cells that concentrate at sites of endothelial 
denudation or injury could give rise to the formation of aberrant channels in otherwise 
obliterated lumen vessels and in the adventitia. Interestingly, it has been found that 
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PAEC of idiopathic PAH patients synthesize lower amounts of nitric oxide, NO. NO, 
an important vasodilator and inhibitor of SMC proliferation, is mostly produced from 
eNOS in PAEC. L-arginine is a substrate of NO synthase to produce NO and L-
citrulline, but L-arginine can also be broken down by arginase thereby reducing the 
bioavailability of NO. This agrees with the finding that PAEC of idiopathic PAH 
patients express a high level of arginase.  PAEC from these patients have also been 
found to proliferate in response to growth factors (such as platelet-derived growth 
factor) and have a high glycolysis rate (Rabinovitch, 2008). The increased 
proliferation is concomitant with malformation of endothelial tubes in culture, which 
is in line with the apoptosis of precapillary vessels and failure to replenish these 
vessels. Changes to the adventitia layer in the remodelled vessels can be quantified by 
increased amount of transforming growth factor β (TGF-β) and accumulation of 
extracellular matrix components such as collagen, elastin, fibronectin, tenascin-C, and 
glycosaminoglycans, in addition to fibroblast proliferation (Kuhr et al., 2012). 
Immunohistochemical studies also demonstrated increased expression of immune 
cells such as macrophages, T cells, fractalkine, and metastasin 1 (also known as 
S100A4) (Rabinovitch, 2008). The increased amount of TGF-b is an interesting 
hallmark of PAH as several researchers have recently found that mutation in BMPR2, 
which encodes a type 2 receptor member (bone morphogenetic protein receptor 2 
[BMPR2]) of the TGF-b superfamily of cell-signalling molecules account for 70% of 
hereditary PAH and 10-40% of idiopathic PAH cases (Ma and Chung, 2017; Navas 
Tejedor et al., 2017).  
 
The breakdown of extracellular matrix, accumulation of collagen, and increased 
endothelial and smooth muscle cell proliferation also lead to enhanced wall stiffness 
(Kuhr et al., 2012). This is another factor that further leads to increased pulmonary 
vascular resistance, which results in increased workload on the right ventricle. Thus, 
right heart failure occurs at a higher frequency in PAH patients (Huang et al., 2010; 
Kuhr et al., 2012).  As with hypoxic pulmonary vasoconstriction, Ca2+ elevation in 
PASMC plays a major role in vascular remodelling as it stimulates the PASMC 
proliferation process (Kuhr et al., 2012). 
In addition, extracellular matrix breakdown also generates fragments that can directly 
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regulate proliferation, migration, and protease activation to further cause local 
pulmonary vascular remodelling. Activation of several proteases such as elastase, 
matrix metalloproteinase (MMP), chymase, tryptase, as well as urokinase-type 
plasminogen activator plasmin system or the tissue- type plasminogen activator 
plasmin system have been shown to promote pulmonary vascular remodelling  
(Guignabert et al., 2015). Extracellular matrix disintegration also causes growth 
factors and other molecules which are previously embedded to be activated. 
Remodelling of the extracellular matrix also leads to exposure of functionally 
important cryptic sites in collagen, elastin, laminins or bronectin, which predisposes 
the vasculature to pulmonary vascular remodelling  (Guignabert et al., 2015; Huang et 
al., 2010; Kuhr et al., 2012).  
One of the examples of how DNA damage can render apoptotic-resistant phenotype 
in PASMC is the upregulation of hypoxia-inducible factor 1α leading to 
downregulation of miR-223, and upregulation of poly (ADP-ribose) polymerase 1 
(PARP-1). Meloche et al., 2015 provided evidence that miR-223 is downregulated in 
human PAH lungs, distal PAs, and isolated PASMCs. They have also shown that 
restoration of miR-223 expression in monocrotaline-induced PAH ameliorated PAH 
by having positive impacts on vascular remodelling, pulmonary resistance, right 
ventricle hypertrophy, and survival (Meloche et al., 2015). 
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Figure 1.1: Schematic illustration of the stages in pulmonary vascular remodeling. 
The stages are i) neomuscularization of peripheral arteries, ii) medial thickening of 
large muscular pulmonary arteries, iii) loss of precapillary arteries, iv) neointimal 
formation in vessels of 100-500µm, v) development of plexiform lesions. Adapted 
from Rabinovitch, 2008.  
 
1.1.3 Relationship between ROS and PH  
	
ROS are major contributors of hypoxic pulmonary vasoconstriction as they can 






















remodelling processes. Increased ROS production, especially superoxide and 
hydrogen peroxide (H2O2), coupled with decreased nitric oxide bioavailability or 
other antioxidants causes vasoconstriction in PASMC, indicating a pathophysiological 
role in hypoxic pulmonary vasoconstriction. ROS mediate their effect via the 
interaction with protein kinases, guanylyl cyclase (Ko et al., 2010) and most 
importantly for this project, K+  channels (Perez-Vizcaino et al., 2010).   
A secondary event that could occur due to endothelial dysfunction is the reduction in 
nitric oxide (a vasodilator) bioavailability. This is because ROS (specifically 
superoxide) bind with NO to form peroxynitrite (ONOO-) which can nitrate tyrosine 
residues on proteins as well as cause lipid peroxidation and single strand breaks in 
DNA (Figure 1.2) (Modun et al., 2014). ROS can increase the intracellular calcium 
concentration directly or; indirectly by inhibiting K+ channels (Harrison et al., 2007; 
Touyz, 2004). 
 
Several research groups have documented the effects of different redox agents such as 
H2O2, dithiothreitol (DTT), 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB), and 
chloramine T (Ch-T) on the pulmonary vasculature (Duprat et al., 1997; Park et al., 
1997a; S. W. Park et al., 2015). However, the results remain contradictory or 
inconclusive. For example, H2O2 has been found to act as either a vasodilator, 
vasoconstrictor or both (S. W. Park et al., 2015). Furthermore, the redox agents 
hypothesized to be implicated in PH mediate their effects by reducing K+ current. 
(see ÔRelationship between K+ channels and PH).  Due to the gap in the current 
literature, the effects of these redox agents on Kv2.1, Kv9.3, and TASK-1 are 
explored in Chapter 3, Chapter 5, and Chapter 6.  
 
1.1.3.1 NADPH oxidases are a source of ROS  
 
Although there are multiple enzymes which are possible candidate for the ROS  
synthesis in PASMC, Mittal et al., 2007 and Touyz, 2004 argued that the primary 
source of vascular ROS is nicotinamide adenine dinucleotide phosphate (reduced 
form) NADPH oxidase complex. NADPH oxidase complex is a heteromeric enzyme, 
where its catalytic subunit is called Nox, catalyzes superoxide production whereby 
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NAD(P)H donates an unpaired electron to oxygen (Figure 1.2) (Touyz, 2004). 
Vascular Nox has at least 4 subunits which are sometimes known as accessory 
proteins: cell membraneÐassociated p22phox and gp91phox (or gp91phox [Nox2] 
homologues, Nox1 and Nox4), and cytosolic subunits, p47phox and p67phox 
(Brandes et al., 2010; Harrison et al., 2007; Touyz, 2004). 
Under normal conditions, Nox is synthesized in a small quantity to function as 
signalling molecules to regulate endothelial function and vascular contraction-
relaxation. Interestingly, the function of Nox can be modulated by physical factors 
(stretch, pulsatile strain, and shear stress) and humoral factors (cytokines, growth 
factors, and vasoactive agents) (Harrison et al., 2007).  Deviation from normal Nox  
function in the events of increased ROS  bioavailability would cause events which are 
characteristics of hypoxic pulmonary vasoconstriction such as increased vessel 
contractility, endothelial dysfunction; and pulmonary vascular remodelling  such as 
lipid peroxidation, inflammation, monocyte invasion, and, accumulation of 
extracellular matrix proteins (Harrison et al., 2007). 
RT-PCR data has confirmed the mRNA expression of Nox1 to Nox5 (except Nox3) in 
the cardiovascular system, with Nox4 having the highest expression compared to the 
rest (Brandes et al., 2010). The mode of activation of Nox depends on its interaction 
with p22phox (a transmembrane scaffolding protein) (Brandes et al., 2010). Of these 
Nox proteins, Nox2 and Nox4 are postulated to be involved in hypoxia-induced 
endothelial dysfunction and PH (Brandes et al., 2010). Both of these proteins have 
been shown to modulate the function of K+ channels during hypoxia and vascular 
remodelling process (Brandes et al., 2010; Buttigieg et al., 2012; Harrison et al., 2007; 
Mittal et al., 2012; Touyz, 2004). 
Mittal et al., 2012 demonstrated that Nox4 is upregulated in hypoxia-induced 
pulmonary hypertension in both rats and mice and helps PASMC proliferation via the 
phosphorylation of retinoblastoma protein. Immunocytochemistry experiments 
performed by Lee et al., 2006 showed that Nox4 is co-localized with TASK-1 and 





Figure 1.2: Molecular scheme of NADPH oxidase complex (its catalytic subunit is called 
Nox) and generation of ROS leading to pulmonary arterial smooth muscle cells (PASMC) 
contraction and vascular remodelling. Abbreviations- NADP(H): nicotinamide adenosine 
dinucleotide phosphate (reduced form), H+: hydrogen ion, O2: oxygen, ¥O
2-: superoxide 
anion, SOD: superoxide dismutase, H2O2: hydrogen peroxide, H2O: water, MAPK: mitogen-
activated protein kinase, PTP: protein tyrosine phosphatase, PTK: tyrosine kinase, MMP: 
matrix metalloproteinase.  O2 molecule received an electron, forming the ROS superoxide 
anion. The superoxide anion has a strong tendency to receive another electron to form a more 
stable peroxide dianion, which can be protonated to form hydrogen peroxide (H2O2), another 
ROS. When superoxide anion meets NO, a reactive nitrogen species, peroxynitrite (ONOO-) 
is formed. Peroxynitrite is extremely reactive because the two O atoms of the peroxide group 
of peroxynitrite are incompletely reduced and the N atom of peroxynitrite is incompletely 
oxidized. Nitrate (O(O)NO-) is formed when intramolecular transfer of two electrons from the 
N atom to the peroxide group occurs. Two missing electrons are provided by other 
biomolecules such as reduced glutathione, GSH, and tyrosine, TyrH. Reproduced from 


























1.1.4 Involvement of K+ channels in hypoxic pulmonary vasoconstriction 
and pulmonary vascular remodelling  
	
When PASMCs are depolarized to above -35mV, either activation of Ca2+ channels to 
initiate an action potential (AP) or activation of K+ channels for hyperpolarization can 
occur (Gurney et al., 2010). PASMC exhibit a large K+ current outflow, suggesting 
that this strong repolarizing effect is essential in preventing the smaller Ca2+ current 
from inducing another AP (Gurney et al., 2010; Ko et al., 2010; Morrell et al., 2009). 
Therefore, K+ channels are fundamental in limiting excitability to maintain the low 
vascular tone, an intrinsic property of the pulmonary arteries (Gurney et al., 2010; 
Kuhr et al., 2012). 
Failure of K+ channels to activate will cause PASMC to remain depolarized, which 
lead to an elevation in the cytoplasmic Ca2+ concentration ([Ca2+]cyt) (Kuhr et al., 
2012). Interaction of Ca2+ with calmodulin (CaM) activates myosin light chain kinase 
which then phosphorylates the regulatory light chain of myosin (Kuhr et al., 2012). 
Subsequently, the myosin ATPase is activated, which then hydrolyses ATP and thus 
provides energy for the cross-bridging cycles between myosin and actin filaments 
(Kuhr et al., 2012). These mechanisms underlie cellular contraction, which in the 
context of PASMC, is termed pulmonary vasoconstriction (Ko et al., 2010; Kuhr et 
al., 2012) (Figure 1.3). 
Through regulation of the resting membrane potential, Ca2+ influx through L-type 
voltage-dependent Ca2+ channels (VDCC) and hence the cytosolic Ca2+ concentration 
are controlled (Kuhr et al., 2012). This has implications in the homeostasis between 
cell proliferation and apoptosis by allowing proliferation of the PASMC population 
while simultaneously inhibiting apoptosis and cytoplasmic caspase activity (Figure 
1.3) (Kuhr et al., 2012). A rise in [Ca2+]cyt in PASMC stimulates cell proliferation 
and migration, leading to pulmonary vascular remodelling (Kuhr et al., 2012). The 
mechanisms involved in the regulation of [Ca2+]cyt directly control vascular wall 
thickness; a major determinant of pulmonary vascular resistance (Kuhr et al., 2012) . 
Because pulmonary vascular resistance is inversely proportional to the fourth power 
of the radius (r) of the pulmonary arterial lumen (pulmonary vascular remodelling 
=8Lη/πr4), a very small change in r would thus cause a large change in pulmonary 
vascular resistance (Kuhr et al., 2012). As a consequence, pulmonary vasoconstriction 
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will also increase by reducing the arterial radius. Pulmonary arterial pressure (PAP), a 
diagnostic criterion for PAH, is a product of pulmonary vascular remodelling  and 
cardiac output (Kuhr et al., 2012). Pulmonary vasoconstriction and vascular medial 
hypertrophy caused by excessive PASMC proliferation and migration contribute 
considerably to the elevated pulmonary vascular remodelling  in patients with 
pulmonary hypertension (Kuhr et al., 2012).  
 
 
Figure 1.3: Schematic representation of the relationship between K+ and Ca2+ channels in regulating 
pulmonary vasoconstriction and vascular remodelling. Closure of K+ channels or opening of Ca2+ 
channels lead to rise in cytoplasmic Ca2+ concentration and pulmonary vasoconstriction (Left); Rise in 
cytoplasmic Ca2+ concentration causes cell cycle progression and vascular remodeling (Right). 
























1.2 Potassium (K+) channels 
	
In general, there are four families of K+ channels, namely calcium-activated K+  
channels, voltage- gated K+  channels (Kv), inwardly-rectifying K+  channels and two-
pore domain K+ channels (K2P) (Figure 1.4) (Levitan and Kaczmarek, 2002). K+ 
channels are usually composed of pore-forming α-subunits and regulatory β-subunits 
(Levitan and Kaczmarek, 2002). K+ channels are very diverse due to three reasons: 
the large number of genes (80 genes) encoding the α-subunit; the heteromeric 
assembly of different α subunits, β-subunits; and the intracellular interaction of 
different signalling proteins with the channel for modulation purposes (Bonnet and 
Archer, 2007; Levitan, 2002). 
Electrophysiology has been used to characterize several K+ channels in the pulmonary 
vasculature and those that are implicated in hypoxic pulmonary vasoconstriction 
include voltage-gated K+ channels (Kv), inwardly-rectifying K+ channels and two-
pore domain K+  channels (K2P), Ca2+ -activated channel (KCa), M-type K+  channels, 
the ATP-sensitive K+  channel (KATP) (Olschewski et al., 2014). However, several 
arguments support the notion that the main mediators are Kv channels, particularly 
Kv1.5 and Kv2.1 (see Kv9.3 channels and modulation of Kv2.1 below) because 
initiation of hypoxic pulmonary vasoconstriction occurs mostly due to hypoxic 
inhibition of Kv channels in PASMC (Archer et al., 1998, 2004; Bonnet and Archer, 
2007). However, TASK channels are potentially interesting candidates due to their 
activation at a very negative membrane potential and therefore is postulated to play a 
role in setting the RMP (Morrell et al., 2009). Therefore, this study will specifically 




Figure 1.4: Families of K+ channels. Clockwise: Voltage-gated K+ channels, Calcium-activated K+ 
channels, Inward rectifier K+ channels, and ÔLeakÕ or Background K+ channels.  
 
1.2 Voltage-gated and two-pore domain K+ channels  
 
1.2.1 Voltage-gated K+ (Kv) channels  
	
Like most of the K+ channels, Kv channels are composed of a tetramer of α subunits 
(Levitan and Kaczmarek, 2002). Each α-subunit has six transmembrane domains 
(TMD) and a single pore-forming domain. The α-subunit is made up of a voltage 
sensor in the fourth TMD region which is rich in positively charged amino acids and a 
domain which is essential for the linkage between the four α-subunits and between α- 
and β-subunits (Levitan, 2002). The β-subunits modulate inactivation kinetics or drug 
sensitivity of the channel (Bonnet and Archer, 2007; Levitan, 2002). 
Kv channels have been postulated to be implicated in hypoxic pulmonary 

























































































biology, and functional characterizations.  Pharmacological profile of adult PASMC 
indicated that a Kv current that can be inhibited by 4-aminopyridine (4-AP) but not 
charybdotoxin is mostly responsible in establishing the membrane potential during 
hypoxic stimulation (Archer et al, 2004). By further analyzing the pharmacological 
profile of the Kv populations that have been studied in expression systems such as the 
Xenopus oocyte, the candidates were narrowed down to Kv1.5 and Kv2.1. The 
pharmacological profile of Kv2.1 has an exact match, where it is susceptible to 4-AP 
and tetraethylammonium (TEA), but insensitive to charybdotoxin (Archer et al., 2004, 
1998; Bonnet and Archer, 2007). 
With molecular biology approaches, it has been found that small pulmonary arteries 
in rat have high Kv channel expression (Archer et al., 1998, 2004). Meanwhile, 
functional characterization of Kv channels have shown that downregulation of Kv 
channels have been implicated in both hypoxic pulmonary vasoconstriction and 
pulmonary vascular remodelling (Guignabert et al., 2015; Olschewski et al., 2006). 
Inhibition of Kv channels causes reduction in the whole cell K+ current, which leads 
to the opening of L-type voltage-gated Ca2+ channels and Ca2+ influx. This further 
causes PASMC contraction and eventually hypoxic pulmonary vasoconstriction. With 
regards to pulmonary vascular remodelling, it has been shown that therapies targeting 
the upregulation of Kv channels such as DCA (dichloroacetate), Kv1.5 gene therapy, 
and dehydroepiandrosterone could have beneficial effects in experimental PAH 
patients (Olschewski et al., 2014).  
With respect to the a-subunits, most studies examining the molecular subtypes of Kv 
channels in PASMCs report the expression of Kv1.1, Kv1.2, Kv1.5, Kv2.1, and Kv9.3 
(Archer et al., 1998, 2004; Yuan et al., 1998c; Osipenko et al., 2000; Coppock et al., 
2001; Davies and Kozlowski, 2001; Platoshyn et al., 2001). Expression levels of 
Kv1.3, Kv1.4, and Kv1.6 are relatively controversial in PASMCs. Archer et al. 1998 
proposed the presence of Kv1.1, Kv1.2, Kv1.3, Kv1.5, Kv1.6, and Kv2.1, but they 
failed to detect Kv1.4. At about the same time, Yuan et al., 1998 demonstrated the 
expression of Kv1.1, Kv1.2, Kv1.4, Kv1.5, Kv1.6, Kv2.1, and Kv9.3, but not Kv1.3. 
A few years later, expression of the Kv3.1 subtype was reported by other groups 
(Osipenko et al., 2000: Coppock et al., 2001; Archer et al., 2004). Although other 
subtypes (Kv1.7, Kv4.1, and Kv9.2) have also been identified (Davies and Lozlowski, 
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2001), Kv1.1, Kv1.2, Kv1.5, Kv2.1, Kv9.3, and additionally Kv3.1 subtypes are 
expressed in PASMCs, and one (or a co-assembly) of these types may act as oxygen 
sensors.  
Combinations of a-subunits with b-subunits increase the diversity of Kv channel 
function in PASMC (Morales et al., 1996). Different combinations can result in 
difference in terms of inactivation and deactivation kinetics, and voltage sensitivity 
(Morales et al., 1996). Among the four types of b -subunits (Kv b 1Ð4) that have been 
identified so far, Kv b 1, Kv b2, and Kv b3 subunits are expressed in PASMCs 
(Standen and Quayle, 1998). Although the exact function of b-subunits is not known, 
it has been postulated that these subunits play a crucial role as a redox sensor and in 
hypoxic adaptation (Prez-Garca and Lpez-Lpez, 2000).  
Functionally, Cogolludo et al., 2006 established the link between the inhibition of Kv 
channels with the activation of thromboxane (TP) receptors in rat and porcine 
pulmonary arteries. TP receptors, coupled with G-protein, Gq, act via protein kinase 
C to inhibit the activation of Kv channels, causing membrane depolarization and 
activation of L-type Ca2+ channels to bring about hypoxic pulmonary vasoconstriction 
and pulmonary vascular remodelling  (Cogolludo et al., 2006). In addition, 
Belohlvkov et al., 2001 have also reported that dopamine receptor agonist pergolide 
and certain serotonin (5-HT) reuptake inhibitors could inhibit Kv channels, leading to 
membrane depolarization and eventually PH. 
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1.2.1.1 Kv2.1 channels 
 
Kv2.1 channels are thought to be essential in modulating neuronal excitability due to 
their expression in virtually every nerve cell (Chiara et al., 1999). For example, Kv2.1 
is the major contributor to the delayed rectifier K+ current in neuronal cells such as the 
hippocampal neurons (Chiara et al., 1999) and cardiac cells (Patel et al., 1997). 
Therefore, Kv2.1 is involved in the repolarization of action potential in these cells. 
Although there is a vast amount of evidence emphasizing the role of Kv2.1 as an 
oxygen-sensitive channel responsible in PH, little is known about the specific oxygen-
sensing component of the channel (Patel et al., 1999, 1997; Patel and Honor, 2001). 
This oxygen-sensing property might be conferred by a built-in component within 
Kv2.1 or as a result of interaction with a binding protein such as Kv9.3 or Nox4, or 
even amphotericin-induced gene and open reading frame (AMIGO) proteins (which 
are the subjects of these studies) or other interacting partners, which are still 
unknown.  
 
1.2.1.2 Kv9.3 channels and modulation of Kv2.1 
 
Kv9.3 channels are electrically-silent channels. Interestingly, Kv2.1 can form a 
heteromer with Kv9.3 and its function is modulated as a result of this interaction 
(Patel et al, 1997). Therefore, Kv2.1, and very possibly Kv2.1/Kv9.3, are major 
contributors to the delayed rectifier K+ current. Both channels are activated by 
intracellular ATP and are reversibly inhibited by hypoxia and the extents of these 
modulations are different for Kv2.1 and Kv2.1/Kv9.3 (Patel et al., 1999, 1997; Patel 
and Honor, 2001). This has led to the speculation that their activities are tightly 
connected to the glycolytic pathway/ metabolic status of the PASMC. There are four 
separate findings which supported their connection with the metabolic state of the 
cells. Rounds and McMurty, 1981 discovered that inhibitors of oxidative 
phosphorylation and glycolysis cause transient pressor responses as well as hypoxic 
vasoconstriction in the perfused rat lung. Two separate findings; the first one 
concerning 2-deoxyglucose and carbonyl cyanide p-
trifluoromethoxyphenylhydrazone (FCCP), and the second one concerning rotenone 
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and antimycin A (inhibitors of activated oxygen species biosynthesis from the 
electron transport chain and ATP synthesis); showed that these compounds inhibit Kv 
channels, raise cytoplasmic Ca2+ concentration and lead to PASMC contraction (Patel 
et al., 1997). Lastly, Evans et al (1994) showed that rise in intracellular ATP levels 
elevated the delayed rectifier K+ current amplitude in rabbit PASMC (Evans et al., 
1994). 
Kv2.1 homomers have a fast open-state inactivation and a slow closed-state 
inactivation (Kerschensteiner, 2003). However, co-expression with Kv9.3 results in 
slow open-state inactivation and a fast and complete closed-state inactivation 
(Kerschensteiner, 2003). Although Kv9.3 is electrically silent, co-expression of Kv9.3 
with Kv2.1 causes Kv2.1 to preferentially exhibit closed-state inactivation 
(Kerschensteiner, 2003). Activation of Kv2.1 might be crucial in preventing action 
potential firing in neurons. Pharmacologically, their co-expression resulted in the 





1.2.2 Two-pore domain K+ (K2P) channels  
Two-pore domain K+ (K2P) channels were discovered relatively recently compared to 
the other families of K+ channels (Goldstein et al., 2001). There are three features 
which make these channels unique, which are, their structure, their constitutive 
activation, and the regulation of their activity by various chemical and physical 
stimuli (Enyedi and Czirjak, 2010; Goldstein et al., 2001). There are six subfamilies, 
divided according to their structure and function in mammals (Enyedi and Czirjak, 
2010). They are namely the TWIK (two-pore domain weakly inward rectifying K+ 
channel); TASK (TWIK-related acid-sensitive K+); TREK (TWIK-related K+); TALK 
(TWIK-related alkaline activated K+); THIK (tandem pore domain halothane-
inhibited K+); and TRESK (TWIK-related spinal cord K+) subfamilies (Enyedi and 
Czirjak, 2010; Lotshaw, 2007).  
 
1.2.2.1 Structure of K2P channels and constitutive activation 
 
The feature which differentiates K2P family from the others is their unique structure 
of four transmembrane domains assembled into two pore-forming regions, hence 
earning them their name (Enyedi and Czirjak, 2010; Goldstein et al., 2001; Lotshaw, 
2007; Mathie et al., 2010b). Secondly, they are constantly open at physiological 
resting membrane potential to allow K+ ions to pass through the channels. This 
second feature earns them the name Ôleak K+ channelsÕ (Goldstein et al., 2001). These 
Ôleak currentsÕ are subjected to little rectification (Goldstein et al., 2001). The 
molecular basis of this leak conductance had been elusive, but mounting evidence 
suggest that this conductance is fundamental to function of nerves and muscles, such 
as to set the resting membrane potential and input resistance in excitable cells, 
particularly in PASMC (Enyedi and Czirjak, 2010; Lotshaw, 2007).   
 
1.2.2.2 Discovery of K2P channels 
 
The discovery of K2P channels started in 1995, when TOK1 was found in the 
sequence database for the yeast Saccharomyces cerevisiae. TOK1 possess eight 
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predicted transmembrane segments and is the first example of a non-voltage-gated 
outward rectifier (Ketchum et al., 1995; Reid et al., 1996).  
In 1996, KCNK0 was cloned from the neuromuscular tissues of the adult fruit fly 
Drosophila melanogaster (Goldstein et al., 2001). KCNK0 was able to restore the 
function of K+ transport in mutant yeast cells (Goldstein et al., 2001). In contrast to 
TOK1, KCNK0 only has four transmembrane segments and is the first example of a 
canonical K+- selective leak conductance channel. KCNK1, the first mammalian gene 
for a 2P/4TM subunit was also discovered but it was later found to be a non-
functional channel (Goldstein et al., 2001).  
 
1.2.2.3 Leak current 
 
Since the early days of electrophysiology, the ÔleakÕ current has remained a mystery 
(Enyedi and Czirjak, 2010; Goldstein et al., 2001). Electrophysiologists noticed that 
the membrane potential rises from a resting potential in order to generate an action 
potential and once the cell is depolarized again, the membrane potential resets itself to 
the resting potential again (Goldstein et al., 2001). Even at the resting potential, the 
ions still  crosses the membrane, and ionic and electrical gradients are established 
(Goldstein et al., 2001). The word ÔleakÕ is used to describe fixed background currents 
when the membrane is at rest and to currents that increases instantaneously with the 
voltage steps (Goldstein et al., 2001). These Ôleak currentsÕ can be attributable to 
movement of non-selective ions across membrane (in the case where the membrane is 
damaged) or to movement of specific ions (Goldstein et al., 2001).   
When a K+ channel is activated, K+ ions are permitted to flow out of the cell down the 
K+ concentration gradient (Goldstein et al., 2001). However, there are negative 
counter ions which remain inside the cells (Goldstein et al., 2001). This causes the net 
outflow of K+ to only go on until the chemical energy favouring this outflow is 
balanced by the electrostatic energy favouring the inflow of K+ ions (Goldstein et al., 
2001). At equilibrium, the chemical and electrostatic forces cancel out each other, 
resulting in zero net movement of K+ ions (Goldstein et al., 2001). Nernst potential is 
the membrane voltage at which a particular ion at a given ionic gradient reaches 
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equilibrium (Goldstein et al., 2001). For example, a hypothetical membrane that only 
permits the passage of K+ ions will have a Nernst potential that is equivalent to the 
equilibrium reversal potential for K+ ions, EK, and is described by equation 1:  
 
Equation 1: Calculation of Nernst potential; R is the gas constant, T is temperature in degrees Kelvin, z 
is the charge of the ion, F is FaradayÕs constant, Kext and Kin the concentrations of K
 
in the external and 
internal compartments. Equation adapted from Goldstein et al, 2001.  
 For physiological K+ concentrations at physiological temperature (37oC), RT/zF is 
~27mV and E is ~-97mV (predicted to be -85mV, if taking K+ concentration as 5mM 
outside and 140mM inside) (Goldstein et al., 2001). However, resting membrane 
potential for mammalian cells is slightly positive, ranging from -60 to -90 mV 
because K+  ions are not the only ions that move at rest (Goldstein et al., 2001). Leak 
Na+ and Cl- ions move across the membrane to reach their Nernst potentials of +67 
and -93 mV, respectively (Goldstein et al., 2001).  The PASMC on the other hand, 
have even more positive range of resting potentials, ranging from -65 to -50mV 
(Platoshyn et al, 2004).   
So, why is this leak current important? Leak current is essential in setting the resting 
membrane potential. Excitability of the cells is governed by whether an action 
potential can be fired. Only when the membrane voltage is shifted past a threshold 
level that an action potential is generated and this happens when the voltage-gated 
channels open (Goldstein et al., 2001). These channels eventually become inactive. 
The key thing to note is that, firing of the next action potential can only happen when 
these channels have recovered from inactivation by returning to the resting membrane 
potential, which is maintained by leak channels (Enyedi and Czirjak, 2010; Goldstein 
et al., 2001; Lotshaw, 2007).  
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1.2.2.4 Gating of K2P channels  
 
As mentioned, another interesting feature about K2P channels is their gating 
mechanism (activation or inhibition) can be regulated by various chemical and 
physical stimuli, ranging from arachidonic acid, pH, inhaled anaesthetics and 
membrane stretch (Enyedi and Czirjak, 2010; Mathie et al., 2010a). Both 
crystallographic data and homology modelling have elucidated that all K+ channels 
share a highly-conserved structure for ion selectivity and gating mechanisms (Mathie 
et al., 2010a). Similar to other K+ channels, K2P channels are thought to have two 
primary conserved gating mechanisms: an activation gate at the intracellular entrance 
to the channel involving key, identified, hinge glycine residues and an inactivation (or 
C-type) gate at the selectivity filter close to the extracellular side of the channel 
(Mathie et al., 2010a). 
Several activators and inhibitors interact differently with either the activation or 
inactivation gates of K2P channels. For example, the inhibition of Drosophila 
KCNK0 and mammalian TASK channels occurs when zinc and hydrogen ions, 
respectively, bind to their inactivation gate (Mathie et al., 2010a). Meanwhile, voltage 
dependence of TASK3 is regulated through its activation gate (Brickley et al., 2007; 
Mathie et al., 2010a). It remains equivocal whether other regulatory gating pathways 
exist, or other regulatory compounds that may interact with either the activation or 



















Table 1: Physiological activators and inhibitors of K2P channels. Adapted from Mathie et al (2010) 
 
Family  Family members Activators Inhibitors 








KCNK7 (K2P 7.1) 
  
TREK TREK1 (K2P 2.1) Acid pHi 
 
 
TREK2 (K2P 10.1) Acid pHo (TREK1) 
 
 
TRAAK (K2P 4.1) Arachidonic acid,  
depolarizing voltage, Gai, 
heat, lysophospholipids, 
Nitric oxide (TREK-1), 
polyunsaturated fatty acids, 
stretch 
 
TASK TASK1 (K2P 3.1) Alkaline pHo (TASK1) Acid pHo 
 




TASK5 (K2P 15.1) 
 
Zinc (TASK3) 
TALK TASK2 (K2P 5.1) Alkaline pHo 
 
 





THIK THIK1 (K2P13.1) Arachidonic acid 
 
 
THIK2 (K2P 12.1) 
  
TRESK TRESK (K2P 18.1) Calcium, Gaq Arachidonic acid 
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Initially, there are thought to be two primary conserved gating mechanisms of K+  
channels: an activation gate at the intracellular entrance to the channel and a distant 
slow inactivation gate at the selectivity filter close to the extracellular side of the 
channel, called the C-type inactivation (Yellen, 2002). However, a third mechanism, 
called the N-type inactivation also exists and this mechanism is restricted to certain 
Kv channels (Mathie et al., 2010a). The N-type inactivation occurs due to binding of 
an auto-inhibitory peptide that is part of the N terminus of the channel protein, which 
inhibits current flow leading to fast inactivating A-type currents (Mathie et al., 2010a; 
Yellen, 2002). The C-type inactivation occurs when the amino acids at the narrow 
selectivity filter pinch shut causing pore closure. This happens at a slower rate than N-
type inactivation (Choi et al., 1991; Hoshi et al., 1991). In KcsA channels, the extent 
of C-type inactivation is determined by the hydrogen bonds between amino acid 
residues in the selectivity filter and its adjacent pore helix (Mathie et al., 2010a). The 
precise residues might vary in different K+ channels, but this mechanism is generally 
accepted as a cognate C-type gating in other K+ channels (Mathie et al., 2010a).   
In the second mechanism, channel opens or closes depending on movement of amino 
acids at the intracellular entrance to the pore region (Mathie et al., 2010a). For Kv 
channels, the stimulus for this to occur is depolarization and the movement of the S4 
transmembrane segment (Mathie et al., 2010a).  
Jiang et al., 2002 have resolved the crystal structures of the closed-state bacterial 
channels KcsA and opened-state MthK (a calcium-gated, inwardly-rectifying, K+ 
channel) in its open state and have discovered the hinge glycine residues were situated 
in the inner helices and that these residues bend to give way for ions passing when the 
channel is open. In most K+ channels, K2P included, these residues are conserved 
(Jiang et al., 2002). Meanwhile, hydrogen ions inhibit TASK1 and TASK3 currents, 
mainly through binding to residues situated next to the GFG selectivity filter (Y. Kim 
et al., 2000; Lopes et al., 2005; Rajan et al., 2000). Moreover, residues in the outer 
pore mouth of TASK1 channels confer ion selectivity and protonation of H98 brings 
about ÔC-typeÕ gating response which causes conformational change in the selectivity 
filter of TASK1 (Yuill et al., 2007).  
It has been suggested that K2P channels are preferentially in the open state after 
noticing that the mutant KCNK0, which is devoid of most of its C-terminus, still has 
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an activation gate and this gate possess a high single channel open probability (Po) of 
0.8 (Ben-Abu et al., 2009). The team also inferred that the reason for such high Po is 
attributable to the presence of glycine residues in K2P channels (Ben-Abu et al., 
2009). The role that these glycine residues play in promoting channel opening is 
further supported by the finding that mutation of these residues with hydrophobic 
residues in both KCNK0 and indeed in TASK3 caused a reduction in Po (Ashmole et 
al., 2009). The situation is a little more complicated with full-length mammalian K2Ps 
as their resting Po is not nearly so high (Ashmole et al. 2009).  
Different amino acids at the activation gate govern different processes to influence the 
P0 of the channel. For example, Ashmole et al. 2009 suggested that natural alanine 
residue interacts with L128 in M2 region to stabilize the closed state of the channel 
whereas in hERG channels an equivalent alanine residue (A653) near the glycine 
hinge has also been shown to interacts strongly to residues in adjacent subunits to 
promote channel closure (Ashmole et al., 2009). In contrast, mutation of A237 to 
threonine stabilizes the channel open state by altering side-chain interactions between 
residues, possibly with N133 in M2 region (Mathie et al., 2010a).  
Moreover, a region of six amino acids in TASK1 and TASK3 (VLRFLT in the case 
of the latter) is imperative for anaesthetic activation, methanandamide inhibition and 
GPCR mediated inhibition (Mathie et al., 2010a). These residues are located at the 
interface between the final transmembrane domain (M4) and the cytoplasmic C 
terminus. This region has been suggested to transduce the signal to the gate ensuing 
the binding of the regulatory molecule instead of being part of the gate of the binding 
site(s) themselves (Andres-Enguix et al., 2007; Talley and Bayliss, 2002; Veale et al., 
2007). Another interesting thing to note is that this region is situated near A237 in 
M4, which implies that regulatory molecule affecting this region might interact with 
the activation gate too (Ashmole et al., 2009; Yuill et al., 2007). The closest finding to 
explain this hypothesis is that several researchers have noticed that TASK channels 
are mildly-sensitive to membrane potential and in the A237 TASK3 mutant, Po 
increased dramatically at a less positive voltage compared to WT (Ashmole et al., 
2009; Yuill et al., 2007). 
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1.2.2.5 Two-pore domain K+ (K2P) channels implicated in the development of PH  
 
The first clue, which pinpointed the involvement of these channels in PH, has come 
from the finding that TREK1 and TASK1 proteins are present in heart, and therefore 
could underlie the cardiac action potential (Gurney et al., 2003). This is further 
supported by RT-PCR, which detected several K2P channels such as TASK-1, 
TASK-2, THIK-1, TREK-2, and TWIK-2 are expressed in the PA, with TWIK-2 
being upregulated in hypoxia and contributed to endothelial-dependent 
hyperpolarization (Nielsen et al., 2013). The speculation that these channels are 
implicated in PH may not be surprising given the fact that they are activated 
constitutively, even at resting conditions (Gurney et al., 2003, Lotshaw, 2007). This 
feature satisfies the criteria of a channel that is hypoxia-sensitive, which are: 1) The 
channels impeded by hypoxia will depolarize membrane only if the channel is open, 
2) The channels must allow K+ passage under resting membrane potential (Lotshaw, 
2007; Nielsen et al., 2013). Functional characterization of these channels, particularly 
using anandamide or bupivacaine (putative TASK-1 blockers) has been shown to 
cause modest rise in the PA tone (Gardener et al., 2004; Nielsen et al., 2013). Recent 
findings have shown that several mutations of TASK-1 channels are connected with 
PH onset (Ma et al., 2013 and Navas Tejedor et al., 2017). Additionally, there is 
evidence suggesting that phosphorylation pathway, which leads to hypoxia-induced 
PH, are mediated through the inhibition of TASK-1 channels (Nagaraj et al., 2013; 
Tang et al., 2009). 
 
 
1.2.2.6 TASK-1 channels 
	
The current generated by TASK channels is pH-sensitive being inhibited by 
acidification due to protonation of H98, hence the name TWIK-related acid-sensitive 
K channel (Kim et al., 1999; Lopes et al., 2005; Lotshaw, 2007). TASK-1 was 
discovered first, and the TASK subfamily later expanded to include, TASK-3 
(KCNK9, K2P9) and TASK-5 (KCNK15, K2P15) (Enyedi and Czirjak, 2010). 
TASK-1 and TASK-3 are structurally closest compared to other members, and they 
also behave in similar manner where endothelial cell acidification and regulation by 
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certain factors affect both channels in the same direction (Enyedi and Czirjak, 2010). 
Interestingly, TASK-2 and TASK-4 actually do not belong to the TASK family but 
rather to TALK family, due to low amino acid sequence resemblance to TASK1 and 
are more sensitive to inhibition in the alkaline pH range (Enyedi and Czirjak, 2010).  
 
 
Involvement of TASK-1 channels in cardiac action potential 
 
The first K2P channel to be cloned from a mouse cardiac cDNA library was termed 
cTBAK-1, and was found to be distributed primarily in the heart (Kim et al., 1999). 
Duprat et al., 1997 have described the TASK-1 channel and Kim et al, 1999 have 
found that the cTBAK-1 is similar to the aforementioned TASK-1. This spurred other 
researchers to speculate the link between expression of TASK-1 in heart/PASMC and 
heart function. However, the evidence suggesting the relative abundance of TASK-1 
in the heart differs, with some investigators citing it as moderate (Duprat et al., 1999) 
while others finding high expression TASK-1 mRNA and protein in the heart (Kim et 
al., 1999; Leonoudakis et al., 1998; Putzke et al., 2007). Since TASK-3 expression 
has been found to be negligible (Y. Kim et al., 2000; Putzke et al., 2007), and the 
silent TASK-5 expression was moderate (Ashmole et al., 2001), TASK-1 is 
speculated to be the primary channels governing cardiac action potential (Enyedi and 
Czirjak, 2010). Interestingly, TASK-1 mRNA expression in rat heart increases as the 
rat developed from embryonic to adult stage (Liu and Saint, 2004). TASK-1 protein 
expression has been confirmed by Western blot and found to be localized in rat atrial 
and ventricular tissue (Jones et al., 2002; Li et al., 2006). Immunofluorescence with 
TASK-1 antibody showed that it was expressed in the intercalated disks and T-tubule 
network in the ventricular cardiomyocytes (Jones et al., 2002; Li et al., 2006). Studies 
using another TASK-1 antibody found the channel was localized throughout the 
myocardium during early development, but are exclusive to the electrical conduction 
system of the ventricles in adult mice and chicken (Graham et al., 2006).  These 
contradicting results showed that robust immunodetection of sparsely-expressed 
channels is challenging compared with highly-expressed cytoplasmic proteins 
(Enyedi and Czirjak, 2010).  
	 36	
The detection of TASK-1 expression in the heart could indicate that TASK-1 is a 
prime candidate that underlies the cardiac background current in guinea pig 
ventricular myocytes, which would mean it could also control action potential 
duration (Backx and Marban, 1993; Jones et al., 2002). Indeed, an outward K+ current 
in mouse cardiomyocytes that was perturbed by the inflammatory phospholipid, 
carbamyl-platelet activating factor (c-PAF), a non-metabolized analog of platelet 
activating factor, and showing characteristics of TASK-1 current, has been described 
(Barbuti et al., 2002). According to Barbuti et al, 2002, the c-PAF-inhibited current 
was inhibited by anandamide, methanandamide, acidosis, and Zn2+. Furthermore,  
TASK-1 expressed in CHO cells was shown to be inhibited by c-PAF (Barbuti et al., 
2002).  This effect is mediated through the PAF receptors linked to the protein kinase 
C (PKC) pathway (Barbuti et al., 2002). The researchers hypothesized that TASK-1 
has a role in PAF-induced arrhythmias, which is observed when PAF is released by 
polymorphonuclear leucocytes following ischemia (Barbuti et al., 2002). Other 
findings have supported this hypothesis where the presence of a TASK-1-like current 
in rat ventricular myocytes that lead to net outward current during the plateau phase 
of the cardiac action potential was demonstrated (Putzke et al., 2007). The same 
authors have also found that a novel TASK-1 inactivator increases the action potential  
(at 50 and 90% of total duration) (Putzke et al., 2007). However, caution has to be 
considered, given that the action potentials were recorded using a high, non-
physiological stimulation rate (4Hz) which itself gives rise to increased action 
potential duration (Putzke et al., 2007).  
There are also several pieces of contradicting evidence suggesting TASK-1 is either 
not the primary channel underlying cardiac background current nor the only channel 
involved. This is illustrated by the finding that pharmacological profiles of the 
background K+ current in rabbit were not identical to those of TASK-1 (Gurney et al., 
2003). It is well-known that cardiac action potential duration can be increased by 
a1A-adrenergic receptors stimulation due to inhibition of a sustained outward current 
(Ravens et al., 1989). Secondly, outward current inhibited by the stimulation with the 
a1A-agonist, phenylephrine was time-independent and this inhibitory effect was 
aborted by extracellular acidosis (Choisy et al., 2004). While acid-sensitivity is a 
feature of TASK-1 channel, the study concluded that acidosis had negligible effect on 
the phenylephrine-sensitive outward current when phenylephrine is absent, and this 
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current is not inhibited by TASK inhibitors such as anandamide, Zn
2+ or ruthenium 
red (Choisy et al., 2004). Additionally, the estimated single channel conductance of 
this channel was too large (at least 78pS) compared to that of a characteristic TASK-1 
channel (14pS) (Choisy et al., 2004; Kim et al., 1999). Conversely, TASK-1 could 
have high conductance as it was found that an outward current inhibited by another 
selective a1-adrenergic receptors agonist, methoxamine, was almost obliterated at 
pH6 (Putzke et al., 2007). The effect of methoxamine can be counteracted by 
a1A-adrenergic receptor blocker, 5-methyl-urapidil, thereby confirming the 
involvement of a1-adrenergic receptors (Putzke et al, 2007). Interestingly, TASK-1 
expressed in Chinese hamster ovary cells can also be reduced by methoxamine, 
strengthening the argument that the current could very well be TASK1 (Putzke et al, 
2007). It was reported that a1-adrenergic receptors couple to Gq to mediate the 
activation of phospholipase C, resulting in hydrolysis of phosphatidylinositol-4,5-
biphosphate (PIP
2
), and this finding is parallel to other studies showing that PIP2 is a 
modulator of TASK channels (Lopes et al., 2005). Angiotensin II receptor which is 
responsible for the development of arrhythmia in the context of ischemia perfusion is 
also activated via the Gq-coupled receptors pathway (Charpentier, 2007).   
Results described above have not allowed for a conclusion to be drawn. Several 
authors reported a current in the heart which is phenylephrine-sensitive and 
resembling the current carried by a voltage-gated K+ channel, Slick (Bhattacharjee et 
al., 2003; Choisy et al., 2004). This, coupled with the fact that other K2P channels 
have been shown to be present in different compartments of the heart, allows for the 
speculation that it is likely that several other channels such as TREK1 and TWIK2 
make up the cardiac background current (Liu and Saint, 2004).  
 
TASK channels support a background current in pulmonary artery smooth 
muscle cells  
 
After establishing the presence and possible involvement of TASK-1 in the heart, 
several researchers sought to perform molecular and functional studies of TASK-1 in 
the PASMC to strengthen the link of TASK-1 with PH (Gurney et al., 2010; Nielsen 
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et al., 2013; Tang et al., 2009).  Aforementioned, the pulmonary circulation behaves 
differently from the systemic circulation, in the sense that the former constricts in 
response to hypoxia to divert blood flow to better oxygenated areas of the lung, 
thereby optimizing the blood perfusion and air ventilation (Gurney et al., 2010; 
Moudgil et al., 2006). This constriction occurs due to cell depolarization, which is 
brought about by inhibition of K+ channels, opening of VGCC which causes Ca2+ 
influx (Gurney et al., 2010; Moudgil et al., 2006). The opposite occurs in the systemic 
circulation where hypoxia causes vasodilation. While the role of Kv channels such as 
Kv1.5 and Kv2.1 are well known, there is a rising consensus that K2P channels 
underlie a background current which could also have an important role (Gurney et al., 
2010; Gurney and Joshi, 2006).  
The electrophysiological data obtained from rabbit PASMC confirmed the presence 
of a non-inactivating K+ current (which persisted even after inactivation of delayed 
rectifier) that was insensitive to glibenclamide and TEA (Evans et al., 1996). This  
suggests that the current is responsible for background conductance and is an 
important regulator of the resting potential and that these features match the 
description of TASK-1 (Evans et al., 1996). Since this current was insensitive to 
classical inhibitors of Ca2+ -activated K+ channels (TEA, charybdotoxin, iberiotoxin, 
apamin), KIR channels (BaCl2) and the Na
+/K+  ATPase (ouabain, digitoxin), as well 
as non-specific K+ -channel inhibitors like quinine (0.100 M) and clofilium (1 mM; 
inhibits Kv1.5, TASK-2, KCNQ1), these channels can be ruled out (Enyedi and 
Czirjak, 2010). There are conflicting results with 4-AP, with studies showing that the 
extent of inhibition with this non-selective K+ channel inhibitor to be variable (Enyedi 
and Czirjak, 2010).  
Voltage ramp recordings in symmetrical K+ conditions have been useful in revealing 
the presence of both voltage-dependent and voltage-independent properties in the 
current, with 4-AP shown to consistently block the former (Gurney and Joshi, 2006; 
Olschewski et al., 2006). This Kv current was found to be inhibited reversibly by 
acute hypoxia in both human and rabbit (Gurney and Joshi, 2006). This would mean 
the channels carrying this current can act as an oxygen sensor and hence control the 
membrane potential (Olschewski et al. 2006).  
In other studies performed by Gurney et al, 2003, the current in question can be 
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modulated by hydrogen ions in the physiological range, with 50% activation at pH7.3. 
This observation was consistent with the properties of current in cells transfected with 
TASK-1 (Duprat et al. 1997; Patel et al. 1999). The resting potential of the PASMC 
was depolarized by 20mV at pH6.5 but hyperpolarized by mV at pH8.5 (Gurney et al, 
2003). This observation further substantiates that TASK-1 underlies a background 
current capable of regulating the resting potential.  
Other evidence supporting the notion that TASK-1 is the underlying current include 
pharmacological data which revealed that halothane activated, while Zn2+ and 
anandamide inhibited the current (Leonoudakis et al., 1998). Although it has been 
proposed that inhibition by Zn2+ will more likely influence TASK-3, others have 
confirmed that TASK-3 has a negligible presence in pulmonary arteries and therefore, 
TASK-3 can be ruled out (Clarke et al., 2004; Gardener et al., 2004). However, 
caution must be taken before jumping to the conclusion that TASK-1 is the only 
contributing factor. This is because there are several pieces of contradictory 
evidences, which showed that halothane could also sometimes inhibit the said K+ 
current and anandamide at a concentration, sufficient to inhibit 90% of the TASK-1 
current in heterologous expression systems could in reality only affect 25% of the said 
K+ current (Maingret, 2001), where it means that there are other components which 
are affected.   
However, this current has been found to be abolished while also leading to membrane 
depolarization if small interfering RNA silencing TASK-1 is applied to cells 
(Olschewski et al., 2006). This fosters the other findings that suggest TASK-1 is 
indeed the channel responsible for background conductance in PASMC and its 
perturbation by hypoxia is the reason for membrane depolarization (Olschewski et al., 
2006). Moreover, this is in line with the role of TASK-1 as an oxygen sensor in 
carotid body and cerebellar granule neurons (Gurney et al, 2003).  
Second compelling evidence to argue that TASK-1 is a contributor of K+ current is 
through the use of microelectrode studies on intact vessels from rat (Gardener et al., 
2004; Gnczi et al., 2006) rather than using isolated or cultured PASMC. The 
response of membrane potential due to pH changes and anandamide remained 
unaltered compared to isolated PASMC. Bupivacaine, a non-specific TASK channel 
inhibitor, still causes depolarization albeit less potently than anandamide. The 
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function of these inhibitors is not affected regardless of presence of classical K+ 
channels inhibitors and in endothelium-free vessels (Gardener et al., 2004).  
In contrast, prostacyclin is a physiological and therapeutic dilator of pulmonary 
arteries (Humbert et al., 2004). A prostacyclin analog, treprostinil, which is a 
prescribed treatment in PH is also believed to target TASK-1 as it was found to 
enhance PASMC current at clinically-relevant concentrations (Humbert et al., 2004). 
It is mediated via a mechanism involving cAMP-dependent phosphorylation 
(Olschewski et al., 2006). Presence of iberiotoxin does not alter the action of 
treprostinil on PASMC current, therefore, allowing BKCa channels to be ruled out 
(Olschewski et al., 2006). Interestingly, this response is abolished when small 
interfering RNA directed against TASK-1 was applied (Olschewski et al., 2006). In 
short, these data suggest that prostanoids may target a current that is carried by, or at 
least partially carried by TASK-1 channels. 
 
1.2.2.7 Mutations of TASK-1 and connection with PH 
 
Ma and colleagues (2013) have used in silico bioinformatics tools to predict 
deleterious mutation and have found a novel missense variant present at c.608 G→A 
(G203D). Furthermore, homologic modeling of hTASK-1 confirmed that G203 is 
present at the highly conserved second pore region of the protein, which is critical for 
the channel gating function (Ma et al., 2013). Another two mutations (G97R and 
V221L) were identified using whole-exome sequencing of probands from patients 
with familial pulmonary arterial hypertension (Ma et al., 2013). In addition, three 
novel mutations with heterozygous amino acid substitutions: T8K, E182K, and 
Y192C, were found during analysis of patients with sporadic pulmonary arterial 
hypertension (Ma et al., 2013). Alignment of the TASK-1 channel with other K2P 
channels reveals that most of the mutations found from their studies occurred at 
conserved residues that were likely to be critical for function and biophysical 
properties of the channel (refer topologic map in Figure 1.5) (Ma et al., 2013). 
The mutation T8K occurs at the N-terminal, which is integral for TASK-1 surface 
expression as it is required to interact with 14-3-3 proteins in order to be transported 
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out of the endoplasmic reticulum (Ma et al., 2013). G97R, G203D, Y192C and 
E182K mutations, which are located in the pore region/ selectivity filter, are 
hypothesized to cause potassium selectivity defects while V221L in the TMD could 
affect dimerization (Figure 1.5) (Ma et al., 2013). 
Electrophysiology studies confirmed that there is a reduction in K+ channel current in 
these six mutant channels (T8K, G97R, E182K, Y192C, G203D, V221L), confirming 
that they are loss of function mutations. Because TASK-1 channel is not voltage-
dependent and are open at negative potentials, these mutations probably cause 
depolarization of the resting membrane potential, which could lead to pulmonary 
artery vasoconstriction. The molecular mechanisms for loss of function probably vary 
according to the location of the mutation in the channel (Ma et al., 2013). 
 
Figure 1.5: Topologic map of the TASK-1 regions where the mutated residues are situated. Sequence 
alignment of the TASK-1 channel with other K2P channels has revealed that these residues are highly 
conserved. Adapted from (Ma et al., 2013).  
 
Besides mutations of conserved residues encoding TASK-1, Antigny and colleagues, 
2016 provided evidence that reduction in TASK-1 (or KCNK3 gene) expression could 
lead to compromised function of TASK-1 channel in human PAH and monocrotaline-
induced PH in rats. Inhibition of TASK-1 current causes membrane depolarization, 
which further brought about neomuscularization and other early haemodynamic 
events in rats that are exposed to monocrotaline (Antigny et al, 2016). Long term 
pharmacological activation of TASK-1 using the phospholipase A2 inhibitor, ONO-
RS-082, significantly reduced PH induced by monocrotaline, as long as the activator 
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is given within two weeks of monocrotaline exposure (Antigny et al, 2016). This is 
because TASK-1 expression would be completely abolished in rats that are exposed 
longer than two weeks (Antigny et al., 2016).   
 
Recently, Navas Tejedor et al, 2017 have identified two other TASK-1 mutations, 
G106R and L214R carried by three patients from two families. These mutations have 
never been identified in control populations and these patients have been confirmed 
not to carry any mutation in the other three genes, BMPR2, TBX4, and EIF2KA4, 
which are well-known for the diagnosis of PAH. Patient 1 was a Caucasian woman, 
carrying a missense mutation (c.766 T>G; p.L214R), who developed an aggressive 
form of PH at the young age of 35 (Navas Tejedor et al., 2017). Meanwhile, patient 2 
was diagnosed even earlier, at the age of 2 months, with a severe form of PH and had 
lung transplantation at age 5 (Navas Tejedor et al., 2017). Patient 2 was a carrier of a 
TASK1 missense variant (c.316G>C; p.Gly106Arg) (Navas Tejedor et al., 2017). 
Patient 3 is patient 2Õs mother, a woman who was diagnosed at age 19 with PAH at 
advanced clinical stage (Navas Tejedor et al., 2017).  
Given the fact that Patient 2 and Patient 3 belong to a high-rate consanguineous, 
Gypsi-Romani family, it is not surprising that SNP-based homozygosity mapping 
revealed that chromosome 2 which encompasses TASK-1 suffered a loss of 
heterozygosity (Navas Tejedor et al., 2017). The G106R mutation affects a highly-
conserved amino acid through evolution and can be found in C. elegans and other 15 
species (Navas Tejedor et al., 2017). The pathogenic consequences of this mutation 
have also been predicted via in silico analysis (Navas Tejedor et al., 2017). The 
mutation involved a replacement of an amino acid with aliphatic hydrophobic side 
chain to another with a basic side chain, with moderate to severe alterations in the 
physicochemical properties [Grantham distance: 125 (0 Ð 215)] (Navas Tejedor et al., 
2017). G106 is situated in between an Ôin-membraneÕ (aa 78-101) and 
ÔtransmembraneÕ (aa 108-128) regions (Navas Tejedor et al., 2017). Patient 3 was a 
heterozygous carrier for this G106R variant (Navas Tejedor et al., 2017). The father 
of Patient 2 was revealed to be an asymptomatic carrier of G106R variant, and this 
coupled with the fact that both father and mother carry the mutation, explained why 
Patient 2 is present with a homozygous TASK-1 mutation (Navas Tejedor et al., 
2017). This phenomenon leads to a double-dose allele defect, has been shown to give 
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rise to a more severe phenotype (incomplete dominance, also known as partial- or 
semi-dominance) (Navas Tejedor et al., 2017).     
 
1.2.2.8 Phosphorylation pathway which causes hypoxia-induced PH acts via 
TASK-1 inhibition 
 
Meanwhile, the pathway through which endothelin-1, ET-1 inhibits TASK-1 channels 
has been established by Tang et al., 2009.  Interestingly, similar to Kv2.1, TASK-1 
activity is also sensitive to hypoxia and the metabolic state of the cells. As stated, the 
stimulus for ET-1 biosynthesis is hypoxia. Focusing on the pathway by which ET-1 
inhibits TASK-1 channel, ET-1 binds to ETA receptors, which then activates PLC to 
cause PIP2 hydrolysis producing diacylglycerol (DAG) and inositol phosphate-3 
(IP3). DAG further activates PKC, which then phosphorylates the serine and threonine 
residues of TASK-1, to inhibit TASK-1 activity.  In contrast to the inhibitory action 
via the PKC pathway, the activity of TASK-1 in human PASMC is activated by the 
cyclic AMP (cAMP)-dependent phosphorylation induced by protein kinase A (PKA). 
For example, prostacyclin is a well-known vasodilator and the drug treprostinil (a 
stable prostacyclin analogue) activates TASK-1 via this pathway. When applying the 
cAMP analogue, 8-bromo-cAMP, an endogenous PKA activator, the same activation 
can also be achieved (Ma et al., 2013). 
Lastly, Nagaraj et al (2013) have shown that TASK-1 colocalized with the Src family 
tyrosine kinase (SrcTk) (Nagaraj et al., 2013). During normoxia, the Src is 
phosphorylated at Tyr419 rendering an active Src, which then binds to TASK-1. This 
interaction is important for TASK-1 activity to maintain negative resting membrane 
potential in hPASMC. Under hypoxia, most Src will assume a closed configuration 
where its Tyr530 is phosphorylated and this prohibit its interaction with TASK-1. 
This causes a decrease in TASK-1 current, rise in intracellular Ca2+ concentration and 
subsequently PASMC depolarization.   
 
In summary, TASK-1 orchestrates an important role in controlling the Ca2+ influx into 
PASMC and maintaining low vascular tone. Further experiments to reveal about the 
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1.3 AMIGO proteins 
	
1.3.1 Discovery of the AMIGO family  
	
In order to look for genes that are involved in neurite outgrowth on HMGB1 
(Amphoterin) substratum, Kuja-Panula et al, 2003 used ordered differential display 
(ODD) and discovered the amphoterin-induced gene and open reading frame 
(AMIGO) family (Chen et al., 2006; Kuja-Panula et al., 2003). As the name suggests, 
the expression of these genes is induced by amphoterin (HMGB1) substrate. They 
have hypothesized that the gene expression could be driven by the binding of 
HMGB1 to receptor of advanced glycation end products (RAGE), a well-known cell 
surface HMGB1 receptor (Chen et al., 2006). 
 
AMIGO family comprises of AMIGO1, AMIGO2 and AMIGO3. Kuja-Panula et al, 
2003 have identified AMIGO2 and AMIGO3 by using AMIGO amino acid sequence 
to look for other homologous proteins, with the homology between family members 
being 50-58% (Kuja-Panula et al., 2003). Meanwhile, two other groups have 
identified AMIGO2 independently and have designated it as Alivin1 and DEGA 
(Rabenau et al, 2004) respectively (Ono et al., 2003; Rabenau et al., 2004). 
 
The AMIGO family encodes a type-I transmembrane protein with six leucine-rich 
repeats (LRR) motifs (explained below) and a single Ig domain (Figure 1.6 and Table 
2). Figure 1.7 depicts the relationship between AMIGO family and other type 1 
transmembrane LRR and Ig-like domain and/or FN-III domain containing proteins, 
together with a number of other brain-enriched LRR-containing proteins (such as 
OMgp, the Nogo-66 receptor paralogues NgR, NgR2 and NgR3 and Slit).   The LRR 
motifs most closely resembles those in Slit (Whitford et al., 2002) and the Nogo 
receptor (Fournier et al., 2001) protein families, which are neuronal LRRs. The Ig 
domain is similar to the immunoglobulin V-set motifs that can be found in T-cell 
receptors and adhesion junction molecules (Kuja-Panula et al., 2003). The presence of 
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LRR and Ig domains, coupled with the fact that AMIGO1 is overexpressed during 
neurite outgrowth, suggest that AMIGO1 plays a role in cell adhesion and supports 
neurite outgrowth (Kuja-Panula et al., 2003; Ono et al., 2003; Rabenau et al., 2004). 
 
 









Figure 1.7: Nearest neighbour dendrogram showing the relationship between AMIGO family and the other type 1 transmembrane 
LRR and Ig-like domain and/or FN-III domain containing proteins, together with a number of other brain-enriched LRR-
containing proteins (such as OMgp, the Nogo-66 receptor paralogues NgR, NgR2 and NgR3 and Slit). Nyctalopin (a gene 
mutated in congenital stationary night blindness) and suprachiasmatic nucleus circadian oscillatory protein (SCOP, a brain-
enriched protein which interacts with K-Ras. Opticin is a small LRR proteoglycan expressed exclusively in the eye while 
synleurin is a ubiquitously expressed LRR-containing transmembrane protein which when ectopically expressed in cells 
intensifies their response to cytokines. LRRC4 (or NAG14) and LRRC4B (or HSM802162) are paralogues of NGL-1. 
Interestingly, LRRC4 has been shown to be exclusively expressed in the brain, is downregulated in brain tumor tissues and may 
have a role in suppression of CNS tumors. Ribonuclease inhibitor (RI) contains the prototypic LRR domain and is included for 
comparison. In the databases, one encounters various nomenclatures and annotations that may point to the same gene. According 
to the nomenclature of the Mouse Genome Informatics (MGI), NLRR1ÐNLRR3 corresponded to the genes officially annotated 
as LRRN1ÐLRRN3. LRRN4 (not shown) is similar in sequence with leucine-rich (LR) repeats and calponin homology (CH) 
domain containing 4 (LRCH4). LRRN5 is GAC-1 as mentioned in the text. LRRN6A is LINGO-1, LRRN6B is LINGO-3, and 





Interestingly, the short cytosolic tail (99 amino acids) has been well conserved during 
mammalian evolution, with the human AMIGO having 96% resemblance with the 
Placental and 90% with the Marsupial AMIGO sequences. This observation led Kuja-
Panula et al, 2003, to believe that this cytoplasmic tail might have important function 
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Table 2: Site of expression and function of several LRR/Ig-domains containing protein families 





Kajander et al, 2011 has resolved the crystal structure of AMIGO1 and suggested that 
the AMIGO1 monomer has a curved structure, where the convex face is made of 
alpha-helices and the concave face is made of beta-sheets (Figure 1.8) (Kajander et 
al., 2011). AMIGO1 also exists as a dimer, where the concave face is the site of 
interaction (Figure 1.8). AMIGO1 is heavily glycosylated, where it has been proven 
to have five glycosylation sites, as predicted in silico (Kuja-Panula et al., 2003). 
These five sites (two sites from the LRR region and three sites from the Ig domain) 
are conserved from teleost to mammals (Kuja-Panula et al., 2003). The three 
glycosylation sites presumably serve to drive the protein into the right conformation 







Figure 1.8: AMIGO1 monomer (Above), AMIGO1 dimer (Below). Adapted from Kajander et al, 2011.  
 
 
1.3.2 Expression of the AMIGOs in mouse tissues 
	
RT-PCR analysis performed in adult mouse tissues revealed that AMIGO1 is almost 
exclusively expressed in central nervous system (CNS) or nervous tissues 
(cerebellum, cerebrum, and retina) (Kuja-Panula et al., 2003). While AMIGO2 and 
AMIGO3 are also enriched in the brain, they have a wider distribution pattern (Kuja-
Panula et al., 2003). AMIGO2 has the highest expression in lung, liver, cerebellum 
and retina and is present at a detectable level in cerebrum, kidney, small intestine, 
spleen, and testis (Kuja-Panula et al., 2003). Interestingly, AMIGO3 does not have a 
specific expression distribution compared to its counterparts (Kuja-Panula et al., 
2003). Relevant to pulmonary hypertension, AMIGO2 and AMIGO3 are expressed in 
the lungs while AMIGO3 is expressed in the heart (Figure 1.9) (Kuja-Panula et al., 
2003). Genomic sequence data suggest that these three proteins are probably present 
in the puffer fish Fugu rubripes (Kuja-Panula et al., 2003). The extracellular parts of 
AMIGO family has also been demonstrated to be similar to Kek protein family 
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(encoded by kekkon genes) found in Drosophila (Musacchio and Perrimon, 1996). 
Their extracellular parts consist of six LRR motifs with cysteine-rich LRRNT and 
LRRCT domains and one Ig domain near the transmembrane region. However, there 
is no homology in their cytoplasmic parts (Kuja-Panula et al., 2003). In addition, 






Figure 1.9: mRNA expression of AMIGO1-3 in various tissues. Red box indicates the site of 






AMIGO1 expression was further studied at mRNA level using in situ hybridization 
and at protein level. Consistent with aforementioned, AMIGO antisense probe emitted 
a strong signal in both developing and adult nervous tissues (Kuja-Panula et al., 
2003). The signal was already detected in the E13 rodent embryo, at dorsal root 
ganglia, trigeminal ganglion, and CNS (Kuja-Panula et al., 2003). AMIGO1 was 
highly expressed in brain (strongest signal in the hippocampus) at later stages of 
development and in adult (Kuja-Panula et al., 2003). 
Polyclonal antisera against the extracellular 10-amino acid peptide sequence that is 
unique in AMIGO1 (not found in AMIGO2 and AMIGO3) were raised (Kuja-Panula 
et al., 2003). The anti-peptide antibodies identified the 75-kD AMIGO1-Ig fusion 
from Drosophila S2 cells and a 65-kD AMIGO1 polypeptide from crude brain 
extracts (Kuja-Panula et al., 2003). 
AMIGO was identified in the search for a gene that is induced by amphoterin to 
promote neurite outgrowth in the hippocampal neurons (Kuja-Panula et al., 2003). 
Another clue that could further prove the hypothesis that AMIGO is directly involved 
in neurite extension is the presence of LRRs and Ig domains in the proteins, which are 
well-known motifs involved in this role (Kuja-Panula et al., 2003). Moreover, 
AMIGO is present in vivo in fibre tracts, where neurite growth is prominent (Kuja-
Panula et al., 2003; Peltola et al., 2011; Zhao et al., 2014). Kuja-Panula et al, 2003, 
established that AMIGO is indeed involved, by showing that a fusion protein 
(containing the extracellular part of the AMIGO and a human IgG Fc part) 
immobilized to a microtitre well plate promotes the adhesion and neurite growth of 
hippocampal neurons, compared to the control where only the human IgG Fc portion 
was present. (Kuja-Panula et al., 2003) After 24 hours of culturing the rat 
hippocampal neurons in vitro onto the AMIGO extracellular matrix, neurite 
outgrowth was already evident (Kuja-Panula et al., 2003). When plated for four days, 
ÔfasciculationÕ, where neurites grow alongside each other by using pioneer axons as 
the substratum for their growth cones, occurs (Kuja-Panula et al., 2003). Interestingly, 
neurite outgrowth was inhibited in the presence of the soluble AMIGO-Ig fusion in 
the culture medium (Kuja-Panula et al., 2003). Therefore, there is a differential 
regulation of neurite outgrowth depending on the form of AMIGO (whether in an 
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immobilized matrix form or in soluble form). The same experiments were also 
repeated in vivo in Zebrafish CNS, where the knockdown of endogenous AMIGO or 
the dominant negative approach using the AMIGO ectodomain caused disrupted 
fasciculation of the medial longitudinal fasciculus (MLF) and post optic commissure 
(POC) fibre tracts, which are also sites where AMIGO is highly expressed during 
Zebrafish CNS development (Zhao et al., 2014). The reason for the difference in the 
ability of AMIGO1 to cause fasciculation when in ECM or soluble form might 
indicate that the protein is part of a signalling pathway, where downstream mediators 
of neurite extension are not activated if AMIGO1 is not forming a scaffold to support 
them (Kuja-Panula et al., 2003; Zhao et al., 2014).  
Next, Kuja-Panula et al., 2003 determined whether the AMIGO proteins require a 
homophilic or heterophilic binding to support neurite outgrowth. Using the bead 
aggregation assay, they have demonstrated that inhibition of homophilic binding of 
the AMIGOs between adjacent neurites will cause defasciculation. However, the 
proteins also have heterophilic binding properties, which suggest that they might have 
a cooperative role during development and in adult mammals (Kuja-Panula et al., 
2003). 
 
1.3.3.1 Colocalization of AMIGO1 with Kv2.1 
	
Staining of adult mouse CNS and mature in vitro hippocampal neurons with specific 
anti-AMIGO antibody showed that the AMIGO was found in cell soma and proximal 
part of neurites (Peltola et al., 2011). Closer observation revealed that AMIGO is 
expressed in punctate/ ring-like clusters (Peltola et al., 2011). Another protein that 
could have such peculiar staining pattern is Kv2.1 (Peltola et al., 2011). From this 
finding, Peltola et al, 2011 sought to double-stain the neurons with both AMIGO and 
Kv2.1 and they discovered that these two proteins are co-localized. The two proteins 
were also co-localized when they were expressed in heterologous system, confirming 
that they have similar temporal expression (Peltola et al., 2011). Dephosphorylation 
causes dispersion of Kv2.1 around cell membrane (Misonou et al., 2004). There are 
two notable stimuli which could induce dephosphorylation, namely hypoxia and 
glutamate treatment (Misonou et al., 2004). Misonou et al, 2004 have demonstrated 
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that CO2 treatment induced a reduction in the molecular mass of Kv2.1, due to 
dephosphorylation of the protein. This is confirmed by the Western blotting of Peltola 
et al, 2011 where the size of Kv2.1 decreased from 125 to 100 kDa after being treated 
with CO2 (Peltola et al., 2011). Strikingly, this does not prevent AMIGO protein from 
coimmunoprecipitating with the dephosphorylated, smaller form of Kv2.1 (Peltola et 
al., 2011).  To visualize the dispersion pattern of Kv2.1 and to determine whether 
AMIGO1 will display the same expression pattern, brain slices from CO2-treated mice 
were immunostained (Peltola et al., 2011). It was found that the AMIGO1 and Kv2.1 
were diffused in cortical neurons, yet the staining of both proteins was still 
concentrated in the soma and the proximal part of neurites (Peltola et al., 2011).. This 
colocalization pattern was also preserved in cultured cortical neurons that have been 
treated with glutamate (Peltola et al., 2011). This shows that AMIGO1 and Kv2.1 are 
very tightly coupled regardless of stimuli-induced dephosphorylation of Kv2.1 
(Peltola et al., 2011).  
 
When studying the evolutionary conservation of AMIGO-Kv2.1 interaction from fish 
to mammals, Zhao et al, 2014 found that, AMIGO1 is mostly expressed in the anterior 
dorsal part of the forebrain area of 28-hour post fertilization Zebrafish larvae (Zhao et 
al., 2014). This is similar to the expression pattern of a 10th-day mouse embryo. In 
adult zebrafish larvae (5-days post fertilization), AMIGO1 expression was detected in 
most brain areas that have functionally active neural circuits (Zhao et al., 2014). 
Again, this finding is similar to the situation in rodents, where AMIGO1 is found in 
postnatal brain during construction of the adult-type circuitry and is found in 
practically all areas of the CNS in most neurons and their fibers in young adults 
(Kuja-Panula et al., 2003; Peltola et al., 2011). These results could indicate that 
AMIGO1 is part of the Kv2.1 channel complex and this interaction has evolved since 





1.3.3.2 AMIGO1 changes voltage-gating properties of Kv2.1  
	
After demonstrating that AMIGO1 and Kv2.1 are colocalized and this colocalization 
is even maintained following Kv2.1 dispersion due to stimulation by glutamate or 
dephosphorylation (Peltola et al., 2011), could AMIGO1 have an impact on the 
function of Kv2.1? Peltola et al, 2011 sought to address the possibility of AMIGO1 
influencing the voltage-dependent activation of Kv2.1 and neuronal delayed rectifier 
current (Ik) (Peltola et al., 2011). They transfected HEK293 cells with either Kv2.1 
alone or in combination with AMIGO1 and recorded currents in the whole-cell 
voltage-clamp configuration. They have assessed current amplitudes and IV 
relationships of Kv2.1 and Kv2.1/AMIGO1. While there are no changes in current 
amplitudes between the two at the maximal membrane depolarization voltage tested 
(+100mV), AMIGO1 dramatically increased the current at voltages from -40mV to 
+20mV (Peltola et al., 2011).  The effect of AMIGO1 on Kv2.1 was most significant 
at the threshold of activation. When Kv2.1 was expressed alone, the cells were 
activated at around -20mV (Peltola et al., 2011). Similar to Kv9.3, AMIGO1 causes 
the Kv2.1 channels to be activated at a more hyperpolarized potential 
(Kerschensteiner, 2003; Peltola et al., 2011). Kv2.1/AMIGO1 current was already 
three-folds higher than Kv2.1 current at -20mV (Peltola et al., 2011). Control cells, 
which were transfected with Kv2.1 and a non-related type-1 transmembrane protein, 
NCAM, showed that currents were not affected by NCAM presence (Peltola et al., 
2011).  
	
The group further characterized the electrophysiological properties of Kv2.1 and 
AMIGO1 using a tail current protocol. Normalized conductance-voltage relationships 
reiterated their findings with the voltage-steps protocol, where AMIGO shifted the 
Kv2.1 activation to a more negative voltage (Peltola et al., 2011). It would be 
interesting to investigate if Kv2.1 channels will be activated even earlier when both 
AMIGO and Kv9.3 are present or when Kv9.3 is already heteromerized with Kv2.1, 
what effect will AMIGO have on the Kv2.1 current.  
 
As highlighted earlier, the cytoplasmic tail of AMIGO was hypothesized to be 
important since it was evolutionarily-conserved yet its function is yet to be 
determined (Kuja-Panula et al., 2003). Peltola et al, 2011 have elucidated the role of 
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various parts of the AMIGO protein, namely the extracellular, transmembrane, and 
cytosolic domains by swapping each of them with NCAM counterparts to produce a 
fusion protein (Peltola et al., 2011). The effect of AMIGO in shifting the Kv2.1 
current to a more hyperpolarized potential was abrogated when the transmembrane 
domain was swapped (Peltola et al., 2011). When the extracellular and cytoplasmic 
domains were swapped, AMIGO efficacy was reduced (Peltola et al., 2011). This 
suggests that the transmembrane domain could be the interaction site of Kv2.1 
(Peltola et al., 2011). However, the extracellular and cytoplasmic domains are also 
important for the Kv2.1 modulation properties yet the mechanism through which they 
act is yet to be determined.  
 
While the AMIGO1-Kv2.1 interaction is proven, there is a possibility that other 
factors could be involved to assist AMIGO1 in modulating Kv2.1 function. (Kuja-
Panula et al., 2003; Peltola et al., 2011) Further experiments to address this would be 
necessary.   
 
 
1.3.3.3 Inhibition of AMIGO1 in cultured neurons changes voltage-gated 
potassium currents  
 
To provide the evidence that AMIGO1 is important in modulating the voltage-gated 
K+ currents native cells, the group used short hairpin RNA/ inhibitory RNA in mature 
14-day old in vitro cultured hippocampal neurons (Peltola et al., 2011). At potentials 
from -40 to -20mV, neurones where endogenous AMIGO1 is inhibited showed a 39-
47% decrease in delayed rectifier current compared to controls (Peltola et al., 2011). 
At potentials over -10mV, the current closely resembles that of control. At -20mV, 
the average current densities of the AMIGO1-inhibited cells (5.13 ± 0.67 pA/pF) were 
also smaller than that in control cells (8.38 ± 1.25 pA/pF) (Peltola et al., 2011). 
 
One might suspect that hippocampal neurones may contain several different Kv 
channels, which might contribute to the delayed rectifier current, instead of Kv2.1 
alone (Peltola et al., 2011). To address this, the group treated the neurons with a 
specific Kv2.1 blocking agent named guangxitoxin (GxTX-1E) (Herrington et al., 
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2006; Peltola et al., 2011). Similar to the inhibitory RNA experiment finding, the Kv 
currents were dramatically altered, confirming that the experimental setup of the 
group partially addressed this limitation (Peltola et al., 2011). The result obtained 
from neurons where AMIGO is inhibited is opposite to neurons with overexpression 
of AMIGO (Peltola et al., 2011). This confirmed the hypothesis that AMIGO is an 
auxiliary subunit of Kv2.1 (Peltola et al., 2011).  
 
In experiments performed in Zebrafish, Zhao et al, 2014 looked at whether the 
inhibition of Kv2.1 in AMIGO1 knockdown morphants created using morpholino 
oligonucleotides could be rescued by restoring Kv2.1 protein expression by co-
injecting Kv2.1 mRNA with the morpholino oligonucleotides. Although the rescue 
effect was not obvious in defects of early (1-5dpf) tract development, there were clear 
rescue effects in behavioural phenotypes indicative of functionally active neural 
circuitries (Zhao et al., 2014). Where Kv2.1 is restored, anatomical connectivity was 
restored to a level sufficient to perform normal sensorimotor functions (Zhao et al., 
2014). The lack of rescue effect in the early tract development could be explained by 
the fact that AMIGO1 and Kv2.1 do not colocalize, even though they are both 
expressed, in early developing brain (Zhao et al., 2014). In mature brain however, 
these two proteins colocalize (Zhao et al., 2014). 
 
 
1.3.3.4 AMIGO1 regulates Kv2.1 protein expression and voltage-gated potassium 
currents  
 
Besides studying the AMIGO1-Kv2.1 interaction in heterologous expression system 
(HEK-293 cells) and in Zebrafish, this interaction has also been studied in vivo in 
mammals using an AMIGO-knockout mouse line (Peltola et al., 2016). The mice bred 
normally without any visible signs of defects in normal caged environment, with no 
appreciable difference observed in Luxol fast blue/cresyl violet staining and 
immunohistochemical staining with common markers for neurons and glia between 
knockout (KO) and wild type (WT) mice (Peltola et al., 2016). However, there is a 
remarkable reduction in Kv2.1 staining in adult mouse brain sections of KO mice 
(Peltola et al., 2016).  The extent of staining was quantified to be 45% less in KO 
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mice when Western blotting with samples made from adult mouse brain membrane 
was performed (Peltola et al., 2016). As a control, Western blot was performed to 
quantify Kv1.2 band intensity and there was no difference between WT and KO 
(Peltola et al., 2016).  
 
 
1.3.3.5 AMIGO1 KO mice displayed disrupted complex behavioural traits, 
possibly due to lack of AMIGO-Kv2.1 interaction 
 
Similar to the findings in in vitro systems, Peltola et al., 2016 reported a reduction in 
the Kv currents at negative membrane potentials around the action potential threshold 
in AMIGO KO mice. As with the hippocampal neurons, there are several types of Kv 
channels expressed in the pyramidal neurons. The group suspected that the 
phenomenon where AMIGO KO mice exhibiting the current reduction can be 
explained by Kv2.1 dysfunction due to lack of AMIGO/Kv2.1 interaction (Peltola et 
al., 2016).  
	
	
1.3.3.6 AMIGO1 knockout mice have altered complex behavioural traits that 
resemble schizophrenia  
 
While AMIGO KO mice displayed normal traits in nociception and motor co-
ordination, studies of more complex behavioural traits revealed some differences 
(Peltola et al., 2016).  AMIGO KO mice travelled more (158%) in the open field test 
arena, in a given test period compared to their WT littermates which suggests that the 
AMIGO KO mice are hyperactive (Peltola et al., 2016). When AMIGO KO and WT 
mice were treated with a low dose of the psychotomimetic drug, MK-801, the 
hyperactivity phenotype was significantly increased in the KO mice, while there was 
no apparent difference in WT mice (Peltola et al., 2016).  These observations were 
also confirmed in AMIGO-deficient Zebrafish larvae (3dpf). This could explain that 




Secondly, AMIGO1 KO mice showed reduced sensorimotor gating compared to WT 
mice (Peltola et al., 2016). Sensorimotor gating allows animals to automatically filter 
out non-related information from important information (Powell et al., 2012). This is 
important for animals to cope in a complex environment (Powell et al., 2012). This 
gating ability was be assessed by measuring the startle response of an animal during 
prepulse inhibition (PPI) (Powell et al., 2012). PPI is a phenomenon whereby a 
weaker prestimulus (prepulse) blocks the reaction of an organism towards a 
subsequent stronger startling stimulus (pulse) (Powell et al., 2012). Strikingly, the 
observation of PPI deficit is well-known in schizophrenia patients (Powell et al., 
2012). This effect of PPI reduction can be remedied by the antipsychotic drug 
haloperidol (Kumari and Sharma, 2002). Treating the AMIGO1 KO mice with 
haloperidol shifted their PPI to normal values observed in their WT counterparts 
(Peltola et al., 2016).  
 
In order to test the difference in social behaviours between WT and AMIGO1 KO 
mice, Peltola et al, 2016 have employed two tests; the resident intruder test and the 
tube test. The resident intruder test assesses how well the mice cope with social stress 
while the tube test determines dominant and subdominant behaviour (Peltola et al., 
2016).. While WT and AMIGO1 KO mice showed no difference in the resident 
intruder test, AMIGO1 KO mice lost significantly more trials than WT mice, 
suggesting that AMIGO1 deficiency contributes to a subdominant behaviour (Peltola 
et al., 2016). 
 
Lastly, the memory consolidation tests were performed to investigate the difference 
between WT and AMIGO1 KO mice (Peltola et al., 2016).. Initially, the group 
employed the Morris water maze for the purpose but upon finding no difference 
between WT and AMIGO1 KO mice, they proceeded to use an IntelliCage to study 
memory consolidation more closely (Peltola et al., 2016). IntelliCage allows the 
screening of several cognitive and behavioural traits of mice living in social groups 
(Peltola et al., 2016).. One of the tasks assessed was ÔpatrollingÕ where a mouse has to 
learn that the ÔcorrectÕ corner is changed in a clockwise manner after every ÔcorrectÕ 
visit (Peltola et al., 2016).. Similar to the 8-arm radial maze, ÔpatrollingÕ serves to 
measure behavioural flexibility and working memory (Too et al., 2014). Peltola et al., 
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2016  reported that the AMIGO1 KO mice showed memory deficiency while 
performing this task.  
 
1.3.3.7 Behavioural changes in AMIGO1-knockout mice resemble schizophrenia  
 
Taken together, AMIGO1 KO mice displayed the four main behavioural features of 
schizophrenia, which are hyperactivity, PPI deficit, subdominant behaviour and 
memory deficiency (Gainetdinov et al., 2001; Huang et al., 2014; Papaleo et al., 
2012). This is possibly not surprising considering that the mouse AMIGO2 (ali1) was 
mapped to a locus 55.3 cm from the centromere on chromosome 15 that is syntenic to 
positional candidate loci for familial AlzheimerÕs disease type 5 and ParkinsonÕs 
disease 8 on human chromosome 12 (Ono et al., 2003). 
 
This finding led Peltola et al., 2016  to speculate that the human AMIGO1 gene is a 
potential candidate gene for schizophrenia. In the adult human CNS, AMIGO might 
be an important component to fine-tune Kv2.1 function and loss of AMIGO and 
hence of Kv2.1, could lead to neurons overexcitability, which in turn could cause an 
overactive CNS (Peltola et al., 2016). Several research groups have published 
evidences that hyperactivity in different brain areas controlling different functions is 
linked with schizophrenia (del Pino et al., 2013; Huffaker et al., 2009; Suh et al., 
2013). Coincidentally, Speca et al., 2014 have shown that Kv2.1 deficiency in mice 
also displayed hyperactive behaviours comparable to the ones observed in AMIGO1 
KO mice. This further strengthens the notion that AMIGO1 mediates its function 
through Kv2.1.  
	
While the role of AMIGO1 has been extensively researched in the brain, the roles of 
AMIGO2 and AMIGO3 remain underexplored. The electrophysiological and 
behavioural alterations due to interrupted AMIGO1-Kv2.1 interaction are striking. It 
would be interesting to probe as to whether disrupted AMIGO2- and AMIGO3-Kv2.1 






As mentioned above, Ono et al, 2003 discovered AMIGO2 separately from Kuja-
Panula et al, 2003 and have designated AMIGO2 as Alivin1 (ali1), after ÒaliveÓ and 
Òactivity-dependent leucine-rich repeat and Ig superfamily survival-related proteinÓ. 
Interestingly, the mRNA expression of ali1 in cultured cerebellar granule neurons are 
upregulated by high (25mM) KCl and/or NMDA concentrations and inhibited by low 
(5mM) KCl concentration in the culture medium, which triggered apoptosis (Ono et 
al., 2003). The upregulation could be explained by the observation that when cells 
were stimulated by 25mM KCl, Ca2+ influx through voltage-dependent L-type Ca2+ 
channels was permitted (Experimented using nifedipine, a specific antagonist for 
voltage- dependent L-type Ca2+  channels) (Ono et al., 2003). These results indicate 
that ali1 mRNA expression is tightly linked with the depolarization-dependent 
survival and/or NMDA-dependent survival state of the granule neuron (Ono et al., 
2003). 
  
Besides Ono et al, 2003, another group, Rabenau et al, 2004 also discovered 
AMIGO2 which they designated as DEGA, after Òdifferentially expressed in human 
gastric adenocarcinomasÓ. DEGA encodes a protein with a signal peptide, five 
leucine-rich repeat motifs, and a single IgG and transmembrane domain (Rabenau et 
al., 2004). Similar to the finding of Kuja-Panula et al., 2003 and Ono et al., 2003, they 
have reported that the function of the cytosolic domain of the protein is still unknown.   
Since an algorithm analysis revealed that approximately one-fifth of the residues are 
either serine or threonine, they have postulated that this might be a docking site for 
signalling pathway intermediates and thus AMIGO2 might be important for signal 
transduction via the phosphorylation pathway (Rabenau et al., 2004). 
In Rabenau et al, 2004Õs studies, ~45% of tumor has reduced DEGA/AMIGO2 
mRNA expression compared to normal tissue from gastric adenocarcinoma patients. 
To further confirm their observation, they have performed a gene-silencing study by 
establishing a DEGA/AMIGO-2 antisense construct in the gastric adenocarcinoma 
cell line (AGS) and found that cells where the AMIGO2 gene is silenced displayed 
morphology change, increased ploidy, chromosomal instability, reduced cell adhesion 
to and migration through collagen (Rabenau et al., 2004). 
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Interestingly, AMIGO2 suppression also led to inhibition of tumourigenicity in nude 
mice although the mechanism is not fully understood (Rabenau et al., 2004). A reason 
proposed by the group based on Kuja-Panula et al, 2003 and their findings is that 
AMIGO2 might be important for tumor adhesion since it acts as a cell adhesion 
signalling molecule. And when the adhesion process is jeopardized, the tumor fails to 
develop (Rabenau et al., 2004). This hypothesis drew similarity to the finding of 
Mafune and Ravikumar, 1992 where silencing of laminin-binding protein expression 
inhibits the adhesion and invasion in a human colon carcinoma cell line. Conversely, 
the loss of E-cadherin (also an adhesion molecule) in gastric cancer cells lead to 
metastasis (Rabenau et al., 2004). This could mean that AMIGO2 might be needed for 
metastasis (Rabenau et al., 2004). The third hypothesis stems from the fact that 
AMIGO2 silencing renders chromosomal instability, which could further inhibit 
several genes that are needed for tumorigenicity of AGS cells (Rabenau et al., 2004). 
An evidence supporting this would be the finding that cells with extra copies of the X 
chromosome and chromosome 18 that carry the ING and DCC tumor suppressors, 




It was widely believed that when myelin-derived inhibitory molecules bind to Nogo-
Receptor (NgR1) and transmembrane receptor, p75/TROY or LINGO1, axon 
regeneration will be inhibited (Ahmed et al., 2013; Fournier et al., 2001; Whitford et 
al., 2002). Although, Chen et al, 2006, suggested that LINGO1 could be an interacting 
partner of NgR1/p75 complex (refer Table 2), a result published by Ahmed et al, 2015 
indicated that AMIGO3 might the interacting partner instead of LINGO1. This is due 
to several reasons: 1) AMIGO3 mRNA and protein levels are significantly increased 
in dorsal root ganglion neuron (DRGN) and retinal ganglion cell following central 
axotomy while LINGO1 expression remains unchanged; 2) Using 
Immunoprecipitation and Western blot techniques, the interaction between AMIGO3 
and NgR1 and p75/TROY is established; 3) AMIGO3 silencing is linked with dorsal 
column (DC) and optic nerve regeneration 4) Following simulation by appropriate 
neurotrophic factors (NTF), AMIGO3 silencing also promotes DRGN and RGC 
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neurite outgrowth in cultures where CNS myelin extracts (CME) have been initially 
added to inhibit such outgrowth (Ahmed et al., 2013). The finding that AMIGO3 
promotes neuronal apoptosis is surprising, considering the fact that its other family 
members, AMIGO1 and AMIGO2, are involved in promoting neuronal survival. 
  
Since AMIGO3 is expressed in both lung and heart (two anatomies important in 
pulmonary hypertension), AMIGO3 could have a role in the pathogenesis of PH 
(Kuja-Panula et al., 2003). The pro-apoptotic nature of AMIGO3 could be beneficial 
in the context of pulmonary vascular remodelling (Huang et al., 2010).  
Another study by Ahn and colleagues (2015) investigated the anti-aging effect of rats 
treated with Gryllus bimaculatus extracts (which are extracts from Gryllus 
bimaculatus crickets that inhibits oxidation at DNA level, evident in the reduced level 
of 8-hydroxy-2Õ-deoxyguanosine (8-OHdG)). In contrast to untreated rats, rats treated 
with the extract showed upregulation of 1053 genes, including AMIGO3 (Ahn et al., 
2015). Although it is difficult to conclude that AMIGO3 might be directly linked with 
the anti-oxidative response and hence the anti-aging effect, it is still tempting to 




Aims and objectives 
Chapter 3 aims to assess the regulation of Kv2.1 by Kv9.3 in tsA-201 cells using 
whole-cell voltage-clamp recording. This chapter also aims to investigate the effect of 
a reactive oxygen species generating enzyme, Nox4 on cells transiently transfected 
with Kv2.1 and Kv2.1/Kv9.3. Our hypotheses are that co-expression of Kv9.3 will 
increase the current amplitude of Kv2.1, causes Kv2.1 to be activated earlier, as well 
as prolong the time constant of deactivation of Kv2.1. With regards to the effect of 
Nox4, we hypothesize that Nox4 will reduce the current amplitude of Kv2.1 and 
Kv2.1/Kv9.3 since reactive oxygen species have been shown to inhibit Kv current. 
This chapter continues to investigate the effect of a Kv2 channel blocker, stromatoxin 
(ScTx), on Kv2.1, Kv2.1/Kv9.3, Kv2.1/Nox4, and Kv2.1/Kv9.3/Nox4. Our 
hypotheses are ScTx reduces the current amplitude of Kv2.1, Kv2.1/Kv9.3, 
Kv2.1/Nox4, and Kv2.1/Kv9.3/Nox4, causes the channels to be activated later and 
will shorten the time constant of inactivation of the channels.  
 
Chapter 4 aims to assess the presence of Kv2.1 and Kv9.3 in rat lungs and hearts. We 
are interested in testing our hypothesis that both Kv2.1 and Kv9.3 are expressed in rat 
lungs and hearts. Since we are testing a novel commercial anti-Kv9.3 antibody, we 
only sought to answer if Kv9.3 channel is expressed in the rat lungs and hearts and 
which cell types express them using immunocytochemistry.  
 
Chapter 5 aims to investigate the modulation of TASK-1 by Nox4 and chloramine T 
(Ch-T). In particular this chapter aims to investigate the regulation of WT TASK-1 
and the gain-of-function K2N R3Q mutant TASK-1 by Nox4 under normoxic 
conditions. Since TASK-1 mutation which caused a reduction in function has been 
implicated in pulmonary arterial hypertension, we hypothesise that co-expression of 
Nox4, a reactive oxygen species producer, will reduce TASK-1 current amplitude. 
TASK-1 protein, when retained by a protein called COP1 in the endoplasmic 
reticulum, causes the channel to produce a very small current. The K2N R3Q mutant 
TASK-1, however, has its retention signal, KR, being mutated to NQ, thereby 
preventing COP1 from retaining the channel. Higher expression of the TASK-1 
channel at the cell surface membrane increases the outward current carried by the 
channel. Our hypothesis is that K2N R3Q mutant could rescue TASK-1 current that is 
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inhibited by Nox4. This chapter also investigates the regulation of TASK-1 channels 
in the presence of a reactive oxygen species agent, Ch-T which produces singlet 
oxygen. Ch-T has been found to differentially affect other K2P channels such as 
TASK-2, TALK-1, and TALK-2 channels. We hypothesise that Ch-T will reduce 
WT-TASK-1 and K2N R3Q mutant TASK-1 currents.  
 
Chapter 6 evaluates the modulation of Kv2.1, Kv2.1/Kv9.3, Kv2.1/Nox4, and 
Kv2.1/Kv9.3/Nox4 by various redox agents such as hydrogen peroxide (H2O2), DTT 
and DTNB. The effect of Ch-T on Kv2.1 and Kv2.1/Kv9.3 was also assessed. We 
tested the hypotheses that these redox agents will reduce the current amplitudes of 
Kv2.1 and Kv2.1/Kv9.3. We then consider how Kv2.1 and Kv9.3 can be differentially 
regulated by a family of cell adhesion molecules called amphoterin-induced gene and 
open reading frame (AMIGO) proteins. This study sought to probe what are the 
consequences in terms of current amplitude, activation threshold, and deactivation 
kinetics if AMIGO proteins are co-expressed with Kv2.1 and Kv2.1/Kv9.3. We 
hypothesized that AMIGO proteins will increase the current amplitude of Kv2.1 and 
Kv2.1/Kv9.3 and cause the channels to be activated earlier and decelerate the 
deactivation kinetics of these channels. In addition, AMIGO2 overexpression has 
been demonstrated to protect cells treated with hydrogen peroxide from cell death. 
Thus, the co-expression of AMIGO2 in the presence of H2O2 was also investigated. 
Our hypothesis for this study is that AMIGO2 will interact with H2O2 in regulating 






Chapter 2: Materials and Methods 
 
2.1 Plasmid preparation and sequencing 
 
Plasmid preparation is performed to multiply the stock of DNA before it can be used 
for transient transfection. First, the DNA is transformed into Escherichia coli and as 
the bacteria multiply, the plasmid DNA that have been taken up are also multiplied. 
Plasmid vectors usually encode one or more antibiotic resistance genes to allow easy 
selection. This is because the bacterium that have taken up the plasmid DNA will 
grow in a culture where an antibiotic such as ampicillin or kanamycin has been added, 
while the bacterium void of the plasmid will not survive in the culture.   
 
In order to extract the plasmid DNA, bacteria are lysed under alkaline conditions to 
denature the bacterial chromosomal DNA and protein. This is followed by 
neutralization and adjustment to high-salt binding conditions in one step. Lysates are 
cleared by centrifugation and are now ready for purification. Common commercial 
kits for purification are available and these kits are named according to the desired 
plasmid yield, such as miniprep, midiprep, maxiprep, megaprep, and gigaprep. Since 
the desired amount of plasmid DNA is small, the QIAprep Spin Miniprep kit (Qiagen, 
The Netherlands) is the most commonly used kit in our lab. A miniprep usually gives 
a plasmid DNA yield of 50 to 100µg. The DNA concentration was measured using 
the Nanodrop spectrophotometer (Implen, Germany) based on the absorbance at 
260nm. This is because nucleic acids have absorbance maxima at this wavelength. 
The ratio of this absorbance maximum to the absorbance at 280nm, also known as the 
260/280 ratio, is an indicator of DNA purity. In our experiments, a 260/280 ratio of ~ 
1.8 was used as an indication that the DNA is ÔpureÕ.  The integrity of the plasmid 
DNA sequence was verified via sequencing. This is a common quality control step 





2.2 Cell culture 
 
The tsA-201 cell line is a transformed human embryonic kidney-293 (HEK-293) cell 
line stably expressing an SV40 temperature-sensitive T antigen. This cell line is 
commonly used in functional expression assays and is ideal for expression of 
recombinant proteins. Mycoplasma has been removed from the cells at European 
Collection of Cell Cultures (ECACC). The identity of both tsA-201 and HEK-293 
have been verified by short tandem repeat (STR) profiling. 
 
Since the transfection efficiency decreases over a period of several months, a frozen 
stock is usually stored as reserve. Recovery of frozen cells from the -80¡C freezer or 
liquid nitrogen is done by releasing the residual liquid nitrogen that is trapped in the 
ampoule, and then defrosting the cells in a 37¡C water bath. The cells are then 
transferred into a tube containing pre-warmed media. The suspended cells are then 
centrifuged to remove any cryoprotectant (DMSO in our case). The supernatant is 
removed and the remaining cell pellet is resuspended in fresh media. The suspension 
is then transferred to a flask and incubated at 37¡C overnight.  
 
tsA-201 cells are routinely passaged either to be cultured into a new flask or grown as 
a monolayer on a poly-D-lysine-coated glass coverslip to be used for 
electrophysiology. Cells are ready to be passaged when they have reached 70-80% 
confluency. First, the morphology of the cells is checked to ensure that they are 
healthy. If the colour of the media has turned yellow, this is either a sign of 
contamination or that the cells are over confluent. The cells are dissociated from the 
flask wall using trypsin and are then re-suspended using media containing DulbeccoÕs 
modified eagleÕs medium (DMEM) (Sigma: #D5671, Germany) supplemented with 
10% heat-inactivated fetal bovine serum (HIFBS) (Sigma #F9665, Germany), 1% 
penicillin and 10mg/ml streptomycin (Sigma #G1146, Germany), 1% non-essential 
amino acids Solution (NEAA) (Sigma #M7145, Germany), and 2mM L-Glutamine 
(Sigma #G7513, Germany). The solution is then centrifuged. The supernatant is 
removed, leaving the cells at the bottom of the tube undisturbed. The cells are then 
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suspended with fresh media and the suspension is either distributed into a new flask 





Transfection is the process of inserting nucleic acids by non-viral methods into a 
eukaryotic cell. In our experiments, cDNAs were introduced into tsA-201 cells via 
calcium phosphate precipitation method. Transfection can be stable or transient, 
where the nucleic acids transfected into the cell are not permanently incorporated into 
the cellular genome.  
 
Nucleic acids can be delivered into a cell via viral or non-viral methods. The viral 
method exploits the virusÕs ability to inject its DNA into a host cell. Meanwhile, some 
of the well-known non-viral methods include calcium phosphate precipitation, 
electroporation or by lipofection. Since transfection is performed extensively in our 
lab, the calcium phosphate precipitation method is employed as it is a reliable and 
economical method.  Besides, it has been documented that the calcium phosphate 
method is an effective transfection method for tsA-201 cells (Chen and Okayama, 
1987).  
 
The calcium phosphate method was devised by F. L. Graham and A. J. van der Eb in 
1973. 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid	 (HEPES)-buffered saline 
solution, together with Na2HPO4 are combined with the CaCl2 solution containing the 
DNA to be transfected. This results in the formation of calcium phosphate precipitate 
that binds the DNA on its surface (Graham and van der Eb, 1973). The fine 
precipitate is usually suspended in the solution and this suspension is then distributed 
to the cells that have been cultured on a glass coverslip in a four-well plate (Graham 
and van der Eb, 1973). When the precipitate adsorbed to the cells, the DNA uptake 
occurs during an incubation in a liquid medium at 37¡C in the continued presence of 
extra calcium chloride (Graham and van der Eb, 1973). After 4-6 hours of incubation, 
the cells are washed with pre-warmed PBS (Graham and van der Eb, 1973). Fresh 
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media, as mentioned in the cell culture section above, are added and the cells are 
further incubated at 37¡C overnight. The cells are now ready to be used.  
 
The final amount of cDNAs of the Kv channels and GFP in each of the well of a four-
well plate was 500ng. An example of calculation is as follows: 
The following is prepared in tube A: The concentration of the Kv2.1 cDNA is 
447ng/µl so, the volume of Kv2.1 cDNA that contains 500ng is 500/447 = 1.12µl.  
The concentration of the GFP cDNA is 232ng/µl so, the volume of GFP cDNA that 
contains 500ng is 500/232 = 2.16µl.  The optimum final concentration of CaCl2 is 
225mM so the volume of CaCl2 from the stock solution of 2M needed to achieve a 
final concentration of 225mM in a total volume of 25 µl is 2.81µl. Water is added 
until the volume in each well is 25µl.  
 
The following is prepared in tube B: The phosphate-free buffer is a mixture of 
280mM NaCl and 50mM HEPES, pH 6.95.   A final concentration of Na2HPO4 of 
1.8mM is optimum for transfection. Na2HPO4 is usually prepared from a stock 
solution with the concentration of 100mM. Therefore, the volume of Na2HPO4 needed 
from the stock solution to achieve 1.8mM is 0.45µl.  
	
The content of tube A is added dropwise to tube B. The mixture is then incubated at 
room temperature for 5 to 15 mins to allow a CaPO4/DNA precipitate to form. 
Contents of the tube is mixed by pipetting up and down gently, before being 
distributed dropwise into the well, onto the cells cultured on a glass coverslip. Cells 
are placed back into incubator for six hours. After six hours, PBS and media are 
warmed in water bath to 37¼C for 30 mins. Cells are washed twice with PBS and 
0.5ml of media is added to each well. Cells are placed back in incubator overnight and 
ready to use for patch-clamping the next day.  
Tube A Tube B 
 1.12µl DNA (0.5 µg) 25 µl phosphate-free Buffer (HEPES) 
2.16µl GFP (0.5 µg) 0.45 µl Na2HPO4 
2.81µl CaCl2 (2 M)  
  18.91µl H2O (up to 25 µl)  
	
Table 3: Example of calculation for the required volume of reagents in calcium phosphate transfection 




Figure 2.1: Image of tsA-201 cells transfected with gene of interest and green fluorescent protein 
(GFP). Two out of six tsA-201 cells are successfully transfected with the gene of interest and GFP 
appeared green under the light microscope. Scale bar is 10µm. Adapted from Thomas and Smart, 2005.   
	
2.4 Patch-clamp electrophysiology 
Patch-clamp electrophysiology is a technique that allows real-time measurements of 
ion channel function either through a single channel, also known as the cell-attached 
patch configuration, inside-out and outside-out configurations, and macroscopic 
currents from the whole-cell. It is worth noting that the data acquired from this 
technique can be interpreted quantitatively, making it a valuable technique for 
researchers (Akita et al., 2012). 
 
Thanks to the improvisation by Hamill et al, 1981, measurement of membrane 
potential and currents from small cells was possible (Akita et al., 2012). This was 
done by pressing a patch electrode onto a cell surface to form a gigaohm seal with the 
cell membrane and by rupturing a piece of membrane that lies directly below the 
electrode by applying a negative pressure (i.e., suction). This causes the electrolyte in 
the microelectrode (internal solution in pipette) and the intracellular solution to 
become as one and this is what is called as whole-cell patch configuration. Such 
improvement also allowed the measurement of the cell capacitance (Neher and Marty, 
1982).   
 
Whole-cell recording occurs when the interior of the pipette becomes continuous with 
the cell cytoplasm, and this allows the measurement of the potential difference and 
current of the entire cell. Meanwhile, single channel recording, as the name suggests, 
allows the measurement current through a single channel at a given potential.  
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Voltage-clamp and Current clamp 
Voltage-clamp electrophysiology controls the voltage across the membrane at a 
certain value so that the current flowing can be measured (Akita et al., 2012). 
Conversely, current-clamp injects current in order to measure the potential difference. 
When current is clamped at 0 (I= 0), the resting membrane potential is measured 
(Akita et al., 2012).   
 
In voltage-clamp, there is an internal electrode which is in contacted with the inside of 
the cell and an amplifier that measures the membrane voltage (Vm) and an external 
electrode which serves as a reference electrode and is inserted in the bath solution 
(Akita et al., 2012). Meanwhile, the command voltage, Vc, is the desired membrane 
potential that is set by the researcher (Akita et al., 2012). In our system, we are using 
the same electrode to inject current and to measure the Vm.  
 
The difference between Vm and Vc is measured by a comparator. If Vm is not equal 
to Vc, the comparator generates a Ôdifference signalÕ (Akita et al., 2012). Sensing the 
signal, the amplifier injects a current into the axon via a current-passing electrode in 
order to make Vm equal to Vc (Akita et al., 2012). This feedback circuit works almost 
instantaneously and keeps Vm as close to Vc as possible (Akita et al., 2012). The 
injected current that is needed to keep Vm as close to Vc can be recorded and 
measured. This means that as voltage-gated ion channel opens or closes over time in 
response to the change in Vm imposed by the voltage clamp, the current generated 
can be recorded and analyzed (Akita et al., 2012).  
 
For example, say the Vc is clamped at 0mV and the Vm is at -65mV, a very brief 
capacitive current is seen, followed by a transient inward and outward currents 
depending on the ionic conductance at the voltage (Akita et al., 2012). The capacitive 
current is initiated because the step from one potential to another alters the charge 
separation, thus causing a potential difference across the membrane (Akita et al., 
2012). Once the new potential is reached, there is no capacitive current (Akita et al., 
2012). Thus, the capacitive current is a transient occurrence (Akita et al., 2012). 
Series resistance is the resistance due to components other than that of the cell 
membrane and consists mostly of component of the pipette shank and a component of 
the pipette tip that contains some broken patch membranes (Akita et al., 2012). The 
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presence of series resistance prevents Vm from getting closer to the Vc as the larger 
series resistance and cell capacitance, the longer is the time needed to reach Vc since 
the time constant for slow capacitive surge, t = series resistance ´ cell capacitance 
(Akita et al., 2012). Secondly, a voltage drop across series resistance will occur, 
yielding an error in the Vc, when a large current in generated in the whole-cell mode 
(Akita et al., 2012). Even when constant Vc is applied, the varying current amplitude 
and series resistance will cause Vm to vary accordingly (Akita et al., 2012). In short, 
the presence of series resistance prevents accurate voltage-clamping. Series resistance 
can be compensated by tuning the potentiometer linked to the current output 
(indicated with SR compensation on the monitor) (Akita et al., 2012). The whole-cell, 
voltage-clamp setup is used in all the electrophysiological experiments described in 
this thesis.  
  
Whole-cell currents were recorded using an Axopatch 200A amplifier (Axon 
Instruments, USA). Currents were digitized using a Digidata 1200 Interface (Axon 
Instruments, USA), and analyzed using pClamp 10.2 software (Axon Instruments, 
USA). Pipettes were fabricated from borosilicate glass using the micropipette puller. 
Pipettes are polished to a final resistance of 4-6MΩ. The external bath solution 
contained the following: NaCl, 145 mM; KCl, 2.5 mM; CaCl2, 1 mM; MgCl2, 3 mM; 
HEPES, 10 mM; pH adjusted to pH 7.4 with NaOH. The internal pipette solution 
contained KCl, 150 mM; MgCl2 3mM; EGTA, 5 mM; HEPES, 10 mM; pH adjusted 





¥! Standard voltage-step protocol 
The standard voltage-step protocol in this study consist of a voltage-step and a 
repolarization step (Figure 2.2). However, this project is only interested in the 
analysis of currents measured at the voltage-step and the time constant measured at 
the repolarization step. The holding potential was -60mV. Test pulses to potentials 
ranging from -100mV to +50mV for a duration of 500ms each sweep was applied in 
10mV increments. In order to better visualize the difference between Kv2.1 and 
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Kv2.1/Kv9.3, Nox4/Kv2.1, and Nox4/Kv2.1/Kv9.3, the ratio of current measured at 
each step to current at +50mV is also determined.  
 
The first variant of protocol repolarized from every potential (-100mV till +50mV) to 
-80mV. However, modification was made when the currents were repolarized to -
50mV for two reasons: 1) to allow measurement of time constant of inactivation and 
2) direct comparison with the data from Zhong et al, 2010.  
 
Figure 2.2: Standard voltage-step protocol. The main steps in this protocol are the voltage-step and the 
repolarization step. Test pulses to potentials ranging from -100mV to +50mV for a duration of 500ms 
each sweep was applied in 10mV increments before being repolarized to -80mV in the first variant or 










¥! Open-state inactivation protocol 
Test pulses to depolarize the membrane to potentials of high open probability 
(+40mV) were given for 32s. Ratio of current measured at the end to current 




Figure 2.3: Open-state inactivation protocol. Cell membrane was held at -60mV and then depolarized 
to -80mV. Test pulse to +40mV to depolarize the membrane to high open probability was given for 
32s. Membrane is then repolarized to -80mV before being returned to holding potential of -60mV. 
 
¥! Closed-state inactivation protocol 
Test pulses to +40mV were given at the beginning and end of each sweep. The length 
of time at which the second pulse is given after the first is increased by 2s for every 
sweep. For example, the first trace comprised of the test pulse of +40mV given at the 
beginning and another pulse is given two seconds later. In the second trace, the first 
pulse is given at the beginning and then four seconds later. This continued for each 
subsequent trace and the last trace comprised of a test pulse at the beginning and at 
28s later. The ratio of the current at the second pulse to that of the first (Ipn/Ip) is 
determined and is proportional to the number of channels that did not inactivate 
(Figure 2.4). Since we are mostly interested in the current at the first pulse and the last 
pulse, a short version of the protocol which include the first trace and the last trace, 








Figure 2.4: Closed-state inactivation protocol. In the first trace, a test pulse to +40mV were given at the 
beginning and a second pulse was given two seconds later. In the second trace, the second pulse were 
given four seconds after the first. In every subsequent trace, the period from the first pulse is increased 
by two seconds. This continued until the 14th trace, where the period between the first pulse and the 
second pulse is 28s. The ratio of the current at the second pulse to that of the first (Ipn/Ip) is 
determined and is proportional to the number of channels that did not inactivate. A shorter version of 
the protocol comprising of the first and 14th trace is created since we are mostly interested in the 






¥! TASK-1 channel protocol 
 
The electrophysiology protocol has a voltage-step and a voltage-ramp part. Only 
currents measured in the voltage-step part will be considered. Currents were measured 
at the resting membrane potential, -80mV, and at the stimulating pulse of -40mV, 
which was given for 500ms (Figure 2.5). The difference between the current 




Figure 2.5: TASK-1 protocol. Membrane is hyperpolarized from -60mV to -80mV and is then 
depolarized to -40mV for a duration of 500ms. Then the membrane is hyperpolarized to  -120mV and 
is subjected to a voltage ramp to +20mV, before being hyperpolarized to -80mV again. The cell is then 
depolarized to -60mV again. Difference between currents measured at the voltage-step at -40mV and at 
-80mV at the start of the protocol is calculated.  
 
2.5 Data analysis and statistical tests 
	
Data were expressed as mean ± SEM. To analyze the difference in absolute current 
across different voltages, two-way ANOVA followed by the appropriate posthoc 
method was used. Data were analyzed using two-way ANOVA, followed by TukeyÕs 
significant difference method when comparing several cell populations across 
different voltages. DunnettÕs test was chosen instead of TukeyÕs test if one of the cell 










comparing three or more groups. Therefore, when there is a need to compare only 
data from two populations across different voltages, two-way ANOVA followed by 
Bonferroni method was chosen. Bonferroni is the suitable method for comparing two 
populations and this method does not assume independence, which is the case in our 
paired data (For example, readings taken from cells exposed to external solution, 
followed by redox agent). 	
	
When comparing data (say normalized current) from two cell populations at one 
voltage, two-tailed, unpaired StudentÕs t-test with WelchÕs correction was used. 
WelchÕs correction was chosen because the sample sizes are unequal. If there were 
three or more populations, say comparing the slow component of time constant of 
deactivation (tslow) of several groups, data were analyzed by one-way ANOVA 
followed by either TukeyÕs test (if there is no group being chosen as a control group) 
or DunnettÕs test (if one of the groups was chosen as control group). 	
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Chapter 3: Modulation of Kv2.1 by Kv9.3, Nox4, and 





Kv2.1, along with Kv1.5, are the most studied ion channels in PH (Archer et al., 
1998). Kv2.1 is present in virtually every cell and is expressed abundantly in the 
pulmonary vasculature (Archer et al., 2004, 1998; Park et al., 2010). It is 
hypothesized to underlie the delayed rectifier current in the PASMC and several 
studies have shown that hypoxia inhibits Kv channel. It is likely that Kv2.1 (probably 
in association with Kv9.3) is a main channel subunit subjected to such inhibition 
(Patel et al., 1999, 1997). Kv2.1 is one of three components contributing to functional 
Kv currents in the arteries, the other two being Kv1.2 plus Kv1.5 with Kvβ1.2 
subunits; and Kv7.4 subunits (Park et al., 2010). Kv2.1 has been established as a 
target protein of reactive oxygen species and oxidation of Kv2.1 has been 
demonstrated to increase excitability of cells, subsequently increasing vulnerability to 
apoptotic cell death (Peers and Boyle, 2015). For example, Kv2.1 oxidation is a 
reported to contribute to neuropathy in conditions such as AlzheimerÕs disease. 
(Cotella et al., 2012; Yu et al., 2016). This has led to speculation that Kv2.1 might act 
as an oxygen sensor. However, there is no evidence of oxygen-sensing property being 
present in Kv2.1, suggesting this property might be conferred by an interacting 
partner.  
 
Kv2.1 can interact with electrically silent Kv (KvS) subunits Kv5−Kv6 and 
Kv8−Kv9, forming functional heterotetrameric Kv2/KvS channels (Stas et al, 2015). 
The association of Kv2.1 with Kv9.3 (Patel et al., 1997, 1999, Kerschensteiner and 
Stocker, 1999, Zhong et al, 2010, Cox and Fromme, 2016) is perhaps the most well-
documented in the context of PH. As mentioned, Kv9.3 is a silent subunit but its 
association with Kv2.1 has been shown to modulate the biophysical and 
pharmacological properties of Kv2.1, where Kv9.3 increases Kv2.1 current amplitude 
(Zhong et al, 2010). Meanwhile, coexpression of Kv9.3 with Kv2.1 decelerates 
Kv2.1Õs open-state inactivation and accelerates closed-state inactivation, thereby 
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causing Kv2.1 to preferentially exhibit closed-state inactivation (Kerschensteiner and 
Stocker, 1999). Such a mode of inactivation has been indicated to regulate membrane 
excitability through the modulation of repetitive firing and back-propagation of action 
potentials in neurons as well as the repolarization of cardiac action potentials 
(Kerschensteiner and Stocker, 1999). Such modulation might also control the PA 
myocytes action potential duration as the effect of Kv9.3 in slowing down the 
deactivation of Kv2.1 is particularly prominent in the voltage range corresponding to 
the resting membrane potential of PA myocytes (Patel et al., 1997). 
Pharmacologically, their co-expression resulted in the reduction in sensitivity to the K 
channel blockers, 4-AP and TEA (Kerschensteiner and Stocker, 1999; 
Kerschensteiner, 2003). 
 
Concurrent with the suggestion that Kv2.1/Kv9.3, instead of homomeric Kv2.1, is the 
main contributor to the delayed rectifier current in the PASMC, it has been reported 
that both Kv2.1 and Kv9.3 (along with Kv1.2 and Kv1.5) protein expressions were 
upregulated in cultured PASMC exposed to 18 hours of hypoxia and this might be 
mediated by hypoxia-inducible factor (HIF)-1 binding to erythropoietin enhancer 
fragments (Dong et al., 2012; Zhong et al., 2010).   
 
The heteromeric Kv2.1/Kv9.3 channels are activated by intracellular ATP and are 
reversibly inhibited by hypoxia and the extent of these modulations are different from 
Kv2.1 alone, suggesting that both subunits have unique characteristics and are 
distinguishable from each other (Patel et al, 1997 and 1999). This has led to the 
speculation that Kv2.1/Kv9.3 activities are tightly connected to the glycolytic 
pathway/ metabolic status of the PASMC. There are four separate findings which 
supported their connection with the metabolic state of the cells.  Firstly, Rounds and 
McMurty (1981) discovered that inhibitors of oxidative phosphorylation and 
glycolysis caused a transient pressor responses in perfused rat lung (Patel et al., 
1997). 2-deoxyglucose and carbonyl cyanide p-trifluoromethoxyphenylhydrazone 
(FCCP) have been shown to inhibit Kv channels, raised cytoplasmic Ca2+  
concentration, and lead to PASMC contraction (Patel et al., 1997). Another separate 
finding has shown rotenone and antimycin A (inhibitors of activated oxygen species 
biosynthesis from the electron transport chain and ATP synthesis) elicited the same 
effects (Patel et al., 1997). Fourthly, Evans et al., 1994 showed that rise in 
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intracellular ATP levels elevated the amplitude of the delayed rectifier K+ current 
amplitude in rabbit PASMC (Patel et al., 1997). 
 
Of all the Nox proteins present in the mouse lung tissue (NOX1, NOXA1, NOXO1, 
p22phox, p47phox, p40phox, p67phox, NOX2, and NOX4), only Nox4 mRNA were 
upregulated in the pulmonary artery vessel of mice kept in hypoxic (10% O2) 
conditions for 21 days (Mittal et al., 2012). Interestingly, silencing of Nox4 reduced 
generation of reactive oxygen species and reduced PASMC proliferation. These 
observations were also replicable in humans where lungs from idiopathic PAH 
patients were reported to have a 2.5-fold upregulation of Nox4 protein in the vessel 
media. For these reasons, Nox4 has been postulated to be an oxygen sensor in 
PASMC. Furthermore, Nox4 is upregulated in hypoxia-induced pulmonary 
hypertension in both rats and mice and probably drive PASMC proliferation via the 
phosphorylation of retinoblastoma protein (Mittal et al., 2012). This implies that 
Nox4 has a link with the pulmonary vascular remodelling process. Since Nox4 
upregulation in the hypoxic condition coincides with Kv2.1 and Kv9.3 upregulation, 
there is a possibility that Nox4 might associate with either Kv2.1, Kv9.3 or both, to 
bring about hypoxic pulmonary vasoconstriction.  
 
 While it is known that, Nox4 silencing or the decrease of Nox4 function using a 
reactive oxygen species scavenger apocynin, reversed the inhibitory effect of hypoxia 
on Kv current density (without affecting the Kv protein level expression), it largely 
remains unknown which Kv channel Nox4 interacted with. There have been data 
provided by Mittal et al, 2012, whereby Nox4 gave rise to oxidation of cysteine 
residues in Kv1.5 channels, which subsequently lead to 55% of reduction in Kv 
current. However, the possible effect of Nox4 on Kv2.1 cannot be ruled out (Mittal et 
al., 2012).  
 
The absence of a specific Kv channel blocker has hindered the investigation into the 
role of Kv2.1 as a delayed current rectifier in several types of cells (Chen et al., 2010; 
Shiau et al., 2003). The identification of spider toxins as specific Kv2 inhibitors has 
been helpful in resolving this. Hanatoxins were the first spider venom peptide to be 
demonstrated as a specific Kv2.1 channel blocker. Hanatoxins bind C-terminal 
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residues of the S3 segment of Kv2.1 and alter the channel gating towards its 
depolarized state (Shiau et al., 2003). 
 
Besides hanatoxins, other more novel spider toxins such as stromatoxin-1, ScTx-1 
from the African tarantula (Stromatopelma calceata) and heteroscordratoxins, HmTx1 
and HmTx2 from Heteroscordra maculate have also been proven as effective Kv2.1 
inhibitors (Shiau et al., 2003). Inhibitory effects of ScTx-1 and HmTx-1 have been 
reported to be as strong as Hanatoxins (Shiau et al., 2003). 
 
An example pointing to the relevance of the use of ScTx-1 is a study performed by 
Tsantoulas et al., 2014, which showed that dorsal root ganglion cells treated with 
ScTx-1 had reduced Kv2 current. This is measured by the reduced refractory period, 
which corresponds to smaller after-hyperpolarization duration and thus shortened 
inter-spike intervals during repetitive discharge (Tsantoulas et al., 2014). In short, 
Kv2 dysfunction could cause action potential to be conducted in the presence of 
sustained input to cause dorsal root ganglion hyperexcitability. Therefore, Kv2 serves 
as a braking mechanism in such condition. If such mechanism is compromised in the 
PASMC, this could lead to PASMC excitability and increased arterial tone, which 
could be debilitating in PAH.   
 
In another study done by Hristov et al., 2012, ScTx-1 reduced the amplitude of the Kv 
current in freshly isolated guinea pig detrusor smooth muscle cells. Although ScTx-1 
did not alter the steady-state activation and inactivation curves, it reduced the 
activation time-constant of the Kv current at positive voltages (Hristov et al, 2012). 
They have postulated that the major contributor of this Kv current is heterotetramer of 
Kv2.1 and a silent Kv channel, by comparing the biophysical characteristics of ScTx-
1-sensitive current with the current profile of such heterotetramer (Hristov et al., 
2012). 
 
In diabetic vascular smooth muscle cells isolated from high fat diet mice, the 
reduction in the Kv current in cells treated with ScTx-1 corresponds to the decreased 
Kv2.1 mRNA and protein levels also interfered with the regulation of the arterial 
tone.  Nieves-Cintrn et al., 2015 further added that the event of Kv2.1 inhibition 
occurs prior to suppression of the large-conductance Ca2+- activated channel subunits 
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and the latter is also observed in the event of chronic hyperglycemia. Taken together, 
their study implicated the function of Kv2.1 in regulating the arterial tone in diabetes 
(Nieves-Cintrn et al., 2015). 
 
Interestingly, Zhong et al., (2010) have found that Kv2.1/Kv9.3 heteromer in HEK-
293 cells have a longer deactivation time compared to Kv2.1 homomer. This can be 
seen by the steeper curve due to repolarization to -50mV from various step voltages 
(Zhong et al., 2010). Secondly, Zhong et al, 2010 have shown that the rat middle 
cerebral arteries (RMCA) current, which is ScTx-1-sensitive, more closely resembled 
the Kv2.1/Kv9.3 current as it has slower deactivation kinetics, rather than the Kv2.1 
current. This led them to hypothesize that Kv2.1/Kv9.3 is the major contributor of the 
delayed rectifier current in RMCA.  
 
In the light of these findings, the current study aims to elucidate the modulation of 
Kv2.1 by Kv9.3. This relationship was probed using several electrophysiology 
protocols. It is also of interest to determine if the presence of Kv9.3 will affect 
interaction of Nox4 with Kv2.1. Following from their research which demonstrated 
the use of ScTx-1 in distinguishing Kv2.1 and Kv2.1/Kv9.3 (Zhong et al., 2010), this 
chapter also aims to probe the effect of this venom on these channels and the results 
from this study would hopefully be extrapolated for future research on native 
PASMC. For the experiments to test the modulation of Kv2.1 by Kv9.3 and Nox4, 
tsA-201 cells are transiently transfected with the respective combination of cDNAs- 
Kv2.1, Kv2.1/Kv9.3, Kv2.1/Nox4, and Kv2.1/Kv9.3/Nox4. Electrophysiology 
protocols used were the standard voltage-step protocol, and open-state inactivation 
and closed-state inactivation protocols. With regards to the experiments to test the 
effect of ScTx-1, a non-perfused setup whereby the toxin was added to the bath 
instead of perfusing the cells with the toxin. This setup was chosen due to the high 
cost of the ScTx-1. An initial set of experiments was performed with Kv2.1 and 
Kv2.1/Kv9.3 in external bath solution, in a non-perfused setup to see if this setup 






Kv2.1 produces functional current while Kv9.3 is a silent channel 
 
Cells were transfected with respective cDNAs and GFP cDNA is used as a reporter 
gene. The standard voltage-step protocol was used for recordings and data were 
expressed as mean ± SEM. Data were analyzed using StudentÕs t-test with WelchÕs 
correction to examine the difference between the two mean values at a certain voltage 
and WelchÕs correction was chosen because of unequal variances in the two 
populations. Two-way ANOVA and Tukey-Kramer (known as TukeyÕs honestly 
significant difference (HSD) on GraphPad Prism 7, USA) as post-hoc analysis, were 
also used. The Tukey-Kramer method was chosen as a follow up for the two-way 
ANOVA because I was interested in comparing every mean with every other mean 
and this method also allows for possibility of unequal sample sizes (Kim, 2015).   
 
Current traces showed that Kv2.1 cells have a high functional current compared to 
either tsA-201 cells expressing Kv9.3, transfected with GFP only or untransfected 
cells (Figure 3.1).  A current density against voltage plot also showed that the Kv2.1 
current density (41.5 ± 11 pA/pF) is significantly higher than that of Kv9.3 (7.5 ± 4 
pA/pF) at -20mV. Kv9.3 current density is comparable to untransfected cells (2.1 ± 
0.5 pA/pF) or cells transfected only with GFP (5.5 ± 2.2 pA/pF) at -20mV (Figure 
3.2). These findings are consistent with the findings of Patel et al., 1997 and 





Figure 3.1: Kv2.1 produces functional current while Kv9.3 is a silent channel. Representative traces of 
















Figure 3.2: Current density of Kv2.1, Kv2.1/Kv9.3, untransfected cells, and cells transfected with GFP 
only plotted against voltage. Data were acquired from the standard voltage-step protocol, where 
currents were activated by application of test pulses at various potentials, ranging from -100mV to 
+50mV for a duration of 500ms each step, with an increment of 10mV in each voltage step. tsA-201 
cells were transfected with Kv2.1 and GFP, or Kv9.3 and GFP, GFP only, or untransfected. Current 
density plotted against voltage showed that the current density of Kv2.1 is significantly higher than 
untransfected cells or cells transfected with Kv9.3 or GFP only from a membrane potential of -20mV 
onwards. Data were analyzed using two-way ANOVA and TukeyÕs honestly significant difference 
method was chosen as the post-hoc, it was found that current density of Kv2.1 was statistically-
significant different from untransfected cells from 0mV to +50mV, with * indicating p ≤ 0.05, ** 
indicating p ≤ 0.01, *** indicating p ≤ 0.001, and **** indicating p < 0.0001. When Kv2.1 is 
compared with cells transfected with Kv9.3+GFP and GFP only, the difference between current density 




Kv9.3 does not affect the endogenous current 
 
The current density of cells expressing Kv9.3 alone (51.3 ± 11.9 pA/pF at 50mV) is 
comparable to untransfected cells (46.5 ± 8.9 pA/pF) and cells transfected with GFP 
only (81.1 ± 17.8 pA/pF) (Figure 3.3). Data analysis performed using two-way 
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ANOVA, with TukeyÕs multiple comparisons test chosen for post-hoc analysis 
revealed that there is no statistically significant difference between the populations. 
This is a clear indication that when Kv9.3 is expressed alone, the channel does not 




Figure 3.3: Kv9.3 does not affect the endogenous current. Current density plotted against voltage for 
tsA-201 cells expressing Kv9.3, untransfected cells, and cells transfected with GFP only. Data were 
acquired from the standard voltage-step protocol, where currents were activated by application of test 
pulses at various potentials, ranging from -100mV to +50mV for a duration of 500ms each step, with 
an increment of 10mV in each voltage step. The current density for each type of cells were comparable, 
as indicated by overlapping mean values and error bars. Data were analyzed using two-way ANOVA 
and TukeyÕs honestly significant difference method was chosen as post-hoc analysis, and it was found 
that the differences between the populations are not statistically significant.  
 
 
Modulation of Kv2.1 by co-expression of Kv9.3 
 
When Kv9.3 is expressed with Kv2.1, the absolute current increased starting from 
potentials where the cells are activated. This is in agreement with the finding of Patel 
et al., 1997, where they reported that Kv2.1/Kv9.3 has higher current amplitude (17µ 
















A at +100mV) than Kv2.1 homomers (5µA at +100mV).  Forster resonance energy 
transfer (FRET) suggested that the stoichiometry of the Kv2.1/Kv9.3 heterotetramer 
consists of three Kv2.1 subunits and one Kv9.3 a-subunit (Kerschensteiner et al., 
2005). Figure 3.4 depicts two important findings: 1) Kv2.1/Kv9.3 is activated earlier 
(at a more negative potential) compared with Kv2.1; 2) The absolute current of 
Kv2.1/Kv9.3 cells were significantly higher than that of Kv2.1 cells from -20mV to 
+50mV, with a p value of at least ≤ 0.05, when analyzed with two-way ANOVA with 
Sidak method chosen for post-hoc analysis. The Sidak method was chosen because it 
is appropriate for comparison of means of two cell populations, and the readings for 
Kv2.1 and Kv2.1/Kv9.3 were obtained independently (in other words, not paired). 
This method also offers higher statistical power which reduces the chance of 



















Figure 3.4: Co-expression of Kv9.3 with Kv2.1 increases the Kv2.1 current amplitude. Current traces 
of A) Kv2.1 and B) Kv2.1/Kv9.3. C) Absolute current of Kv2.1 and Kv2.1/Kv9.3 against test potential 
ranging from -100mV to +50mV. The current of the Kv2.1 and Kv2.1/Kv9.3 cells were analyzed using 
two-way ANOVA with Sidak method. The analysis revealed that current amplitudes of Kv2.1/Kv9.3 
were significantly higher than Kv2.1 from -20mV to +50mV, with * indicating p ≤ 0.05, ** indicating 
p ≤ 0.01, *** indicating p ≤ 0.001, **** indicating p < 0.0001.  
 
 
In order to better distinguish the activation thresholds of Kv2.1 and Kv2.1/Kv9.3, the 
current density at each potential was normalized to the highest current density 
(current density measured at +50mV). The activation threshold is given as the 
potential at which the gradient of the slope is the highest. The rationale behind this is 
that, when the current rises significantly from the baseline at a certain potential, that 







threshold for Kv2.1 is -20mV because this is the point where it is apparent that the 
current started to rise significantly from the baseline. The co-expression of Kv9.3 
with Kv2.1 shifts the activation threshold to -40mV (Figure 3.5 and Figure 3.6). The 
normalized current of Kv2.1/Kv9.3 at -30mV is significantly higher than that of 







Figure 3.5: Kv9.3 shifts the activation threshold of Kv2.1 to a more negative potential. Magnified 
current traces of cells transiently transfected with A) Kv2.1 and B) Kv2.1/Kv9.3 resulting from 
currents being activated at various potentials. Kv2.1 channels are activated at -20mV, while 
Kv2.1/Kv9.3 activated at an earlier potential, -40mV.  Two-tailed, unpaired StudentÕs t-test with 
WelchÕs correction was used to analyze the difference between normalized current of Kv2.1 and 














































Figure 3.6: Comparison of Kv2.1/Kv9.3 with Kv2.1. A) To assess the steady-state activation, 
conditioning pulses from -100mV to +50 mV (increment: 10 mV) were applied.  After each voltage step, 
voltage was clamped to -80mV. The relative open probabilities derived from the initial currents were plotted 
against the voltages of the depolarizing step and fitted with a Maxwell-Boltzmann function (Refer Equation 
2 below). B) Ratio of sustained outward currents at different membrane potentials from Kv2.1/Kv9.3 cells to 













Equation 2: Boltzmann fit function. This equation describes the fraction of channels that are activated 
(Po/ Po.max) as a function of the membrane potential, Vm. V1/2 is the potential at which conductance is 
halfway between the Conductance (Bottom) and Conductance (Top) and was calculated to be 1.11 ± 
2.1 mV for Kv2.1 and -14.98 ± 2.1 mV for Kv2.1/Kv9.3. Conductance (Bottom) and Conductance 
(Top) are made into constants equal to 0.0 and 1.0, respectively. R is the universal gas constant, T is 




Effect of co-expression of Nox4 with Kv2.1 or Kv2.1/Kv9.3  
 
When Nox4 is present with Kv2.1, the current amplitude closely resembled that of 
Kv2.1 homomer (Figure 3.7). Furthermore, co-expression of Nox4 with Kv2.1/Kv9.3 
did not affect the current amplitude of the Kv2.1/Kv9.3 heteromer (Figure 3.7). 
Considering that Nox4 is a major reactive oxygen species producer in the PASMC 
and that reactive oxygen species cause deleterious effect via inhibition of Kv currents, 
the initial hypothesis would be that co-expression of Nox4 with either the homomer or 



































the heteromer will reduce the current amplitude. However, this effect is not seen in 
the results. In Chapter 6, we were interested to test the hypothesis that Nox4 
overexpression sharpened the response of cells transiently transfected with Kv2.1 and 




Figure 3.7: Co-expression of Nox4 with Kv2.1 or Kv2.1/Kv9.3 does not affect the current amplitude. 
Representative traces of A) Kv2.1 and B) Kv2.1/Nox4; C) Kv2.1/Kv9.3 and D) Kv2.1/Kv9.3/Nox4; E) 
Absolute current of Kv2.1, Kv2.1/Kv9.3, Kv2.1/Nox4, and Kv2.1/Kv9.3/Nox4 against test potential 
ranging from -100mV to +50mV. Two-way ANOVA followed by Tukey honestly significant 
difference method was used to analyze the difference between Kv2.1, Kv2.1/Kv9.3, Kv2.1/Nox4, and 
Kv2.1/Kv9.3/Nox4 and it was found that the there is no significant difference between Kv2.1 and 
Kv2.1/Nox4 and between Kv2.1/Kv9.3 and Kv2.1/Kv9.3/Nox4. Similar to Kv2.1 and Kv2.1/Kv9.3, the 
difference between Kv2.1/Nox4 and Kv2.1/Kv9.3/Nox4 is also statistically significant, with * 









Kv2.1/Kv9.3/Nox4 cells show two types of steady-state activation trend 
 
Initial set of experiments were performed where recordings were obtained for five 
cells transiently transfected with Kv2.1/Nox4 and Kv2.1/Kv9.3/Nox4. Taking -30mV 
as the test potential to be analyzed, the normalized current of the first five 
Kv2.1/Kv9.3/Nox4 cells recorded is significantly lower than that of the 20 
Kv2.1/Kv9.3 cells recorded at the same time (Figure 3.8 A). Meanwhile, the 
normalized current of Kv2.1/Kv9.3/Nox4 cells recorded at a later stage is similar to 
that of Kv2.1/Kv9.3 (Figure 3.8 B). The two trends will be explained separately later 
in Figure 3.9 and Figure 3.10.  
 
Whether co-expression of Nox4 with Kv2.1/Kv9.3 abolishes the effect of Kv9.3 in 
modulating Kv2.1 by causing the cells to be activated at a more negative potential 
remains elusive. This could be down to the transient effect of Nox4 or the unstable 
nature of the superoxide that Nox4 generates compared to the application of H2O2, 
which is constantly being perfused onto cells. Another argument would be that 
recombinant system might not the be the best way to study the effect of Nox4 as the 
function of Nox4 could be governed many other factors such as physical factors 
(stretch, shear stress, and pulsatile strain) and humoral factors (growth factors, 
cytokines, and vasoactive agents) in native settings. Moreover, the presence of 
regulatory proteins which might be important for Nox4 to propagate its effect might 
be missing as we are using heterologous expression system, and the absence of the 






Figure 3.8: Kv2.1/Kv9.3/Nox4 cells show two types of steady-state activation trend. Plot of normalized 
current against various step voltages. A) Kv2.1/Kv9.3/Nox4 appears to have similar trend to Kv2.1 and 
Kv2.1/Nox4, indicating that Nox4 abolishes the effect of Kv9.3 on Kv2.1. B) Kv2.1/Kv9.3/Nox4 
seems to show similar trend to Kv2.1/Kv9.3, indicating that Nox4 does not have any effect on either 
Kv2.1 or Kv9.3.  
 
 
Nox4 abolishes the effect of Kv9.3 in shifting the activation threshold of Kv2.1 to 
a more polarized potential in one series of experiments 
 
Kv2.1/Kv9.3 is activated at a more negative potential compared with Kv2.1 and 
Kv2.1/Nox4. Observing a subset of cells expressing Kv2.1/Kv9.3/Nox4, the 
heterotetramer lost the property of Kv2.1/Kv9.3 and instead displayed a similar trend 
to Kv2.1 (Figure 3.8 A and Figure 3.9). The normalized current at -30mV were 
analyzed using one-way ANOVA followed by TukeyÕs multiple comparison test to 
see if there is a difference between all the groups. The statistical analysis revealed that 
there is a significant difference between Kv2.1 and Kv2.1/Kv9.3 and also between 
Kv2.1/Nox4 and Kv2.1/Kv9.3 but there is no difference between Kv2.1/Kv9.3/Nox4 
and Kv2.1/Kv9.3, with the p value being 0.0586, which is quite close to the threshold 
p value that is taken to be significant.  The normalized currents at -30mV were also 
analyzed using one-way ANOVA followed by DunnettÕs test with Kv2.1/Kv9.3 set as 
the control group, to see if there is a difference between the other groups compared 
with Kv2.1/Kv9.3. The statistical analysis revealed that there is a significant 






































difference between all the groups compared with Kv2.1/Kv9.3 (Figure 3.9). This 
could indicate that Nox4 abolishes the Kv9.3Õs effect on Kv2.1 activation threshold.    
 
Figure 3.9: Nox4 abolishes the effect of Kv9.3 on the activation threshold of Kv2.1. A) Plot of 
normalized current for Kv2.1, Kv2.1/Kv9.3, Kv2.1/Nox4, and Kv2.1/Kv9.3/Nox4. B) Bar chart 
depicting the normalized current at V=-30mV for the respective cells, and Kv2.1/Kv9.3 has the highest 
normalized current at that potential, indicating that the heteromer channels are activated earlier than the 
rest. The difference between the normalized currents at -30mV for Kv2.1, Kv2.1/Nox4, and 
Kv2.1/Kv9.3/Nox4 were compared to that of Kv2.1/Kv9.3, using one-way ANOVA with DunnettÕs 
method was also used to analyze if there is a difference between the normalized current of 
Kv2.1/Kv9.3 with other groups. It revealed that there is a statistical significant difference of between 
Kv2.1 and Kv2.1/Kv9.3 (with *** indicating p ≤ 0.001), between Kv2.1/Kv9.3 and Kv2.1/Nox4 (with 
* indicating p ≤ 0.05), and between Kv2.1/Kv9.3 and Kv2.1/Kv9.3/Nox4 (with * indicating p ≤ 0.05).  
 
Nox4 does not abolish the effect of Kv9.3 in shifting the activation threshold of 
Kv2.1 to a more polarized potential in another series of experiments 
 
In another subset of Kv2.1/Kv9.3/Nox4 cells, the trend is similar to that of 
Kv2.1/Kv9.3 (Figure 3.8 B and Figure 3.10). This, instead, indicates that Nox4 does 
not have any effect on Kv9.3 or Kv2.1. When the data were analyzed using one-way 
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ANOVA with DunnettÕs method, with Kv2.1/Kv9.3 being set as the control group as 
it is of interest to know if the other cell groups are different from Kv2.1/Kv9.3, it 
revealed that only Kv2.1 and Kv2.1/Nox4 are significantly different while the 
difference between Kv2.1/Kv9.3/Nox4 and Kv2.1/Kv9.3 is not significant (Figure 
3.10B) 
Figure 3.10: Nox4 does not abolish the effect of Kv9.3 in shifting the activation threshold of Kv2.1 to a 
more polarized potential. A) Plot of normalized current for Kv2.1, Kv2.1/Kv9.3, Kv2.1/Nox4, and 
Kv2.1/Kv9.3/Nox4. B) Bar chart depicting the normalized current at V=-30mV for the respective cells, 
and there is no significant difference between the normalized current of Kv2.1/Kv9.3 and 
Kv2.1/Kv9.3/Nox4, indicating that Nox4 does not abolish the Kv9.3 effect on Kv2.1Õs activation 
threshold. The difference between the normalized currents at -30mV for Kv2.1, Kv2.1/Nox4, and 
Kv2.1/Kv9.3/Nox4 were compared to that of Kv2.1/Kv9.3, using one-way ANOVA followed by 
DunnettÕs test, with Kv2.1/Kv9.3 being set as the control group, with **** indicating p < 0.001.  
 
	
Deactivation time constants of Kv2.1: effect of Kv9.3 
Consistent with the findings of Zhong et al, 2010, the difference in the slope resulting 
from the repolarization to -50mV from various step voltages for Kv2.1 and 
Kv2.1/Kv9.3 was also observed in our experiments. The steps taken to analyze the 
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slopes for Kv2.1 and Kv2.1/Kv9.3 are depicted in Figure 3.11 and Figure 3.12, 
respectively.  Although we observed that most of the current slopes resulting from the 
repolarization to -50mV occurred for every step voltage, we have chosen to current 
slope from +20mV, which corresponds to the 13th trace. This is for the ease of 
comparison with the current trace from the same voltage step that was chosen by 
Zhong et al., 2010. This slope/curve was fitted with a two-phase exponential function 
on pClamp 10.2 software (Axon Instruments, USA), with the recommended fitting 
method, Chebyshev. In addition, we have selected the option for forced positive of the 
measurement of time constants, t and the number of terms were fixed to be 2, in order 
to calculate tfast and tslow. The two-phase exponential equation is given below 
(Equation 3). This fit also solves for the current amplitude, A and the constant y-
offset, C for each component i. The longer deactivation kinetics of Kv2.1/Kv9.3 are 
apparent in the current traces shown in Figure 3.13 C, where the steeper slope of the 
current trace for Kv2.1 corresponds to a faster deactivation kinetic compared to that 
of Kv2.1/Kv9.3. The steepness of the slope for Kv2.1/Nox4 is almost similar to that 
of Kv2.1, indicating that the presence of Nox4 does not alter the deactivation kinetic. 
 
Equation 3: Two-phase exponential function used in the fitting of curve resulting from the 
repolarization from +20mV to -50mV. A is the current amplitude, C is the constant y-offset, i is the 




Figure 3.11: Steps to determine the slow and fast deactivation time constants (tslow and tfast) of 
current traces from a Kv2.1 cell. A) Overview of the voltage steps and the slopes resulting from 
repolarization from various potentials to -50mV. B) Magnification of the slopes, with the 13th trace, 
which corresponds to repolarization from +20mV, highlighted in red. C) The trace corresponding to 
repolarization from +20mV that was chosen for analysis. D) The trace corresponding to repolarization 
from +20mV that was fitted using the two-phase exponential equation using the Chebyshev method on 





Figure 3.12: Steps to determine the slow and fast deactivation time constants (tslow and tfast) of 
current traces from a Kv2.1/Kv9.3 cell. A) Overview of the voltage steps and the slopes resulting from 
repolarization from various potentials to -50mV. B) Magnification of the slopes, with the 13th trace, 
which corresponds to repolarization from +20mV, highlighted in red. C) The trace corresponding to 
repolarization from +20mV that was chosen for analysis. D) The trace corresponding to repolarization 
from +20mV that was fitted using the two-phase exponential equation using the Chebyshev method on 
pClamp 10.2 software, and the number of terms were fixed to be two, so that tslow and tfast can be 
determined. 
 
The decay of the tail current resulting from repolarization to -50mv from +20mV was 
measured and the slope is fitted with bi-exponential functions which then allowed for 
calculation of the slow and fast components. Co-expression with Kv9.3 increases the 
tslow and tfast of Kv2.1, evident in the reduction in steepness of the current decay 
slope of cells transfected with Kv2.1/Kv9.3 compared with Kv2.1 (Figure 3.13C). 
The results were quantified in a bar chart also supported this finding, where the time 
constants for Kv2.1 were (tslow = 63.7 ± 4.2 ms, tfast = 9.0 ± 0.8ms, n=12) compared 
with Kv2.1/Kv9.3 (tslow = 120.1 ± 5.5 ms, tfast = 31.0 ± 2.0 ms, n=15) (Figure 
3.13D) and the StudentÕs t-test performed to analyze the difference between cells 
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transfected with Kv2.1 compared with Kv2.1/Kv9.3 revealed that there is a statistical 
difference between them.  Measurement of the deactivation time constant is a method 
to distinguish Kv2.1 and Kv2.1/Kv9.3. The observation here is in line with the results 
published by  other researchers ((Hristov et al., 2012; Zhong et al., 2010). 
Kv2.1/Nox4 displayed fast deactivation kinetics, similar to the trend seen in Kv2.1 
cells while Kv2.1/Kv9.3/Nox4 cells showed a more similar trend to Kv2.1/Kv9.3 






Figure 3.13: Kv9.3 prolongs the slow component of the deactivation time constant (tslow) of Kv2.1 but Nox4 does not have any 
effect on the deactivation kinetics of Kv2.1 and Kv2.1/Kv9.3. Current traces at the slope where the repolarization from various 
voltage steps to -50mV occurs for A) Kv2.1 and B) Kv2.1/Kv9.3. C) The 13th trace resulting from repolarization from +20mV 
for Kv2.1 (Black) and Kv2.1/Kv9.3 (Red). D) Bar chart depicting the two components of the deactivation time constant (tslow 
and tfast) of Kv2.1 and Kv2.1/Kv9.3, where time constants for Kv2.1 were (tslow = 63.7 ± 4.2 ms, tfast = 9.0 ± 0.8ms, n=12) 
compared with Kv2.1/Kv9.3 (tslow = 120.1 ± 5.5 ms, tfast = 31.0 ± 2.0 ms, n=15). StudentÕs t-test with WelchÕs correction was 
used to analyze whether the difference between the two populations were statistically significant, with p ≤ 0.05 taken as the 
threshold value. StudentÕs t-test revealed that the differences in both tslow and tfast were statistically significant, with **** 
indicating that p < 0.0001. Cells expressing the channels were patched with external solution perfusion. Bar chart depicting the 
two components of the deactivation time constant (tslow and tfast) of E) Kv2.1 compared with Kv2.1/Nox4 (tslow = 85.2 ± 15.9 
ms, tfast = 17.2 ± 3.9 ms, n=6), and StudentÕs t-test revealed that there is no statistically significant difference between them and 
F) Kv2.1/Kv9.3 vs Kv2.1/Kv9.3/Nox4 (tslow = 127.5 ± 11.6 ms, tfast = 27.2 ± 8.5 ms, n=7),  and there is no significant 
difference between them.  
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Modulation of Kv2.1 in terms of open-state and closed-state inactivation 
 
 
Kv9.3 decelerates the open-state inactivation of Kv2.1 
 
According to Kerschensteiner et al, 2003, co-expression of Kv9.3 with Kv2.1 will 
cause a deceleration of the open-state inactivation. This state of inactivation can be 
tested by applying a test pulse at +40mV for 32s to see how the current decay 
compared to the current at the starting point of the pulse. The representative traces in 
Figure 3.14A and Figure 3.14B confirmed the observation of Kerschensteiner et al, 
2003, where Kv2.1/Kv9.3 showed a slower decay of current by the end of the pulse 
compared with Kv2.1. However, when the results were plotted as normalized current 
(current at the end of the pulse, IPn, normalized to current at the start of the pulse, IP) 
over time, the Kv2.1/Kv9.3 trend was not significantly different from that of Kv2.1 
(Figure 3.14C).   
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Figure 3.14: Kv9.3 slows the open-state inactivation of Kv2.1. Recordings were obtained using the 
open-state inactivation protocol outlined in Chapter 2. Cells were injected with a test pulse at +40mV 
for 32s, then repolarized to -80mV before being returned to the holding potential -60mV.  
Representative traces for A) Kv2.1 and B) Kv2.1/Kv9.3. C) Normalized current, IPn/IP plotted against 
holding time for cells transfected with GFP, Kv2.1, Kv2.1/Kv9.3 and Kv9.3 cells. Although the error 
bars of Kv2.1 did not overlap with that of Kv2.1/Kv9.3, StudentÕs t-test with WelchÕs correction 
performed on the difference in the normalized current at the end point showed that there is no 




























Kv9.3 accelerates Kv2.1 closed-state inactivation 
 
Interestingly, it has also been published that co-expression of Kv9.3 with Kv2.1 
accelerates the closed-state inactivation of Kv2.1. Closed-state inactivation can be 
determined by giving two test pulses, in which the holding time between the two 
pulses increases in every sweep. It had been found that the current density of the cells 
transfected with Kv2.1 decreases as the period at which the second test pulse is given 
increases. When Kv9.3 is expressed with Kv2.1, the current density decreases faster, 
as can be seen in the representative traces (Kv2.1 in Figure 3.15A compared to 
Kv2.1/Kv9.3 in Figure 3.15B). This effect is also shown when the results were 
quantified in a plot of current ratio at the end of the pulse compared with start of the 
pulse, Ipn/IP against holding time, where from the third test pulse onwards there is 
non-overlapping readings and error bars for Kv2.1 and Kv2.1/Kv9.3 (Figure 3.15C). 
The reduction of current at different holding time between the first and second pulse 
was analysed using two-way ANOVA, followed by Sidak test as post-hoc. I have 
chosen Sidak as post-hoc because the cell readings for Kv2.1 are independent from 
those of Kv2.1/Kv9.3, hence making it a suitable post-hoc and this method has higher 
statistical power than the commonly used Bonferroni test. The analysis revealed that 
when the holding time between the first and second pulse was 16s, 20s, and 28s, there 
is a significant difference between the current ratio (IPn/IP) for Kv2.1 and 







Figure 3.15: Kv9.3 accelerates Kv2.1 closed-state inactivation. Recordings were obtained using the 
closed-state inactivation protocol outlined in Chapter 2. Cells were hyperpolarized to -100mV before 
being injected with a test pulse at +40mV twice and then returned to the holding potential of -60mV. 
For the first sweep, the gap between the first test pulse and the second test pulse was 2s. The gap 
between the test pulses were increased by 2s in subsequent sweep, meaning the gap was 4s in the 
second sweep, 6s in the third sweep and so on. Representative current traces for A) Kv2.1 and B) 
Kv2.1/Kv9.3 in the closed-state inactivation protocol. C) Plot of current ratio at the second pulse 
compared with first pulse, IPn/IP against holding time. The current ratio IPn/IP is proportional to the 
number of channels that did not inactivate. Two-way ANOVA followed by Sidak test to analyse the 
current ratio when the gap between first and second pulse at every holding time revealed that there is a 
statistically-significant difference for Kv2.1 and Kv2.1/Kv9.3 when the holding time is 16s, 20s, and 





















Modulation of Kv2.1, Kv9.3, and Nox4 by stromatoxin (ScTx-1)  
 
 
To assess the effect of ScTx-1 on Kv2.1, Kv2.1/Kv9.3, Kv2.1/Nox4 and 
Kv2.1/Kv9.3/Nox4 cells, tsA-201 cells were transfected with the respective 
combination of cDNAs and electrophysiology recordings were obtained in the 
absence and presence of 100nM ScTx-1. According to Escoubas et al., 2002, this is 
the concentration that permits ~90% inhibition of Kv2.1/Kv9.3 current based on 
observation in experiments performed using expressed channel. Due to the high cost 
of ScTx-1, patch clamp electrophysiology was performed on cells cultured on a 
coverslip that was immersed in external solution with ScTx-1 added, without being 
perfused. In a normal experiment setup, cells are perfused with external solution or 
external solution with redox agents added. Standard voltage-step protocol, as 
described in Chapter 2 (Materials and Methods), was used.  
 
Effect of ScTx-1 on current amplitude and activation threshold 
 
In line with the published results of other research groups, ScTx-1 does indeed act as 
a Kv2.1 blocker by reducing the current amplitude as the difference between current 
amplitude at 30mv, 40mV, and 50mV for Kv2.1 and Kv2.1/ScTx-1 is statistically 
significant (Figure 3.16 C). However, ScTx-1 does not have any impact on the 







Figure 3.16: ScTx-1 decreases the current amplitude of Kv2.1 but does not affect the activation 
threshold of Kv2.1. tsA-201 cells were transiently transfected with Kv2.1. Electrophysiology 
recordings were obtained using the standard voltage-step protocol. 100nM ScTx-1 was used for treated 
cells. Representative current traces of A) Kv2.1 and B) Kv2.1/ScTx-1; C) IV relationship of Kv2.1 
(purple) and Kv2.1/ScTx-1 (black); D) Normalized current against voltage plot for Kv2.1 (purple) and 
Kv2.1/ScTx-1 (black). Two-way ANOVA followed by Sidak as post-hoc was used to analyze the 
difference between the current from the tsA-201 cells transfected with Kv2.1 without ScTx-1 treatment 
(purple) and with ScTx-1 treatment (black) at every voltage.  **  indicates p ≤ 0.01 and *** indicates p 
≤ 0.001.   
 
Surprisingly, the presence of Kv9.3 renders the effect of ScTx-1 on current amplitude 
of Kv2.1 ineffective (Figure 3.17 C). This is contrary to the results published by 
Zhong et al, 2010 who proposed that the ScTx-1-sensitive RMCA current has a more 
similar profile to Kv2.1/Kv9.3 current, in terms of longer deactivation kinetics and a 
shift in the activation threshold towards a more negative membrane potential. 
However, it must be emphasized that they have compared native RMCA with 







blocker also does not have any effect on the activation threshold of Kv2.1/Kv9.3 





Figure 3.17: ScTx-1 does not have an impact on the current amplitude and activation threshold of 
Kv2.1/Kv9.3. tsA-201 cells were transiently transfected with Kv2.1/Kv9.3. Electrophysiology 
recordings were obtained using the standard voltage-step protocol. 100nM ScTx-1 was used for treated 
cells. Representative current traces of A) Kv2.1/Kv9.3 and B) Kv2.1/Kv9.3/ScTx-1; C) IV relationship 
of Kv2.1/Kv9.3 (orange) and Kv2.1/Kv9.3/ScTx-1 (black); D) Normalized current against voltage plot 
for Kv2.1/Kv9.3 (orange) and Kv2.1/Kv9.3/ScTx-1 (black). Two-way ANOVA followed by Sidak test 
was used to analyze the difference between the current from the tsA-201 cells transfected with 
Kv2.1/Kv9.3 without ScTx-1 treatment (orange) and with ScTx-1 treatment (black) at every voltage.  
There is no statistically significant difference between the current of Kv2.1/Kv9.3 without or with 


































Similar to the results where ScTx-1 reduces the current amplitude of Kv2.1, the Kv2 
blocker is also effective despite the presence of Nox4. This effect is apparent in the 
representative current traces comparing Kv2.1/Nox4 (Figure 3.18 A) and 
Kv2.1/Nox4/ScTx-1 (Figure 3.18 B) and also the IV graph (Figure 3.18 C). The 
current amplitudes at 30mV, 40mV, and 50mV were statistically significant when 
comparing Kv2.1/Nox4 in the absence and presence of ScTx-1 (Figure 3.18C).  It is 
surprising as to why the presence of Kv9.3 renders ScTx-1 ineffective in reducing 
Kv2.1 current yet the presence of Nox4 does not have any effect on ScTx-1. Perhaps, 
this further confirms that Nox4 does not regulate Kv2.1 (as has been demonstrated 
earlier) and therefore, its presence does not change the interaction of Kv2.1 with 
ScTx-1.  The Kv2 blocker also does not alter the activation threshold of Kv2.1/Nox4 







Figure 3.18: ScTx-1 decreases the current amplitude of Kv2.1/Nox4 but does not affect the activation 
threshold of Kv2.1. tsA-201 cells were transiently transfected with Kv2.1/Nox4. Electrophysiology 
recordings were obtained using the standard voltage-step protocol. 100nM ScTx-1 was used for treated 
cells. Representative current traces of A) Kv2.1/Nox4 and B) Kv2.1/Nox4/ScTx-1; C) IV relationship 
of Kv2.1/Nox4 (brown) and Kv2.1/Nox4/ScTx-1 (black); D) Normalized current against voltage plot 
for Kv2.1/Nox4 (brown) and Kv2.1/Nox4/ScTx-1 (black). Two-way ANOVA followed by Sidak test 
was used to analyze the difference between the current from the tsA-201 cells transfected with 
Kv2.1/Nox4 without ScTx-1 treatment (brown) and with ScTx-1 treatment (black) at every voltage. 
The analysis revealed that the current amplitudes at 30mV, 40mV, and 50mV were statistically 
significant for Kv2.1/Nox4 and Kv2.1/Nox4/ScTx-1.  * indicates p ≤ 0.05, *** indicates p ≤ 0.001, and 




































Since ScTx-1 does not have any effect on the current amplitude and activation 
threshold of Kv2.1/Kv9.3, it is not surprising that the toxin does not affect 
Kv2.1/Kv9.3/Nox4 (Figure 3.19 C and Figure 3.19 D). Concurrent with the 
observation with Kv2.1/Nox4, the presence of Nox4 does not have any impact on 





Figure 3.19: ScTx-1 does not have an impact on the current amplitude and activation threshold of 
Kv2.1/Kv9.3/Nox4. tsA-201 cells were transiently transfected with Kv2.1/Kv9.3/Nox4. 
Electrophysiology recordings were obtained using the standard voltage-step protocol. 100nM ScTx-1 
was used for treated cells. Representative current traces of A) Kv2.1/Kv9.3/Nox4 (pink) and B) 
Kv2.1/Kv9.3/Nox4/ScTx-1 (black); C) IV relationship of Kv2.1/Kv9.3/Nox4 (pink) and 
Kv2.1/Kv9.3/Nox4/ScTx-1 (black); D) Normalized current against voltage plot for Kv2.1/Kv9.3/Nox4 
(pink) and Kv2.1/Kv9.3/Nox4/ScTx-1 (black). Two-way ANOVA followed by Sidak test was used to 
analyze the difference between the current from the tsA-201 cells transfected with Kv2.1/Kv9.3/Nox4 
without ScTx-1 treatment (pink) and with ScTx-1 treatment (black) at every voltage. There is no 
statistically significant difference between the current of Kv2.1/Kv9.3/Nox4 without or with ScTx-1 
treatment at every voltage.  
Kv2.1/Kv9.3/Nox4 Kv2.1/Kv9.3/Nox4/ScTx-1A) B)





























Effect of ScTx-1 on time constants of deactivation  
Consistent with the finding of Zhong et al., 2004 and the results in Figure 3.13D, the 
tslow of Kv2.1/Kv9.3 heteromer is significantly longer than that of Kv2.1 homomer 
(Figure 3.20) even in non-perfused setup. Since it is postulated that Kv channels in 
PASMC are mostly expressed as Kv2.1/Kv9.3 heteromers, this finding could have 
implications on how slow deactivation kinetics are favoured in the PASMC, allowing 
more K+ ions efflux, to dampen the cell excitability.  
 
Figure 3.20: Kv2.1/Kv9.3 has a significantly longer tslow compared with Kv2.1 in non-perfused setup. 
tsA-201 cells were transiently transfected with Kv2.1 or Kv2.1/Kv9.3. Electrophysiology recordings 
were obtained using the standard voltage-step protocol. The current slope resulted from repolarization 
from +20mV to -50mV were fitted using the bi-exponential function, with the Chebyshev method and 
number of terms were fixed at 2, to allow for calculation of tslow and tfast. Bar chart showing tslow 
and tfast for Kv2.1 (purple) and Kv2.1/Kv9.3 (orange). StudentÕs t-test was used to analyze the 
difference between tslow and tfast of Kv2.1 and Kv2.1/Kv9.3, with p ≤ 0.05 taken as statistically 
significant value. t-test revealed that tslow of Kv2.1/Kv9.3 is significantly higher than that of Kv2.1, 































As demonstrated in the current traces, the gradient of the slopes remained unchanged 
in the absence or presence of 100nM ScTx-1 (Figure 3.21A, Figure 3.21 B, Figure 
3.21 C). The slopes were fitted with a bi-exponential function using the recommended 
Chebyshev method, and number of terms were fixed at two in order to quantify the 
slow and fast components of the deactivation kinetics, tslow and tfast. The bar chart 
showed that there is no difference in the tslow and tfast of Kv2.1, Kv2.1/Kv9.3, and 
Kv2.1/Nox4 in the absence and presence of ScTx-1 (Figure 3.21 D, Figure 3.21 E, 
Figure 3.21 F). This could indicate that ScTx-1 does not affect the deactivation 
kinetics of the channels.  
 
 
Figure 3.21: Addition of ScTx-1 does not alter the tslow or tfast of Kv2.1, Kv2.1/Kv9.3, and 
Kv2.1/Nox4. tsA-201 cells were transiently-transfected with the respective cDNAs and recordings 
were obtained using the standard voltage-step protocol. Current traces during repolarization to -50mV, 
from +20mV of A) Kv2.1 with and without ScTx-1, B) Kv2.1/Kv9.3 with and without ScTx-1, C) 
Kv2.1/Nox4 with and without ScTx-1; Current traces (slopes) were fitted with bi-exponential function 
using the recommended Chebyshev method and number of terms were fixed at two to allow calculation 
of tslow and tfast. Bar charts depicting the mean ± SEM of tslow and tfast for D) Kv2.1 and 
Kv2.1/ScTx-1; E) Kv2.1/Kv9.3 and Kv2.1/Kv9.3/ScTx-1; and F) Kv2.1/Nox4 and Kv2.1/Nox4/ScTx-
1. StudentÕs t-test was used to analyze the difference between Kv2.1 with and without ScTx-1, 
Kv2.1/Kv9.3 with and without ScTx-1, Kv2.1/Nox4 with and without ScTx-1. StudentÕs t-test did not 
reveal any significant difference between the cell populations, indicating that ScTx-1 treatment does 









































































































Results presented here on the modulation of Kv2.1 by Kv9.3 agree with the research 
that has been published by other groups. In terms of Kv9.3 increasing the current 
amplitude of Kv2.1, Patel et al, 1997 and Zhong et al, 2010 have reported similar 
findings. Interestingly, co-expression of Kv9.3 with Kv2.1 also causes Kv2.1 to be 
activated earlier (at a more negative/hyperpolarized potential) compared with Kv2.1 
homomers. Such modulation might have positive impacts in PH as it will allow more 
K+ ions to leave the cell at a given potential (therefore higher Kv2.1 current) and a 
longer time for the efflux to occur since the channels are opened earlier. Functional 
interaction of Kv2.1 and Kv9.3 agrees with the finding of Zhong et al, 2010 who 
concluded that the predominant ion channels expressed in the PASMC are likely to be 
Kv2.1/Kv9.3 heteromers instead of Kv2.1 homomers.  
 
Kv9.3 also delays the open-state inactivation while accelerating the closed-state 
inactivation of Kv2.1. This means that the Kv2.1/Kv9.3 favours the closed-state 
inactivation, allowing for speedier recovery before the next action potential. When 
resolving the current decay to study two components of the deactivation kinetics, 
namely the slow and fast deactivation time constants, it was found that Kv9.3 
prolongs both components. This could probably have positive consequences in PH 
since the time taken for the channels to deactivate is lengthened thus slowing down 
depolarization, thereby reducing excitability of the PASMC.  
 
RNA expression levels for Kv2.1, Kv9.3, and Nox4 are upregulated during hypoxia 
(Archer et al, 2004, Mittal et al, 2007, Mittal et al, 2011). It is interesting to note that 
although Kv2.1 and Kv9.3 are upregulated, hypoxia decreases the sustained outward 
current (Dong et al., 2012). This could be perhaps due to a modulating factor that 
inhibits the channels in hypoxia. There are countless of debates as to where Reactive 
oxygen species  are derived, the mitochondria or NADPH oxidase (Harrison et al., 
2007; Lee et al., 2013; Mittal et al., 2012, 2007). Our hypothesis was reactive oxygen 
species are derived from NADPH oxidase and thus Nox4 would be the candidate of 
interest. This is because Nox4 is abundantly expressed in lung tissues and is the only 
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NADPH oxidase subunit that was significantly upregulated in PASMC in response to 
chronic hypoxia in PASMC derived from rats and mice lung tissue. Nox4 has also 
been shown to contribute to pulmonary vascular remodelling  in systemic vasculatures 
and pulmonary arteries (Brandes et al., 2010; Mittal et al., 2012). Although Mittal et 
al, 2011 argued that Nox4 colocalizes with Kv1.5 but not Kv2.1, we were interested 
to see if the co-expression of Kv9.3 with Kv2.1 would change that, in other words, if 
Kv9.3 is needed for interaction of Nox4 with Kv2.1. Consistent with this argument, 
my study found that Nox4 does not significantly alter the electrophysiological 
properties of Kv2.1 homomers, either in terms of current amplitude, activation 
threshold, and deactivation kinetics. In one series of experiment, it was found that the 
co-expression of Nox4 with Kv2.1/Kv9.3 abolished the effect of Kv9.3 in shifting the 
activation threshold (meaning the behaviour was more similar the Kv2.1 rather than 
the Kv2.1/Kv9.3). However, in another series of experiment, Kv2.1/Kv9.3/Nox4 cells 
displayed a similar behaviour to Kv2.1/Kv9.3. The five cells in the first series of 
experiment that displayed a similar behaviour to Kv2.1 could indicate that the 
presence of Nox4 is interrupting the Kv2.1-Kv9.3 interaction. We hypothesized that 
Nox4 is binding to the site of Kv2.1-Kv9.3 interaction, or that presence of Kv9.3 
helped Nox4 docked to a site which allows Nox4 to interfere with the Kv2.1-Kv9.3 
interaction. Alternatively, Nox4 might directly modulate Kv9.3, thereby inhibiting it 
from modulating Kv2.1. However, in the latter series of experiment, 
Kv2.1/Kv9.3/Nox4 cells behaved more similarly to Kv2.1/Kv9.3 cells. Although 
Kv9.3 is a silent channel, it is structurally similar to Kv2.1, which perhaps explains 
why they are able to heteromultimerize in the first place (Kerschensteiner, 2003). This 
being said, if Nox4 has been shown not to modulate Kv2.1, then even the presence of 
Kv9.3 that can ÔpotentiallyÕ bring Nox4 into a close proximity to Kv2.1 will not cause 
any difference to the Kv2.1 properties. As to the possibility that Nox4 directly 
modulates Kv9.3 thereby interfering with Kv9.3-Kv2.1 interaction, the likelihood is 
small since Nox4 fails to regulate Kv2.1.  
 
While most researchers proposed Nox4 as the only predominant NADPH oxidase 
subunit upregulated in hypoxia, Buttigieg et al, 2012 concluded that Nox2 is the 
predominant oxygen sensor that modulates activity of Kv channels in H146 cells, 
which is a model system for native pulmonary neuroepithelial bodies (NEB). The 
authors demonstrated that Nox2 was coupled with Kv3.3 and Kv4.3 and that these 
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complexes colocalized at the plasma membrane. This feature of being expressed in 
the membrane would be expected if the ion channels or the NADPH oxidase subunit 
were to be an airway-based sensor (Buttigieg et al., 2012). By using Nox2 siRNA, 
they showed that hypoxic-response in H146 cells was severely reduced (Buttigieg et 
al., 2012). In contrast, when Nox4 siRNA were used, cells retained a residual hypoxic 
response (Buttigieg et al., 2012). They concluded that Nox2 is the predominant 
oxygen sensor while Nox4 plays a minor role in hypoxia-sensing (Buttigieg et al., 
2012). It must be emphasized that while H146 cell, and by inference pulmonary NEB, 
is a good model system to dissect the hypoxic responses mediated by different 
Nox/K+ channel complexes in airway chemoreceptors (Buttigieg et al., 2012), it might 
not be a good representative model of the whole pulmonary vasculature as it lacks 
Kv2.1 and Kv9.3, which are abundantly expressed in lung and heart (Archer et al., 
2004; Patel et al., 1999). To date, it has never been shown whether Nox2 can form 
complexes with either Kv2.1 or Kv2.1/Kv9.3. Taken together, there is a possibility 
that Nox2, instead of Nox4, could be the protein regulating Kv2.1 and Kv9.3, and 
these unique Nox/Kv channel combinations might play different roles in different 
anatomy (Buttigieg et al., 2012).  
 
Although there are several pieces of evidence supporting the role of Nox proteins in 
hypoxia-sensing, Patel and Honore, 2001, proposed that NADPH oxidase subunits are 
not a universal oxygen-sensor. For example, the finding of Archer et al, 1999 which 
showed that hypoxic inhibition of K+ cells in PASMC was still observed in Nox2 
knock-out animals, is contradictory to the observation of Buttigieg et al, 2012. Thus, 
Nox proteins are likely not to be the only regulatory subunits that confer oxygen-
sensitivity upon Kv channels. 
 
The redox regulation of different cell types might also explain the discrepancy of 
which Nox subunit or Kv channels are the main players in hypoxia-sensing (Buttigieg 
et al., 2012; Conforti et al., 2000). For example, Kv2.1 has been constantly reported to 
be sensitive to hypoxic inhibition in cDNA-transfected L cells, but such inhibition is 
only observed in a subset of transfected COS cells and not detected at all in Kv2.1 
mRNA-injected Xenopus oocytes (Conforti, et al, 2000, Patel et al, 1997, Hulme et al, 
1999, Patel and Honore, 2001). Collectively, these results indicate that the same Kv 
channel can be subjected to different regulation by redox status depending on the 
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different regulatory proteins present in the host cells. Therefore, with regards to the 
discrepancy in results from the two series of experiment performed in this study, 
summarizing that Kv2.1/Kv9.3/Nox4 showed two trends of steady-state activation, it 
is likely that the regulatory proteins present in the tsA-201 cells in one series of 
experiment was not present in another. In the case of tsA-201 cells, it was found that a 
large subset of Kv2.1/Kv9.3 cells is not susceptible to modulation by Nox4.  
 
Parallel to the observation of other research groups, the Kv2 blocker, ScTx-1 reduces 
the current amplitude of both Kv2.1 and Kv2.1/Nox4. This might suggest that Nox4 
does not regulate or interact with Kv2.1. In other words, the presence of Nox4 does 
not affect the interaction of Kv2.1 with ScTx-1. However, it is surprising that the co-
expression of Kv9.3 with Kv2.1 renders the toxin ineffective in reducing the Kv2.1 
current amplitude. This is contradictory to the results published in the Supplementary 
Material section of Zhong et al, 2010Õs paper titled ‘Stromatoxin-sensitive,	
heteromultimeric	 Kv2.1/Kv9.3	 channels	 contribute	 to	 myogenic	 control	 of	
cerebral	arterial	diameter:	Heteromultimeric	Kv2.1/Kv9.3	channels	and	cerebral	
myogenic	response’,	where the inhibitory effect was already evident in the presence 
of 30nM ScTx-1. Furthermore, they have also shown that the native RMCA current 
which is sensitive to ScTx-1 has a similar profile to Kv2.1/Kv9.3 channels which are 
heterologously expressed in HEK-293 cells, in terms of deactivation kinetics and 
voltage-dependence of activation. The native RMCA current and Kv2.1/Kv9.3 
channels have longer deactivation kinetic profiles and a negative shift in their 
activation thresholds, compared with homotetrameric Kv2.1 channels, which have an 
accelerated current decay during deactivation and are activated at a more positive 
voltage.  
The reason for the discrepancy between observation in this study and the published 
result might be due to the effect of Kv9.3 increasing the Kv2.1 current amplitude, 
which might offset the current reduction effect of ScTx-1. The discrepancy in results 
of this experiment with what has been published could also arise due to difference in 
how the experiments have been performed, where in our experiment the tsA-201 cells 
were not perfused with 100nM ScTx-1, but instead the cells were constantly in the 
bath containing 100nM ScTx-1. This non-perfusion setup whereby the cells are 
constantly in contact with ScTx-1 might have affected the results of experiments by 
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desensitizing the channels to the inhibitory effect of the venom. In both experiments 
measuring the current amplitude, activation threshold, and time constants of 
deactivation, our initial data have consistently showed that there is no difference 
between the cells recorded in perfused and non-perfused setup. For example, the 
observation that Kv2.1/Kv9.3 having a significantly longer tslow compared with 
Kv2.1 in a non-perfused setup matched the observation made in Chapter 3, where 
perfused cells are used. Given that now a difference is being seen in our results 
compared to what have been published by other authors, results from the small 
number of trials of non-perfused cells might be misleading and perhaps the trials 
should be repeated to establish if there is a change in results due to the setup.  
Another reason explaining this phenomenon could be that the inhibitory effect of 
ScTx-1 on Kv2.1/Kv9.3 is transient and therefore constant application of ScTx-1 
could mean the effect was not captured or recorded. There are several examples 
where after a certain toxin stimulated an inhibition or activation effect on an ion 
channel, the channel is returned to its resting state (baseline) and then the current 
going through the channel is either further increased or decreased, exceeding the 
baseline level. An example would be the effect of Aristolochic acid on TREK1 and 
TREK2 channels. The compound activates the channels but after the compound is 
washed off, the current is initially restored to the baseline but then dropped off to a 
level lower than the baseline. Overall, the result regarding the neutral effect of ScTx-1 
on Kv2.1/Kv9.3 is inconclusive and warrants further experiments.  
Despite having an effect on the current amplitudes of Kv2.1 and Kv2.1/Nox4, the 
toxin does not cause an alteration to the activation thresholds. It must be emphasized 
that the comparison of activation thresholds between control cells (absence of ScTx-
1) and cells in the presence of ScTx-1 were not done in the publication of Zhong et al, 
2010. Thus, the result presented in this chapter provided a new insight as to the 
different action of ScTx-1 on Kv2.1, where the venom causes current reduction 
without causing the channel to be activated earlier or later.  
The observation that there is a slower deactivation kinetic in Kv2.1/Kv9.3 compared 
with Kv2.1 alone is consistent with the findings of Zhong et al, 2010. This difference 
is clearly observed in the current traces of representative cells. The attempt to 
quantify the deactivation kinetics was done by fitting the slopes with two exponential 
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components to allow calculation of tslow and tfast. StudentÕs t-test performed to 
investigate as to whether there are differences between the tslow of Kv2.1 and 
Kv2.1/Kv9.3 revealed that tslow of Kv2.1/Kv9.3 is significantly higher than Kv2.1 
(p=0.0030). However, there is no significant difference with tfast between Kv2.1 and 
Kv2.1/Kv9.3.  When testing whether ScTx-1 has an effect in shortening or prolonging 
the time constants of deactivation of the channels, it was found that ScTx-1 does not 
have any impact on the deactivation kinetics of the channels.  
One of the objectives of the experiments carried out above was to assess whether 
ScTx-1 is a good pharmacological tool to distinguish between Kv2.1 and 
Kv2.1/Kv9.3, Kv2.1/Nox4, and Kv2.1/Kv9.3/Nox4.  
Results highlighted from this study showed that the toxin is indeed a Kv2.1 blocker, 
but its effect on Kv2.1/Kv9.3 is rather inconclusive. Patch clamp data from other 
publications showed that the biophysical characteristics of the ScTx-1-sensitive 
current is similar to the one of heterotetrameric Kv2.1/silent Kv channels (likely 
Kv2.1/Kv9.3) (Chen et al., 2010; Druzin et al., 2011; Hristov et al., 2012; Nieves-
Cintrn et al., 2015; Zhong et al., 2010). However, experiments by these groups were 
done in native systems and they have mentioned that presence of homotetrameric 
Kv2.1 channels cannot be ruled out and it is difficult to deduce that ScTx-1 is acting 
exclusively on Kv2.1/Kv9.3 or on Kv2.1 (Chen et al., 2010; Hristov et al., 2012). 
Therefore, it might be difficult to conclude that ScTx-1 differentially regulates Kv2.1 
and Kv9.3.  Perhaps it might be better to increase the number of trials, or to adhere to 
the perfused setup during whole cell recording when it is economically feasible, 
before doing whole cell recording on native PASMC to compare the current profile 






Chapter 4: Protein expression of Kv2.1 and Kv9.3 in rat 




After performing the functional studies to understand how Kv9.3 can modulate the 
electrical behaviour of Kv2.1, it was of interest to determine the distribution of these 
ion channels in the lung and heart tissue. Zhong et al, 2010 attempted to dissect the 
expression of Kv2.1 and Kv9.3 in dissociated single rat medial cerebral arteries 
myocytes by using proximity ligation assay and they have confirmed the 
colocalization of both ion channels. They used the proximity ligation assay due to the 
scarcity of a reliable commercial anti-Kv9.3 antibody that can be used for 
immunohistochemistry. In this chapter, we have used a novel anti-Kv9.3 antibody 
from Alomone Labs, Israel. Kv9.3 mRNA has been reported to be widely expressed 
in several tissues, such as brain, cochlear nucleus, lungs and PASMC but Kv9.3 
protein expression has so far only been demonstrated in cerebral artery smooth 
muscle cells (Zhong et al., 2010) and placenta (Bocksteins, 2016; Shepard and Rae, 
1999). Using immunohistochemistry, I sought to find out whether Kv2.1 and Kv9.3 
are expressed in rat lung and heart cells and if they are found to be present, it was of 
interest to know which type of cells are immunopositive. In contrast to Western 
blotting, immunohistochemistry allows the visualization of where these proteins are 
present, providing more specific insights of the types of cells. By counting the cells 
that are positively-stained by the antibodies we will have an insight as to what 
proportion of cells express the respective ion channels. 
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4.2 Materials and Methods 
 
Tissue preparation and Immunohistochemistry  
 
Rabbit polyclonal anti-Kv2.1 and anti-Kv9.3 antibodies were acquired from Alomone 
Labs, Israel.  Sprague Dawley male rats, aged P30, with average weight of 225g, were 
decapitated using spine-dislocation method. A total of 10 rats were used. All animal 
procedures were conducted in Charles River, Margate, UK, in accordance with 
guidelines of the Animal Welfare and the Humane Treatment of Animals policy. By 
inserting a syringe needle filled with phosphate-buffered saline (PBS) into the 
trachea, the lungs were washed with PBS till the lungs appeared pale. The lungs and 
heart were isolated and fixed with 10% neutral buffered formalin (NBF) for 48 hours 
on a shaker. Next, the organs were dehydrated by immersing them in 50% ethanol for 
two hours, twice; 70% ethanol for one hour, followed by 90% ethanol for 2 hours, and 
100% ethanol for one hour, twice. The organs are blotted dry with tissue paper before 
being immersed with xylene/xylol (Thermo Fisher Scientific) for one hour, twice.   
 
The organs were then infiltrated with molten paraffin (Thermo Fisher Scientific) for 
one hour, twice and then left at room temperature to cool overnight. Paraffinization 
was performed using the Leica embedding centre (Leica Biosystems, Germany). 
Briefly, the organs were stored in the warming compartment for about 15 mins to 
allow the excess wax to be melted. Then a thin slice of the organ was cut off using a 
blade. The tissue slice was placed in the centre of a metal cassette and molten paraffin 
was dispensed on the tissue slice and a plastic cassette placed on top. The tissue slice 
was left to cool at 4¡C for 30 min and then at room temperature overnight. The metal 
part was removed leaving the tissue embedded in paraffin within the plastic cassette. 
The embedded tissue slice was sliced to a thickness of 3 micrometres using Leica 
RM2255 fully automated rotary microtome (Leica Biosystems, Germany). The tissue 
slices were then mounted on glass slides (Superfrost Ultraplus Adhesion slides, 
Thermo Fisher Scientific). Deparaffinization was performed by putting the glass 
slides in the 60¡C incubator, for one hour, to melt the excess paraffin.  
 
The tissue slices were rehydrated in xylene/xylol for 10mins, three times; blotted dry 
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with tissue paper; re-immersed in 100% ethanol for 5 mins, twice; 96% ethanol for 5 
mins, once and in 70% ethanol for 5 mins, once. Antigen retrieval is done by boiling 
the tissue slices with 1X Rodent Decloaker (Biocare Medical), for 25 mins. In order 
to prevent non-specific staining due to presence of endogenous peroxidase, the 
samples were treated with a solution consisting of methanol and ice-cold hydrogen 
peroxidase in a ratio 1:1, for 20 mins. The samples were then washed in water for 
5mins, and in 1X Tris-buffered saline (TBS), pH7.2, (Zytomed, Germany) for 5mins, 
twice. The samples were treated with 1X proteinase K (Biocare Medical, US) for 15 
mins. Then the samples were washed with distilled water for 5mins, and then twice 
with 1X TBS on a shaker. Non-specific binding sites were blocked with 10% bovine 
serum albumin (BSA) (Sigma Aldrich, Germany) for one hour. BSA was diluted in 
PBS prior to use. Then, samples were washed with TBS on a shaker for five times, 
5mins each. To block rodentÕs IgG, samples were treated with Rodent Block M 
(Biocare Medical, US) for 30mins.  The samples were subjected to five washes with 
TBS for 5mins each time, on the shaker.  
 
Primary antibodies were prepared in the correct dilution using the antibody diluent 
(Biocare Medical, US), where the optimum concentration of rabbit polyclonal anti-
KV2.1 was determined to be 1:50 whereas anti-Kv9.3 was 1:1000. The diluted 
antibodies were vortexed before use. The protocol for determining the optimum 
antibody dilution is outlined below in ÔOptimization protocols and negative controlsÕ.  
The area to be stained on the slide was marked with ImmEdge hydrophobic barrier 
pen (Vector Labs, US). Slides were blotted dry quickly and 50µl of primary antibody 
was spotted on the sample area. Samples were incubated at 4¡C overnight in the dark.  
 
The samples were washed with TBS for seven times, 20mins each. Samples were 
treated with alkaline phosphatase (BioCare Medical, US) for 30mins at room 
temperature. Then the slides were washed in TBS for four times, 5mins each. In order 
for the staining to develop, Vulcan Fast Red (Warp Red Chromogen Kit, BioCare 
Medical, US) was spotted on the samples. After 4-6 mins, formation of a bright 
fuchsin-red precipitate will be noticed and the glass slides were examined on the 
microscope. When the signal of staining is intense enough, the slides were submerged 
in water to quench the reaction. Care must be taken to ensure that the staining was not 
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over-developed. Nuclear counterstaining was performed by spotting the samples with 
haematoxylin (Invitrogen, US) for 1min. The samples were then washed with distilled 
water, followed by TBS for 3-5 min and finally in tap water for 10min on the shaker. 
Dehydration was done by submerging the slides in 100% ethanol, three times, and 
xylol for two times. The slides were then blotted dry and mounted with Pertex 





The sections were examined using the Leica DM 2500 microscope (Leica 
Biosystems, Germany). Images were acquired using Leica DFC290 HD digital 
camera and Leica QWin imaging software with identical image system settings (Zhu 
et al., 2008) (Leica Biosystems, Germany). There might be variations in every tissue 
section, even if the tissue section was taken from the same rat. Therefore, it is 
necessary to capture multiple distinct ROI (region of interest) of a tissue section.  The 
ROIs were captured randomly to ensure that not only the regions where the cells were 
positively-stained were captured but instead the ROIs should be representative of the 
tissue section. Depending on the area of the tissue section, the number of ROIs that 
were needed to be captured was determined.  
 
 
Cell counting and statistical analyses 
 
Cell counting was performed using the ImageJ software (National Institutes of Health, 
US) to determine the percentage of cells that are positive for either Kv2.1 or Kv9.3 
(stained red) vs total number of cells (representative of nuclear staining).  Cells are 
stained blue due to the binding of haematoxylin to the nucleus of the cells. If the cell 
is stained blue and red, as the detection method used was Vulcan Fast Red, this 
signified that the cell is positively-stained by either the Kv2.1 or Kv9.3 antibody 
(Figure 4.1 gives an indication of a positively-stained cell and a negatively-stained 
cell). Data are presented as the mean ± standard error of mean (SEM). Graphical and 
statistical analyses were conducted using GraphPad Prism7 (GraphPad, US). 
Statistical comparisons between two groups were performed using an unpaired 
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StudentÕs t-test with Welch correction, and p-value ≤ 0.05 was considered to be 
statistically significant.  
 
Percentage of immunopositive cells in were determined by the following formula: 
ABCDEF	GH	ICCBJGKGLIMINE	OEPPL
QGMRP	JBCDEF	GH	OEPPL
  ! 100 (%) 
!
The average of percentage of immunopositive cells in a particular organ of ÔnÕ 
number of rats is determined. The reason that we have decided not to use a software 
to estimate the positively-stained area is due to the risk of false positive (type 1 error) 
as there might be artefacts which are stained red but not blue (essentially not a cell) 
and get counted as a cell. Besides, counting the number of immunopositive cells per 
square area assumes that each square area has the same density of cells.  
 
For example, for a tissue section with an area of 1000mm2, ten fields of images of 
10X resolution were captured. In these ten fields, there were an average of 40,000 
cells and out of this, 4000 immunopositive cells were observed. Data are presented as 
the average of the total number of positively-stained cells over total number of cells 
present ± SEM. The results are depicted in a bar chart.  
 
An example of how the calculation was done is as follows: For a section of Rat 2 Left 
lung that was stained with Kv2.1, ten fields of images were captured. The total 
number of cells in these ten fields is 41,584 cells. Out of this total, 4303 cells were 
stained red (immunopositive). Thus the percentage of immunopositive cells compared 
with total cells present would be 10.35%. Meanwhile, in Rat 3 Left lung, 11 fields 
were captured (because the section area was slightly bigger than Rat 2Õs left lung), 
and total number of cells is 45,879 and out of this total, 2604 cells were 
immunopositive. So, the percentage of immunopositive cells is 5.68%. The average of 
the percentages from the nine rats analyzed was calculated and variation in the 





Figure 4.1: Image of rat lung cells taken at 40X resolution using Leica DM 2500 microscope (Leica 
Biosystems, Germany). All cells were stained blue as haematoxylin is a stain that targets the cell 
nucleus. The black arrow indicates a cell that was both stained blue and red. The antibody used in this 
experiment was against Kv2.1, thus the cell was then considered to be expressing the Kv2.1 protein. 










Optimization protocol and negative controls 
 
The primary antibodies used were rabbit polyclonal anti-Kv2.1, catalogue number: 
APC-012, and anti-Kv9.3, catalogue number: APC-133 (both from Alomone Labs, 
Israel). In order to determine the optimum concentration of these primary polyclonal 
antibodies, tissue slices were first stained with the antibody of the following dilutions: 
 
Anti-Kv2.1 antibody- 1:50, 1:100, 1:200, 1:500, and 1:1000 
Anti-Kv9.3 antibody- 1:50, 1:100, 1:200, 1:500, 1:1000, and 1:2000 
 
The concentrations above have been used in other reference papers recommended by 
the antibody provider, Alomone Labs and were used as a guideline for our 
experiments (Costigan et al., 2010; Richardson and Kaczmarek, 2000; Shepard and 
Rae, 1999).  Since there might be differences in our protocols compared to other 
published papers (such as in development methods used), it is a good practice to 
establish the optimum conditions according to our needs. The optimum primary 
antibody concentration would be the one which allows us to clearly discriminate a 
positively-stained cell from a cell that has only been stained blue by haematoxylin and 
more importantly, one which does not stain in a specific fashion (meaning all the cells 
are stained, unless it has been published to be an antigen that is ubiquitously 
expressed in the cells) or produce a lot of background staining (also known as 
background noise). Referring to Figure 4.2 and Figure 4.3, the optimum 
concentrations of Kv2.1 was found to be 1:50 and that for Kv9.3 was 1:1000. This 
process of distinguishing positively-stained and negatively-stained cells can also be 
aided by performing negative control experiments which omit primary antibody 
application in the protocol.  
 
The optimum development period where the Vulcan Fast Red (Warp Red Chromogen 
Kit) is applied on the tissue is established during this optimization session. The 
optimum development time for slides stained with Kv2.1 primary antibody was 
established to be 4 minutes while slides stained with Kv9.3 primary antibody was 6 






Optimization of IHC protocol 
 
There are two reasons to perform the optimization of IHC protocol- 1) To establish 
the optimum concentration of antibody so that the immunopositive cells can be 
distinguished, yet the amount of background staining is minimal; 2) To determine the 
time duration of development of stain with Vulcan Fast Red. As shown in Figure 4.2 
and Figure 4.3, the ideal dilutions of antibody to be used were found to be 1:50 for 




Figure 4.2: Optimization protocol to determine the appropriate concentration of Kv2.1 to be used to 
stain tissues. Heart tissues stained with polyclonal Kv2.1 antibody in the following dilutions- A) 1:50, 
B) 1:100, and C) 1:200, where scale indicates 140µm. The square sections of these images are enlarged 
as follows- D) 1:50, E) 1:100, and F) 1:200, where scale indicates 23.3µm. It is clear that the cells in D 
are stained red when a dilution of 1:50 of the antibody is used whereas the cells in E and F are not 




Figure 4.3: Optimization protocol to determine the appropriate concentration of Kv9.3 to be used to 
stain tissues. Heart tissues stained with polyclonal Kv9.3 antibody in the following dilutions- A) 1:500, 
B) 1:1000, and C) 1:2000, where scale indicates 140µm. The square sections of these images are 
enlarged as follows- D) 1:50, E) 1:1000, and F) 1:2000, where scale indicates 23.3µm. The cells in D) 
and E) are both stained red whereas cells in F) are not. To prevent false positive result, the antibody 
dilution of 1:1000 is chosen since the image E) showed that this dilution will result in clear staining of 
cells.  
 
Cells that are positively-stained with the antibodies are compared with negative 
controls  
 
Negative controls are slides of rat heart and lungs tissues which are not stained with 
the primary antibodies. It is clear in Figure 4.4 and Figure 4.5 that the rat heart and 
lung tissues that act as negative controls only have cells stained in blue due to 





Figure 4.4: Rat heart cells that are positively-stained with the antibodies are compared with negative 
controls. A) Negative staining, Rat heart cells stained with B) polyclonal anti-Kv2.1 antibody, 1:50 
dilution and C) polyclonal anti-Kv9.3 antibody, 1:1000 dilution (right). The negative staining in A) 
shows that while the cells are stained blue with haematoxylin, they are not stained red as in B) and C). 




Figure 4.5: Rat right lung cells that are positively-stained with the antibodies compared with negative 
controls. A) Negative staining, Rat right lung cells stained with B) polyclonal anti-Kv2.1 antibody and 
C) polyclonal anti-Kv9.3 antibody (right). The negative staining in A) shows that while the cells are 





Distribution of Kv2.1 in rat left lung, right lung, and heart 
 
Kv2.1 is mainly expressed in the epithelium, especially in goblet cells, and smooth 
muscle cells of the lung (Figure 4.1, Figure 4.6 A and B). As evident in Figure 4.6 C, 
all heart cells in all six animals appeared to be expressing Kv2.1 and therefore there 
are no error bars plotted in the bar chart column (Figure 4.6D). Cells from several rats 
were counted and data were expressed as mean percentage of positively-stained cells 
± SEM.    
 
 
Figure 4.6: Protein expression of Kv2.1 in rat A) left lung, B) right lung, and C) heart. Scale indicates 
140µm. D) Bar chart showing the percentage of cells expressing Kv2.1 in the rat left lung, right lung, 
and heart. ÔnÕ indicated in the bar chart represents the number of animals used and therefore denotes the 
number of independent trials of the experiments. 
 
 
Distribution of Kv9.3 in rat left lung, right lung, and heart 
 
Similar to Kv2.1, Kv9.3 is also expressed in epithelium and smooth muscle cells in 
the lung (Figure 4.7 A and B). All the heart cells are stained red, indicating 
immunopositivity for Kv9.3 (Figure 4.7 C). Cells from several rats were counted and 
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data were expressed as mean percentage of positively-stained cells ± SEM, as plotted 
in Figure 4.7D.  
 
 
Figure 4.7: Protein expression of Kv9.3 in rat A) left lung, B) right lung, and C) heart. Scale indicates 
140µm. D) Bar chart showing the percentage of cells expressing Kv2.1 in the rat left lung, right lung, 
and heart. ÔnÕ indicated in the bar chart represents the number of animals used and therefore denotes the 
number of independent trials of the experiments.  
 
 
Presence of Kv2.1 with Kv9.3 in rat left lung, right lung, and heart  
 
As highlighted in the bar charts above (Figure 4.6 D and Figure 4.7 D), Kv2.1 and 
Kv9.3 are expressed at the same levels in rat lungs and hearts. Figures below allow 
the visualization of the compartments where these two proteins are expressed and we 
can infer that they are expressed in approximately the same compartments in the left 
lung (Figure 4.8), right lung (Figure 4.9), and heart (Figure 4.10). Further 
immunohistochemistry experiments with serial sections (series of sections of the same 
organ from the same rat) should be performed to investigate whether Kv2.1 and 




Figure 4.8:  Presence of Kv2.1 and Kv9.3 in rat left lungs. Positive staining of epithelial cells and 
smooth muscle cells in the rat left lungs with anti-Kv2.1 antibody (left) and anti-Kv9.3 antibody 





Figure 4.9: Presence of Kv2.1 and Kv9.3 in rat right lungs. Positive staining of epithelial cells and 
smooth muscle cells in the rat right lungs with anti-Kv2.1 antibody (left) and anti-Kv9.3 antibody 





Figure 4.10: Presence of Kv2.1 and Kv9.3 in rat hearts. Positive staining of rat heart cells with anti-




The expression of Kv2.1 in rat PASMC is well-documented and the results from this 
experiment found that Kv2.1 is indeed present in rat lungs and hearts. In terms of the 
breakdown of cell types, it has been found that adult murine myocardium consists of 
approximately 56% myocytes, 27% fibroblasts, 7% endothelial cells, and 10% 
vascular smooth muscle cell (Banerjee et al., 2007). 
 
Although Kv9.3 has been shown to regulate Kv2.1 function, the protein expression of 
Kv9.3 in rat heart and lung has never been demonstrated using immunohistochemistry 
due to the non-availability of a reliable, commercial primary antibody. I have used the 
rabbit polyclonal anti-Kv9.3 antibody from Alomone Labs, Israel but the reliability of 
the antibody remains inconclusive. In future experiments, staining using sm22 or a-
smooth muscle cell actin, which target smooth muscle cells, and CD31, which targets 
endothelial cells, should be carried out to confirm that the anti-Kv9.3 antibody is 
really targeting these cell types. By performing these additional staining for 
endothelial and smooth muscle cells, we would be able to carry out cell counting to 
determine the proportion of cell types expressing Kv2.1 and Kv9.3 and see whether 
these cell types express the ion channels in different amount. Another control 
experiment that could be used to confirm the specificity of the anti-Kv2.1 and anti-
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Kv9.3 antibodies would be staining of the tsA-201 cells transiently-transfected with 
the Kv2.1 and Kv9.3 cDNAs.    
 
Several authors have published the high level of mRNA expression of Kv2.1 and 
Kv9.3 in smooth muscle cells (Archer et al., 2004; Patel et al., 1997; Platoshyn et al., 
2004). Zhong et al, 2010 confirmed the co-expression of the two proteins in rat 
middle cerebral artery myocytes using proximity ligation assays. While the results in 
this chapter could indicate that Kv9.3 is expressed abundantly in rat hearts and lungs, 
the colocalization of Kv2.1 and Kv9.3 cannot be confirmed. In future experiments, 
staining of serial tissue sections with both antibodies should have been carried out, 
which will then enable us to compare whether these proteins are expressed in the 
same cell types or are expressed at close proximity to each other. Double staining 
using both antibodies conjugated with different fluorescent dyes could also be done 













5.1 Introduction  
 
There are several pieces of evidence implicating TASK-1 in PH. TASK-1 mutations 
have been identified in PH patients (Ma et al., 2013) and Antigny et al. (2016) 
provided further evidence that the expression of TASK-1 (KCNK3 gene) is reduced 
and the function of the channel is compromised in both human PAH and 
monocrotaline-induced PH in rats. During the development of monocrotaline-induced 
PH, TASK-1 current in freshly isolated PASMC and PAEC was found to decrease 
and this led to membrane depolarization (Antigny et al., 2016). Chronic inhibition of 
TASK-1 also gives rise to neomuscularization and early haemodynamic signs of PH 
(Antigny et al., 2016). These are associated with excess proliferation of PAEC, 
PASMC, adventitial fibroblasts, and pulmonary and systemic inflammation, 
eventually leading to pulmonary vascular remodelling  (Antigny et al., 2016). By 
restoring TASK-1 function using a pharmacological activator, monocrotaline-induced 
PH is dramatically reversed in rats (Antigny et al., 2016). Navas Tejedor et al, 2017 
identified two further mutations in TASK-1 channels which supported the claim that 
compromised TASK-1 functions could lead to cell depolarization and eventually 
causing pulmonary vasoconstriction. 
 
Mutations in several genes have been included in the PAH panel of genes for clinical 
testing. 70% of hereditary PAH and 10-40% of idiopathic PAH cases have been 
linked to mutations in bone morphogenetic protein receptor 2, BMPR2 gene (Ma and 
Chung, 2017).  Gene mutations such as activin receptor-like type 1, endoglin, 
SMAD9, TBX4, EIF2KA4, and caveolin 1 have also been associated with PAH (Ma 
and Chung, 2017). Interestingly, the finding of Navas Tejedor et al., 2017 
demonstrated that patients having missense mutation in TASK-1 but do not carry a 
mutation in BMPR2, TBX4, and EIF2KA4, are still susceptible to PAH (Navas 
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Tejedor et al., 2017). Although TASK-1 mutation is very rare, it might be worthwhile 
to consider it as a standard in PAH diagnosis in the future.  
 
Another interesting finding which links TASK-1 to PH is the colocalization of TASK-
1 with Nox4. It is hypothesized that there is a possible interaction between them since 
they are expressed together (Lee et al, 2006, Buttigieg et al, 2012, Mittal et al, 2012). 
It is widely known that TASK-1 current can be inhibited by low extracellular pH and 
hypoxia (Mathie et al., 2010a). The fact that TASK-1 channels can be inhibited by 
hypoxia makes it seem plausible that TASK-1 channels are expressed in oxygen-
sensing cells such as pulmonary neuroepithelial bodies (NEB) (Lee et al., 2006). 
Since TASK-1 per se is not capable of sensing oxygen, this capability must be 
conferred by a regulatory protein which interacts with TASK-1 (Lee et al., 2006). It 
was proposed that this interacting partner is Nox4 (Lee et al., 2006). The group went 
on to validate via confocal microscopy experiments that Nox4 does indeed colocalizes 
with TASK-1 in the plasma membrane (Lee et al., 2006). Interestingly, co-expression 
of Nox4 with TASK-1 dramatically magnified the effect of hypoxia on reducing 
TASK-1 current and this effect is abolished when siRNA and NADPH oxidase 
inhibitors targeting Nox4 are present (Lee et al., 2006). Co-immunoprecipitation data 
from several groups confirmed that Nox4 interacts with TASK-1 (Lee et al., 2006, 
Cutz et al., 2009 and Buttigieg et al, 2012). It has also been shown that Nox2 formed 
molecular complexes with Kv3.3 and Kv4.3 but not with TASK-1, indicating that 
different affinity of Nox proteins to different K+ channels could confer different 
physiological functions (Lee et al., 2006). In contrast to the data where the inhibition 
of TASK-1 current by hypoxia is augmented by the presence of Nox4 (Lee et al, 
2006), other studies concluded that Nox2 is the predominant oxygen sensor as this 
isoform, but not Nox4, suppressed hypoxia-induced serotonin release (Cutz et al, 
2009). In addition, downregulation of Nox2 mRNA also inhibited the hypoxia-
sensitive outward current (Cutz et al., 2009). These conflicting data warrant deeper 
further investigation into the functional relationship of TASK-1 and Nox4.  
 
TASK-1 current is very small in mammalian expression system. This is because WT 
TASK-1 contains a dibasic motif KR at N-terminus and a tribasic motif KRR at the 
C-terminus, which act as retention signals (OÕKelly and Goldstein, 2008; Zuzarte et 
al., 2009). These motifs are binding sites of a chaperone protein, COP1, which retain 
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TASK-1 in the endoplasmic reticulum, causing reduced surface expression, and thus 
reduced whole-cell current (OÕKelly and Goldstein, 2008; Zuzarte et al., 2009).  
However, binding of another chaperone protein, 14-3-3, will sterically hinder these 
sites from interacting with COP1, thus supporting the trafficking of TASK-1 channels 
to the plasma membrane (OÕKelly and Goldstein, 2008; Zuzarte et al., 2009). There 
are several ways to increase the surface expression of TASK-1 such as ablation of the 
dibasic motif at the N-terminus (OÕKelly and Goldstein, 2008) and phosphorylation of 
the serine residue (-RRSSV) at the C-terminus to prevent COP1 binding even in the 
absence of 14-3-3 (Kilisch et al, 2016).  
A small outward TASK-1 current might make it difficult to detect any changes of the 
current due to the presence of an activator or an inhibitor. Therefore the experiments 
in this chapter have additionally used a TASK-1 variant, where the KR residues 
specifically at position 2 and 3 of the N-terminus have been mutated to NQ (K2N 
R3Q) (OÕKelly and Goldstein, 2008). Ablation of this retention signal has been 
reported to increase surface expression by 2.7 fold (Zuzarte et al., 2009).  
ROS production escalates in many pathophysiological states such as apoptosis and in 
diseases where inflammation is involved such as PH (Binder et al., 1999). It is thus of 
interest to study how ROS modulate TASK-1 channels in the absence and presence of 
Nox4. Duprat et al., 2005 have shown that chloramine-T (Ch-T), which produces a 
ROS known as singlet oxygen, strongly activates TALK-1 (104.9±8.4%) and TALK-
2 (70.7±15.3%), while inhibiting TASK-2 (46.5±2.5%,). This shows that the 
sensitivity of TALK family to ROS is dependent of their redox status (Duprat et al., 
2005). Ch-T affects TASK-2 and TALK-1 at all potentials. However, Ch-T did not 
affect current kinetics of TALK-1 but Ch-T causes TASK-2 to be activated earlier 
(129.5±2.7ms) in comparison with control (140.4 ± 7.5ms) (Duprat et al., 2005). 
 
Noteworthy, ROS seem to have specific targets. For example, the most commonly 
described ROS, superoxide, affects the gating properties of channels from the same 
family in different ways (Duprat et al., 2005). Superoxide activates TALK-2 and 
TASK-2, but inhibits TALK-1 (Duprat et al., 2005). Interestingly, TALK-2 is almost 
silent at rest but ROS induce a high level of activation (Duprat et al., 2005). While 
xanthine/ xanthine oxidase or rose bengal has a bigger effect on TASK-2 than on 
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TALK-1, Ch-T has a stronger effect on TALK-1 (Duprat et al., 2005). This again 
exemplifies that ROS have specific modes of action on the channels and it would be 




5.2 Results  
 
Presence of a leak current in cells transfected with WT TASK-1 is confirmed  
 
tsA-201 cells were transfected with WT-TASK-1 + GFP, Nox4 + GFP, GFP only, or 
were untransfected. The electrophysiology protocol used to obtain recordings has a 
voltage-step and a voltage-ramp part. Only currents measured in the voltage-step part 
will be considered. Currents were measured at the resting membrane potential, -
80mV, and at the stimulating pulse of -40mV, which was given for 500ms. Cells were 
then hyperpolarized to -120mV before being ramped up to +20mV. The cells are then 
repolarized to -80mV before returning to the holding potential of -60mV. Functional 
current is defined as the difference between the current at -40mV (the activation 
potential) and -80mV (resting membrane potential). The current at respective points 
were measured using pClampfit 10.2. Results were stated as Mean ± SEM.  
 
The current from WT TASK-1-transfected cells (167.4 ± 29 pA) is significantly 
higher than that in control cells, such as untransfected cells (77.5 ± 17.9 pA) or cells 
transfected with GFP (86.4 ± 5.1 pA) or Nox4 + GFP only (70.4 ± 8.9 pA) when data 
were analyzed with one-way ANOVA followed by DunnettÕs test. In this analysis, all 
the groups compared with WT TASK-1 because we are interested to see if the other 
groups are different from WT TASK-1 and it was found that the differences between 
these groups compared with WT TASK-1 were statistically significant, p ≤ 0.05. 
When all the groups were analyzed using one-way ANOVA followed by TukeyÕs test, 
it was found that untransfected cells and cells transfected with Nox4 were 
significantly different from WT-TASK-1 but cells transfected with GFP were not 
statistically significant, with the p value (0.0544) near the cut-off point that we have 
set which was p ≤ 0.05. This control experiment also showed that expression of Nox4 




Figure 5.1: Presence of a leak current in cells transfected with WT TASK-1. A) Representative current 
traces for WT TASK-1, cells transfected with GFP only or Nox4 only, and untransfected cell. Cells 
transfected with the respective cDNAs were recorded using the protocol where cells were 
hyperpolarized to -80mV, and a stimulating pulse at -40mV were given for 500ms. Functional current 
is defined as the difference between the current at -40mV (the activation potential) and -80mV (resting 
membrane potential). B) Bar chart showing the functional current of untransfected cells, cells 
transfected with GFP, Nox4 only, and WT TASK-1. Data were expressed as mean ± SEM and were 
analyzed using one-way ANOVA followed by DunnettÕs test as we were interested to know whether 
there is a difference between all the other groups compared with TASK-1. It was found that the 
differences were statistically significant, with * indicating p ≤ 0.05. However, when the data were 
analyzed using one-way ANOVA followed by TukeyÕs multiple comparison test, the differences 
between WT-TASK-1 and untransfected cells and cells transfected with Nox4 are still statistically 
significant, but the difference with cells transfected with GFP only was near the threshold (p = 0.0544).  
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Gain-of-function mutant TASK-1, K2N R3Q produces significantly higher 
current than that of WT TASK-1 
 
The K2N R3Q mutant TASK-1 channel (also referred to as mutant TASK-1) is a 
mutant where the retention signal, KR, at the N-terminus has been ablated by 
changing the KR residues to NQ. This prohibits the binding of COP1 to TASK-1, 
thereby inhibiting COP1 from retaining the TASK-1 protein in the endoplasmic 
reticulum. This allows the trafficking of the TASK-1 channel to the surface 
membrane. In effect, the higher number of channels expressed on the membrane 
causes the increase in outward current. In line with the conclusions drawn by OÕKelly 
and Goldstein, 2008 and Zuzarte et al, 2009, the current of cells transfected with K2N 
R3Q mutant TASK-1 (389.6 ± 6.6 pA) is approximately 2.7-fold higher than those 

















Figure 5.2: Current produced by K2N R3Q gain-of-function mutant TASK-1 is significantly higher 
than that of WT TASK-1. tsA-201 cells were transfected with WT TASK-1 + GFP and Mutant TASK-
1 + GFP and electrophysiology recordings were obtained with a protocol where the cells were first 
hyperpolarized to -80mV from a holding potential of -60 mV. The cells were then given a test pulse at -
40mV for 500ms. Cells were then hyperpolarized to -120mV before being ramped up to +20mV. The 
cells are then repolarized to -80mV before returning to the holding potential of -60mV. Functional 
current was taken to be the difference between the current measured at -80mV and at +40mV. The 
difference between the functional currents produced by the cells were analyzed using StudentÕs t-test 
with Welch correction due to presence of unequal variances. A) Representative traces for WT TASK-1 
and K2N R3Q Mutant TASK-1 cells. B) Bar chart depicting current of WT TASK-1 compared with 
K2N R3Q Mutant TASK-1; ** indicates that the K2N R3Q Mutant TASK1 current is significantly 
higher than that of WT TASK-1, p = 00093 (p ≤ 0.01), indicated by **. 
 
 
Nox4 does not have any effect on the current of WT or mutant TASK-1 under 
normoxia  
 
Lee et al, (2006) have demonstrated that Nox4 inhibits WT TASK-1 under hypoxic 
conditions. This project aims to investigate whether this is true with K2N R3Q mutant 
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TASK-1 under normoxic conditions. Figure 5.3 shows that the effect of Nox4 on WT 
and mutant TASK-1 is not significant. 
 
 
Figure 5.3: Nox4 does not have any effect on the current of WT or K2N R3Q mutant TASK-1 under 
normoxia. A) Representative traces for WT TASK-1 and WT TASK-1/Nox4 cells. B) Representative 
traces for K2N R3Q Mutant TASK-1 and K2N R3Q Mutant TASK-1/Nox4 cells. Bar charts comparing 
C) current of WT TASK-1 (167.5 ± 29 pA) compared with WT TASK-1/Nox4 (176.3 ± 21.6 pA) 
(p=0.3730) and D) current of K2N R3Q mutant TASK-1 (389.6 ± 61.6 pA) compared with K2N R3Q 
mutant TASK-1/Nox4 (360.8 ± 36.5 pA) (p=0.5334). Functional current was taken to be the difference 
between the current measured at -80mV and at +40mV. The difference between the functional currents 
produced by the cells were analyzed using StudentÕs t-test with Welch correction due to presence of 
unequal variances. 
 
Following from the results above which suggest that Nox4 does not regulate TASK-1, 
we were interested to find out if Nox4 acts as an oxygen sensor only at hypoxic 
condition, in other words, in the presence of a ROS agent. Although Nox4 is 
constitutively active, results in Chapter 3 demonstrated that co-expression of this 
protein with either Kv2.1 or Kv2.1/Kv9.3 did not affect the current amplitude, 
















































































could act as an oxygen sensor in the presence of a ROS agent and not in normoxic 
conditions. 
 
In order to test the hypothesis that Ch-T affects the K2N R3Q mutant TASK-1 co-
expressed with Nox4, cells transfected with K2N R3Q mutant TASK-1 and Nox4 
cDNAs were perfused with 1mM Ch-T. As mentioned previously and demonstrated 
in the results above (Figure 5.2), there is a very low current going through the WT 
TASK-1 channel and in order to detect any changes in the current due to the presence 
of Ch-T, we used the gain-of-function K2N R3Q mutant TASK-1 instead. Another 
modification has been made in the protocol is the use of the high K+ external buffer 
(25mM KCl), instead of the usual low K+ external buffer (2.5mM KCl), following 
from the observation made by Lee et al, 2006, to increase the outward current through 
the gain-of-function K2N R3Q mutant TASK-1 channel.  
 
 
Ch-T does not affect the current of K2N R3Q mutant TASK-1/Nox4 cells 
 
As evident in Figure 5.4, the current traces showed that Ch-T does not have a 
significant effect on the current activated by K2N R3Q Mutant TASK-1 co-expressed 
with Nox4. When the functional currents were analyzed for K2N R3Q mutant TASK-
1 in the absence and presence of Ch-T (553.4 ± 60.7 pA vs 545.5 ± 62.2 pA) and K2N 
R3Q mutant TASK-1/Nox4 in the absence and presence of Ch-T (525.6 ± 96.2 pA vs 








Figure 5.4: Ch-T does not affect the current of mutant TASK-1/Nox4 cells. Cells were transfected with 
the respective cDNAs or combination of cDNAs. The electrophysiology protocol used were the same 
as the one described above. During recordings, cells were first perfused with external solution for 15 
sweeps and then with Ch-T for the other 15 sweeps. Representative current trace of Mutant TASK-1 in 
the absence and presence of 1mM Ch-T. Bar chart showing the mean current ± SEM of Mutant TASK-
1 in the absence vs presence of Ch-T (553.4 ± 60.7 pA vs 545.5 ± 62.2 pA), Mutant TASK-1/Nox4 and 
Mutant TASK-1/Nox4 in the absence vs presence of Ch-T (525.6 ± 96.2 pA vs 469.6 ± 95.3 pA). One-
way ANOVA with Tukey HSD post-hoc analysis revealed that there is no statistically significant 










































































TASK-1 mutations have been identified in PH patients, implicating the channel in the 
pathological state of PH (Ma et al., 2013). For years, BMPR2, activin receptor-like 
type 1, endoglin, SMAD9, TBX4, EIF2KA4, and caveolin 1 have been used as the 
standard gene mutations for diagnosis of PH patients (Guignabert et al., 2015). In 
addition to loss of function TASK-1 mutations, reduction in TASK-1 expression 
could also compromise the function of this channel (Antigny et al., 2016). Research 
on monocrotaline-induced PH in rats showed that reduction in TASK-1 current 
caused membrane depolarization, which further led to neomuscularization and early 
haemodynamic events (Antigny et al, 2016).   Recently, Navas Tejedor et al, 2017 
have demonstrated that patients having missense mutation in TASK-1 but do not 
carry mutation in BMPR2, TBX4, and EIF2KA4, are still susceptible to PAH. This 
observation further strengthens the implication of TASK-1 in the disease.  
 
The relationship between TASK-1 and Nox4 is well documented. Nox4 has been 
shown to be upregulated in hypoxia and it colocalizes with TASK-1 (Lee et al, 2006, 
Mittal et al, 2007, Mittal et al, 2011, Buttigieg et al, 2012). Although TASK-1 is 
present in specialized cells that have oxygen-sensing properties, such as carotid 
bodies, neuroepithelial bodies, and PASMC, TASK-1 per se is not an oxygen sensor 
(Lee et al., 2006). Thus, it is postulated that an interacting partner of the ion channel 
is the one conferring such property. Nox4 has been shown to colocalize and regulate 
the function of TASK-1 in hypoxia (Lee et al, 2006).  
 
Results from this current study confirmed that K2N R3Q gain-of-function mutant 
TASK-1  has higher current than WT TASK-1, whereby the mutation of the retention 
signal KR to NQ in the N-terminus (OÕKelly and Goldstein, 2008; Zuzarte et al., 
2009), improves the trafficking of the channel to the membrane, thereby increasing 
current that flows through the channel. Since the difference in current at -80mV and at 
-40mV is very small in WT TASK-1, any inhibition to the current might be difficult 
to visualize, especially if the inhibition effect is very small. Therefore, we decided to 
measure the effect of Nox4 on the K2N R3Q mutant TASK-1 and compare it with the 
WT TASK-1. In line with the results published by Lee et al, 2006, Nox4 does not 
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inhibit either the WT or K2N R3Q mutant TASK-1 current in normoxia. We initially 
hypothesized that since Nox4 colocalizes with TASK-1 and that Nox4 is 
constitutively active, the ROS generated from Nox4 might be sufficient to create the 
hypoxic inhibition effect on TASK-1. From this study, we can conclude that this is 
not the case. This agrees with several results that have been published where Nox4 
only acts as an oxygen sensor when there is a change from normoxic to hypoxic 
conditions (20% O2 to 1% O2) (Lee et al, 2006, Mittal et al, 2011). This showed that 
the colocalization of Nox4 with an ion channel is not enough to affect the ion channel 
and that a stimulus (hypoxia) must be present. This is consistent with the findings of 
Lee et al, 2006, where they showed that Nox4 does not affect Kv1.5 current in 
normoxia even though they colocalize together. On the other hand, Mittal et al, 2011 
showed that Nox4 does inhibit Kv1.5 current in rat PASMC isolated from rats 
exposed to chronic hypoxia for three weeks. In short, these arguments might suggest 
that Nox4 functions as an oxygen sensor in hypoxia and it might be that Nox4 inhibit 
TASK-1 current by inducing a conformational change during binding or by any other 
manner, as simply generating ROS (such as H2O2) is not enough to affect TASK-1 
current. This is further supported by the observation that 326 mM H2O2 applied to 
cell-attached or outside-out patches does not affect TASK-1, TASK-3 and TASK-1/3 
heteromer transiently-transfected on HeLa cells although 16mM H2O2 applied to 
inside-out patches activated these channels (Papreck et al., 2012). From this 
experiment, it was concluded that ROS does not affect TASK activity and ROS are 
likely not the hypoxic signal that increases membrane excitability due to inhibition of 
TASK channels (Papreck et al., 2012). The latter could suggest that Nox4 is 
responding to other factors that causes hypoxia and not to ROS.  
 
It is tempting to speculate that restoration of BMPR2 (mutation associated with large 
percentage of PH patients) and/or TASK-1 function could alleviate PH. Bone 
morphogenetic protein (BMP) synthesis is prioritized in bones that support weight, 
like tibia and as a result, lighter bones (possibly ribs or bone structures that protects 
the heart and lungs) do not heal well (Palencia-Desai et al., 2015). The issues with 
restoration of BMP by injection are its high cost and that it might stimulate too much 
bone growth, and oftentimes at undesirable places (Tannoury and An, 2014).  Levin, 
2013 has suggested that while most focus has been dedicated to understanding the 
transcriptional and biochemical regulation of cell proliferation and differentiation, 
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bioelectrical properties could also have a profound impact on these processes (Levin, 
2013, Adams et al, 2016). This could mean that the function of TASK-1 goes beyond 
controlling K+ ion movement across the cells to control vasoconstriction, as TASK-1 
could very well affect gene expression or the bioelectrical crosstalk that could have 
downstream effects in controlling cell behaviour and morphogenesis which could lead 
to pulmonary vascular remodelling. This is in agreement with the study of Leithner et 
al., 2016 which showed that TASK-1 is pro-proliferative. While being pro-
proliferative is not normally viewed as a beneficial function in the case of PH, as 
pulmonary vascular remodelling  occurs due to uncontrollable cell proliferation of 
certain cell types that causes lumen obstruction, TASK-1 could be supporting the 
proliferation of cells that can help with clearing aberrant inflammatory cells, or to 
increase the proportion of cells that can provide a negative feedback loop to stop the 
proliferation of the problematic cell types (such as PAEC and collagen). These 
speculations await deeper research into the understanding of TASK-1 function and its 
associated partners.  
 
The effect of singlet oxygen produced by Ch-T on TASK-2 (Duprat et al., 2005) 
piqued our interest as to what effects this ROS  agent might have on TASK-1 channel 
coexpressed with an oxygen-sensor protein, Nox4. It might not be surprising that no 
change in current is observed in the K2N R3Q mutant TASK-1, either expressed 
alone or with Nox4, in the presence of Ch-T. This is because TASK-1 and TASK-2, 
despite having similar names, actually belong to different families (Enyedi and 
Czirjak, 2004). TASK-2 belongs to the TALK family instead of the TASK family. 
(Enyedi and Czirjak, 2004). Moreover, the modes of action of ROS are very specific 
(Duprat et al., 2005). The singlet oxygen produced by Ch-T affects K+ channels 
belonging to the same family in different ways, as it inhibits TASK-2 while strongly 
activating TALK-1 and TALK-2 (Duprat et al., 2005). More interestingly, different 
ROS agents regulate these channels in different manner (Duprat et al., 2005). The 
most commonly known ROS, superoxide, affects both TASK-2 and TALK-2, but not 
TALK-1 (Duprat et al., 2005). The fact that TASK-1 is unaffected compared with the 




Chapter 6: Modulation of Kv2.1, Kv9.3, and Nox4 by 
hydrogen peroxide (H2O2), dithiothreitol (DTT), 5-5Õ-
dithiobis-2-nitrobenzoic acid (DTNB), chloramine-T (Ch-T), 






Hydrogen peroxide (H2O2) is a well-known ROS in the pulmonary vasculature 
(Harrison et al., 2007). The question as to whether the main producer of H2O2 in the 
pulmonary vasculature is Nox4 or mitochondria still remains unanswered (Brandes et 
al., 2010; Harrison et al., 2007; Lee et al., 2013; Mittal et al., 2012). The hypothesis 
that Nox4 is the primary H2O2 producer will be studied. In contrast with other Nox 
proteins (Nox1−Nox3 and Nox5), Nox4 produces H2O2 instead of superoxide 
(Nisimoto et al., 2014). However, this result has also been debated because the 
possibility of Nox4 producing superoxide and compartmentalizing it in the 
membrane, thereby preventing detection, cannot be ruled out (Nisimoto et al., 2014).  
 
Although there is much evidence pointing to the harmful effects of ROS to biological 
processes which could lead to inflammation and hypertension (Harrison et al., 2007; 
Touyz, 2004), there is also evidence substantiating the role of H2O2 as a signalling 
molecule in the presence of other harmful stimuli in order to initiate a counter 
balancing mechanism to take place (S. W. Park et al., 2015) 
One of the potential targets of H2O2 is Kv channels. However, it still remains 
controversial as to whether H2O2 activates Kv channels and therefore acts as a 
vasodilator or it inhibits target channels and acts as a vasoconstrictor (S. W. Park et 
al., 2015). This is because there has been evidence supporting either sides of the 
argument and some even reporting that both are true (S. W. Park et al., 2015).  
Reasons that could account for these different findings could be the experimental 
design and the vascular bed or vessels used in research (S. W. Park et al., 2015).   
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In short, the effect of H2O2 on Kv channels still remains controversial. Therefore, it 
would be interesting to explore the effects of H2O2 on Kv2.1. Whether co-expression 
of Kv9.3 with Kv2.1 abolishes or modulates the effect of H2O2 is unknown but was 
explored. Thus, it is of interest to see how Nox4 regulates both Kv2.1 and Kv9.3 in 
the presence of H2O2. In Chapter 3, it was found that Nox4 does not inhibit Kv2.1 and 
Kv2.1/Kv9.3 current amplitude and does not have any effect on their activation 
threshold. Perhaps, this was due to the fact that the experiments were performed in 
normoxia and hence the effect of Nox4 was not visible.  
Various studies have confirmed the relationship between the redox status of the cells 
and the effect on Kv channels (Archer et al., 2004; Park et al., 1997, Ward and 
McMurty, 2009). Park et al, 1997 showed that the reducing agent dithiothreitol (DTT) 
decreased Kv current while oxidizing agent, 2,2Õ-dithio-bis(5-nitropyridine), DTNBP 
increased Kv current. DTT also accelerated the inactivation kinetics while DTNBP 
accelerated activation kinetics (Park et al., 1997). 
 
However, this argument that, when the cell is oxidized or reduced will activate or 
inhibit Kv channels respectively, has been debated as other research has shown that 
oxidizing agent and reducing agent do not always have opposing effect on Kv current. 
The reason as to why remains elusive. To illustrate this point, Park et al., 1997, have 
studied the effect of DTT and DTNBP on the activation and inactivation time course 
of Kv current in the PASMC (Park et al., 1997). For the activation time course 
experiments, DTNBP reduced the time constant significantly while DTT had no effect 
on the activation time constants of Kv currents in the PASMC. However, DTT does 
not have an exactly opposing effect to that of DTNBP, because DTT increased the 
time constants at potentials <10mV but decreased the time constants at potentials 
>40mV (Park et al., 1997). In terms of inactivation time course, DTT decreased the 
fast component of time constant but it does not affect the slow component. DTNBP 
does not have any effect in either of the time constant components (Park et al., 1997).  
 
In our studies, we are interested in the effects of reducing (DTT) and oxidizing (5,5Õ-
dithiobis-2-nitrobenzoic acid (DTNB)) agents on Kv2.1, Kv2.1/Kv9.3 channels. In 
addition, the effect of these agents on the co-expression of Nox4 with Kv2.1 or 
Kv2.1/Kv9.3 was also probed.  
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Similar to the pulmonary vasculature, ROS such as superoxide, hydroxyl radical, 
hypochlorous acid (HOCl), and hydrogen peroxide play a pathogenic role in the 
colonic tissues (Prasad and Goyal, 2004). These ROS are usually generated following 
the polymorphonuclear neutrophils oxidative burst and they can combine with 
ammonia (NH3), which is abundant in the colon (10-70 mM luminal), to produce 
colon-specific amine-based oxidants such as monochloramine (NH2Cl) (Prasad and 
Goyal, 2004). Chloramine-T (Ch-T) is known for the generation of the ROS, singlet 
oxygen molecule (Duprat et al., 2005). Unlike other oxidizing agents such as H2O2 
and DTNB which specifically oxidizes cysteine residues, chloramine-T and NH2Cl 
can oxidize both cysteine and methionine residues (Prasad and Goyal, 2004). 
In mouse colonic myocytes, there are two major components of Kv currents known as 
transient outward K+ current (Ito) and sustained delayed rectifier K+ current (Idr) (Koh 
et al., 1999; Prasad and Goyal, 2004). Ito has fast activation and inactivation kinetics 
at subthreshold potentials and is blocked by external 4-aminopyridine. Idr activates 
above -10mV, but does not inactivate and is suppressed by tetraethylammonium 
(Prasad and Goyal, 2004). It has been shown that Ito is conducted by Kv4.1, Kv4.2 
and Kv4.3 (Koh et al., 1999). 
Interestingly, both Ch-T and NH2Cl inhibit Ito while enhancing Idr at the same time, 
whereas the cysteine-specific oxidizing agents have no effect on Idr but cause a partial 
and slow inhibition of Ito by inducing the channel to open at a more negative potential 
(about 18mV earlier) (Prasad and Goyal, 2004). 
Secondly, cysteine-specific reducing agents such as DTT and GSH abolished the 
effect of H2O2 and DTNB on Ito but they did not reverse the effect of NH2Cl and Ch-
T on either Idr or Ito (Prasad and Goyal, 2004). This shows that chemically-distinct 
oxidizing agents can modulate Kv channels in a different way. Since the cysteine-
specific H2O2 and DTNB have no effect on Idr, this suggests that modification of Idr 
by Ch-T and NH2Cl could result from methionine oxidation alone (Prasad and Goyal, 
2004). Meanwhile, suppression of Ito could result from oxidation of cysteine or 
methionine or both (Prasad and Goyal, 2004).   
In relation to pulmonary hypertension, Tanaka et al., 1998 suggested that suppression 
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of Ito channels (native A-type channels) could be explained by oxidation and this then 
can lead to a pathogenic effect such as arrhythmias in the heart.   
Since there is an established link between Ch-T and Kv current in colonic cells, it 
would be interesting to investigate whether Ch-T, which produces singlet oxygen, 
affects Kv2.1 and such regulation might be crucial in PH.  
Amphoterin-induced gene and open reading frame (AMIGO)-1 was discovered by 
Kuja-Panula et al, 2003 and has been shown to colocalize with Kv2.1. This led to the 
speculation that AMIGO1 could be an interacting partner of Kv2.1 (Kuja-Panula et 
al., 2003). Peltola et al, 2011, demonstrated that AMIGO1 changes the voltage-gating 
properties of Kv2.1 by increasing the current at voltages from -40mV to +20mV and 
causing the channel to be activated at more negative potentials, and influences the 
expression level of Kv2.1 in mammals. AMIGO1-Kv2.1 interaction has been shown 
to be essential, as mice lacking such interaction (due to AMIGO1 KO) displayed 
altered complex behavioural traits that resemble schizophrenia (Peltola et al., 2016). 
Interestingly, a separate study found that Kv9.3 mRNA levels in prefrontal cortical 
parvalbumin neurons were significantly lower (in situ hybridization reported 23% 
lower while microarray revealed 40% lower) in schizophrenia subjects (monkeys) 
(Georgiev et al., 2014). The group hypothesized that Kv9.3 is responsible for the 
precise detection of coincident excitatory synaptic inputs to parvalbumin neurons, 
which is important for the synchronization of cortical neural networks in γ-
oscillations and therefore vital for cognitive functions (Georgiev et al., 2014). The 
relationship of Kv9.3 and Kv2.1 has been established by several authors and has been 
confirmed in Chapter 3 (Kerschensteiner, 2003; Patel and Honor, 2001; Patel et al., 
1997, 1999). However, it has never been addressed what are the modes of regulation 
that will result when both AMIGO1 and Kv9.3 are co-expressed with Kv2.1 and what 
are the impacts of such modulation in the context of PH.  
!
Since AMIGO1 has been demonstrated to interact with Kv2.1, we are interested to 
probe whether AMIGO2 is also an auxiliary subunit of Kv2.1 even though the 
similarity between AMIGO1 and AMIGO2 is only 48% (Kuja-Panula et al., 2003; 
Peltola et al., 2016, 2011; Zhao et al., 2014).  While most studies pinpointed the role 
of AMIGO2 in promoting cell survival (Chen et al., 2012; Hossain et al., 2011; 
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Rabenau et al., 2004), the benefits of AMIGO2 in the context of PVR remains 
elusive. PVR occurs due to overgrowth of PASMC and PAEC and one of the stimuli 
that causes PVR is hypoxia (Huang et al., 2010; Kuhr et al., 2012). Hossain et al, 
2011, showed that AMIGO2 expression is sensitive to hypoxia and AMIGO2 
overexpression protected endothelial cells from cell death when the cells are treated 
with 50mM of H2O2 for five days. As discussed in Introduction, promotion of 
apoptosis is beneficial in PVR as overgrowth of PAEC will cause the lumen to be stiff 
and increases the resistance to blood flow (Huang et al., 2010; Kuhr et al., 2012). 
However, it could also be argued that it is the inappropriate accumulation of 
inflammatory cells or failure of the proteasome to clear dysfunctional cells plays a 
more important role in promoting PVR (Guignabert et al., 2015).  Pro-proliferation 
mechanisms to maintain the survival of normal, functional endothelial cells in the 
pulmonary vasculature should not bring adverse effects. Secondly, whether H2O2 
inhibits or activates K+ channels and thus act as a vasoconstrictor or a vasodilator, 
respectively is unclear (S. W. Park et al., 2015). Some researchers have even reported 
that H2O2 could act as both vasoconstrictor and vasodilator, depending on the 
concentration (<10mol/L elicits vasoconstrictor effect, while higher concentration will 
elicit the opposite) (Archer et al., 2004; S. W. Park et al., 2015).  One of the 
hypotheses that could explain this phenomenon could be the absence of a regulatory 
protein that will allow H2O2 to have an effect on Kv2.1. In a nutshell, it is a challenge 
to decipher whether the role of AMIGO2 in protecting endothelial cells is favourable 
in PVR. It is noteworthy that AMIGO2 has never been shown to co-express with 
Kv2.1 in vitro, hence how and whether AMIGO2 regulates Kv2.1 is not known. This 
study sought to address what are the implications of co-expression of AMIGO2 with 
Kv2.1 and Kv2.1/Kv9.3, in the absence and presence of H2O2.  
 
It is rather unanticipated that AMIGO3 promotes neuronal apoptosis, an effect that is 
opposite from its family members, AMIGO1 and AMIGO2 (Ahmed et al., 2013). In a 
study assessing the anti-aging effects of rats treated with extracts from Gryllus 
bimaculatus crickets, it has been demonstrated that AMIGO3 is one of the genes that 
was upregulated in rats with reduced level of 8-hydroxy-2Õ-deoxyguanosine (8-
OHdG) (Ahn et al., 2015). The authors suggested that the anti-oxidative effects were 
a consequence of AMIGO3 upregulation (Ahn et al., 2015). Accordingly, the effect of 
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AMIGO3 co-expression with Kv2.1 is being investigated in this study so that more 
understanding of how AMIGO3 could regulate Kv2.1 can be gained.  
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6.2 Results  
 
Effect of H2O2 on current amplitude and activation threshold 
 
The representative traces without or with the addition of 1mM H2O2 appeared similar 
and the quantification of the current of several cells confirmed that this redox agent 
does not exert an effect on the current amplitude (Figure 6.1). The standard voltage-
step protocol was used to obtain recordings, where cells were depolarized from -100 
mV to +50mV in increment of 10mV every sweep. Current measurement taken at the 
voltage-step from -100 to +50mV revealed that H2O2 does not make a difference to 
the current amplitude of Kv2.1 (Figure 6.1). Furthermore, analysis of normalized 
current also demonstrated that H2O2 does not have an impact on the activation 
threshold of Kv2.1 (Figure 6.1).  
 
Data were expressed as mean current amplitude ± SEM in the plot of current against 
voltage, and as mean normalized current ± SEM in the plot of normalized current 
against voltage. In terms of comparing the differences in current amplitude across all 
voltages, two-way ANOVA was used as I was examining two factors, which are 
presence of 1mM of H2O2 and voltages. Bonferroni method was chosen to accompany 
the two-way ANOVA as I was only analyzing two means each time and this method 
does not assume independence. The reason I have not used the Sidak method, despite 
it providing a higher statistical power and was the method recommended by the 
GraphPad Prism software, was that this method assumes that each comparison is 
independent of the others, in other words, cells that are perfused with external 
solution cannot be perfused with 1mM H2O2. Since the recordings were paired, 
meaning the same cell was used to obtain recording for external solution and 1mM 
H2O2, the Bonferroni method is appropriate in this case (Kim, 2015). Data analysis 
for normalized current were carried out using the StudentÕs t-test to examine the 
difference between cells without and with 1mM H2O2 at -30mV. The WelchÕs 










There is no apparent difference in the current traces of Kv2.1/Kv9.3 in the absence 
































Figure 6.1: H2O2 does not affect the current amplitude and activation threshold of Kv2.1. tsA-201 
cells were transfected with Kv2.1+GFP and the standard voltage-step protocol was used. Cells were 
perfused with external solution (Kv2.1) and then 1mM of H2O2 (Kv2.1/ H2O2). Representative 
traces for A) Kv2.1 and B) Kv2.1/H2O2. C) Plot of current against voltage for Kv2.1 and 
Kv2.1/2O2. D) Normalized current vs Voltage plot for Kv2.1 and Kv2.1/H2O2. Data were expressed 
as mean ± SEM. Two-way ANOVA with Bonferroni method to analyze the difference in current 
amplitude across all voltages did not reveal a statistically-significant difference between cells 
perfused without or with 1mM H2O2. StudentÕs t-test with WelchÕs correction was used to analyze 
the difference between normalized current of Kv2.1 and Kv2.1/H2O2 at -30mV because the 
variances were unequal and it revealed that there was no statistically-significant difference between 
cells perfused with external solution and H2O2. 
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step confirmed this finding (Figure 6.2 C). As demonstrated in Chapter 3 (Figure 3.5 
and Figure 3.6), the activation of Kv2.1/Kv9.3 (-40mV) occurs at a more negative 
potential than Kv2.1 (-20mV). Addition of H2O2 does not abolish the effect of Kv9.3 
on Kv2.1, as the activation threshold did not shift to a more similar trend to Kv2.1 





Figure 6.2: H2O2 does not affect the current amplitude and activation threshold of Kv2.1/Kv9.3. tsA-
201 cells were transfected with Kv2.1/Kv9.3 + GFP and the standard voltage-step protocol was used. 
Cells were either perfused with external solution (Kv2.1/Kv9.3) or 1mM of H2O2 (Kv2.1/Kv9.3/H2O2). 
Representative traces for A) Kv2.1/Kv9.3 and B) Kv2.1/Kv9.3/H2O2. C) Plot of current against voltage 
for Kv2.1/Kv9.3 and Kv2.1/Kv9.3/H2O2. D) Normalized current vs Voltage plot for Kv2.1/Kv9.3 and 
Kv2.1/Kv9.3/H2O2. Data were expressed as mean ± SEM. Two-way ANOVA with Bonferroni method 
to analyze the difference in current amplitude across all voltages did not reveal a statistically-
significant difference between cells perfused without or with 1mM H2O2. StudentÕs t-test with WelchÕs 
correction was used to analyze the difference between normalized current of Kv2.1/Kv9.3 and 
Kv2.1/Kv9.3/H2O2 at -30mV because the variances were unequal and it revealed that there was no 




































Nox4 is thought to be an H2O2 producer in the pulmonary vasculature (Mittal et al., 
2007, Nisimoto et al., 2014). However, results in Chapter 3 showed that Nox4 does 
not regulate Kv2.1. Therefore, it is not surprising that Nox4 does not facilitate or 
mediate the effect of H2O2 on Kv2.1. Results in Figure 6.3 showed that H2O2 does not 





Figure 6.3: The presence of H2O2 does not have any effect on the current amplitude and activation 
threshold of Kv2.1/Nox4. Cells were either perfused with external solution (Kv2.1/Nox4) or 1mM of 
H2O2 (Kv2.1/Nox4/H2O2). Representative traces for A) Kv2.1/Nox4 and B) Kv2.1/Nox4/H2O2. C) 
Current vs Voltage plot for Kv2.1/Nox4 and Kv2.1/Nox4/H2O2. D) Normalized current vs Voltage plot 
for Kv2.1/Nox4 and Kv2.1/Nox4/H2O2. Data were expressed as mean ± SEM. Two-way ANOVA with 
Bonferroni method to analyze the difference in current amplitude across all voltages did not reveal a 
statistically-significant difference between cells perfused without or with 1mM H2O2. StudentÕs t-test 
with WelchÕs correction was used to analyze the difference between normalized current of Kv2.1/Nox4 
and Kv2.1/Nox4/H2O2 at -30mV because the variances were unequal and it revealed that there was no 





































H2O2 does not alter the current amplitude or the activation threshold of 
Kv2.1/Kv9.3/Nox4 
 
The presence of H2O2 does not have any effect on the current amplitude of 
Kv2.1/Kv9.3/Nox4 (Figure 6.4). Moreover, it does not abolish the effect of Kv9.3 on 
the Kv2.1/Nox4 in shifting the activation threshold to a more negative (polarized) 
potential (Figure 6.4).  
 
 
Figure 6.4: H2O2 does not alter the current amplitude or the activation threshold of Kv2.1/Kv9.3/Nox4. 
Cells were either perfused with external solution (Kv2.1/Kv9.3/Nox4) or 1mM of H2O2 
(Kv2.1/Kv9.3/Nox4/H2O2). Representative traces for A) Kv2.1/Kv9.3/Nox4 and B) Kv2.1/Kv9.3/Nox4/ 
H2O2. C) Current vs Voltage plot for Kv2.1/Kv9.3/Nox4 and Kv2.1/Kv9.3/Nox4/H2O2. D) Normalized 
current vs Voltage plot for Kv2.1/Kv9.3/Nox4 and Kv2.1/Kv9.3/Nox4/H2O2. Data were expressed as 
mean ± SEM. Two-way ANOVA with Bonferroni method to analyze the difference in current 
amplitude across all voltages did not reveal a statistically-significant difference between cells perfused 
without or with 1mM H2O2. StudentÕs t-test with WelchÕs correction was used to analyze the difference 
between normalized current of Kv2.1/Kv9.3/Nox4 and Kv2.1/Kv9.3/Nox4/H2O2 at -30mV because the 
variances were unequal and it revealed that there was no statistically-significant difference between 


































Effect of H2O2 on deactivation kinetics  
 
After assessing the effect of H2O2 on the current amplitude and activation threshold 
and finding that the effects are not apparent, another method to assess whether H2O2 
has any effect on Kv2.1, Kv9.3, and Nox4 was used. The slow and fast components of 
the time constant of deactivation, tslow and tfast, were measured. The current traces 
in Figure 6.5 showed that the gradient of the slope resulting from repolarization to -
50mV from a step potential of +20mV (the 13th trace) is similar for Kv2.1, 
Kv2.1/Kv9.3, Kv2.1/Nox4, and Kv2.1/Kv9.3/Nox4 regardless of the presence of 
H2O2. The bar charts showed that the tslow and tfast of the respective cells did not 
change in the absence or presence of H2O2. Data were expressed as mean ± SEM and 
StudentÕs t-test with WelchÕs correction was used to compare the tslow or tfast for 
cells with or without H2O2. Two-way ANOVA was also used to analyze the 
difference in the means, because we are testing two factors which are the presence of 
H2O2 and the time constants (tslow and tfast). The multiple comparison tests were 
done using the Bonferroni method. Bonferroni is the most commonly used method as 
it is easy to understand, and confidence intervals can be computed. Since we are only 
analyzing two means each time, Bonferroni is appropriate. Furthermore, since the 
recordings were paired, meaning the same cell was used to obtain recording for 
external solution and 1mM H2O2, I have chosen the Bonferroni method, which does 






Figure 6.5: H2O2 does not alter the deactivation kinetics of Kv2.1, Kv2.1/Kv9.3, Kv2.1/Nox4, and Kv2.1/Kv9.3/Nox4.Current 
traces of the slope resulting from repolarization to -50mV from a step potential of +20mV for A) Kv2.1 vs Kv2.1/ H2O2, C) 
Kv2.1/Kv9.3 vs Kv2.1/ Kv9.3/H2O2, E) Kv2.1/Nox4 vs Kv2.1/Nox4/H2O2, G) Kv2.1/Kv9.3/Nox4 vs Kv2.1/Kv9.3/Nox4/2O2. 
Bar charts depicting the tslow and tfast from the slopes for B) Kv2.1 vs Kv2.1/ H2O2, D) Kv2.1/Kv9.3 vs Kv2.1/ Kv9.3/H2O2, F) 
Kv2.1/Nox4 vs Kv2.1/Nox4/H2O2, H) Kv2.1/Kv9.3/Nox4 vs Kv2.1/Kv9.3/Nox4/2O2. In the bar charts, data were expressed as 
mean ± SEM. StudentÕs t-test with WelchÕs correction was used to analyze the difference between cells perfused with external 
solution and H2O2 in terms of tslow and tfast and it was found that there is no statistically significant difference between both 
time constants of cells perfused with external solution or H2O2. Two-way ANOVA with Bonferroni test showed that the 


































































































































Effect of DTT on current amplitude and activation threshold  
Cells were transfected with either Kv2.1, Kv2.1/Kv9.3, Kv2.1/Nox4, or 
Kv2.1/Kv9.3/Nox4 cDNAs and GFP cDNA was used as a reporter. Cells were either 
perfused with external solution or 5mM DTT when recordings were obtained using 
the standard voltage-step protocol outlined in Chapter 2. Data were expressed as mean 
current amplitude ± SEM or mean normalized current ± SEM across all voltages. 
StudentÕs t-test with WelchÕs correction was used to analyze the difference between 
the normalized current of cells at -30mV, without and with 5mM DTT, as the 
variances were unequal. Multiple comparison test to compare differences in current 
amplitude across all voltages were done using two-way ANOVA and Bonferroni 
method. Since I was only comparing two populations (for example, Kv2.1 cells 
without or with 5mM DTT) at a time, Bonferroni method is recommended as it can 
compute confidence intervals and it does not assume independence. I have excluded 
the Sidak method even though it has a higher statistical power because this method 
requires samples to be independent, meaning cells that are used for reading without 
5mM DTT cannot be used for recordings with 5mM DTT. Since the readings are 
paired in the experiments, Sidak method would not be appropriate (Kim, 2015).   
 
Although it has been shown that DTT decreased the Kv current in rabbit PASMC 
(Park et al., 1997), results from this chapter demonstrated that DTT has no effect on 
the current amplitude of Kv2.1 (Figure 6.6). Consistent the findings of (Park et al., 
1997), results in Figure 6.6 showed that 5mM DTT has no significant effect on the 
steady-state activation, whereby the activation threshold of Kv2.1 were not altered 
despite the presence of DTT. Park et al., 1997 have also shown that DTT does not 
have any effect on the steady-state inactivation of Kv current. The experiments to 
investigate the steady-state inactivation of Kv2.1 and or Kv9.3 were not performed in 
this chapter and therefore a comparison with the studies performed by another group 






Figure 6.6: DTT does not alter the current amplitude and activation threshold of Kv2.1. Cells were 
transfected with Kv2.1 + GFP.  The standard voltage-step protocol was used to obtain recordings and 
cells were either perfused with external solution (Kv2.1) or with 5mM DTT (Kv2.1/DTT). 
Representative current traces for A) Kv2.1 and B) Kv2.1 with DTT. C) Current vs Voltage plot for 
Kv2.1 and Kv2.1/DTT. D) Normalized current vs Voltage plot for Kv2.1 and Kv2.1/DTT. Data were 
expressed as mean ± SEM. Two-way ANOVA with Bonferroni method to analyze the difference in 
current amplitude across all voltages did not reveal a statistically-significant difference between cells 
perfused without or with 5mM DTT. StudentÕs t-test with WelchÕs correction was used to analyze the 
difference between normalized current of Kv2.1 and Kv2.1/DTT at -30mV because the variances were 
unequal and it revealed that there was no statistically-significant difference between cells perfused with 
external solution and 5mM DTT. 
 
In addition to the finding that DTT does not alter the activation threshold of Kv2.1, 
results displayed in Figure 6.7 revealed that DTT does not have any impact on the 
current amplitude and activation threshold of Kv2.1/Kv9.3. Although Kv9.3 is a silent 































in Chapter 3, Figure 3.8 and Figure 3.9. However, in the presence of DTT, 





Figure 6.7: DTT does not alter the current amplitude and activation threshold of Kv2.1/Kv9.3. Cells 
were transfected with Kv2.1/Kv9.3 + GFP.  The standard voltage-step protocol was used to obtain 
recordings and cells were either perfused with external solution (Kv2.1/Kv9.3) or with 5mM DTT 
(Kv2.1/Kv9.3/DTT). Representative current traces for A) Kv2.1/Kv9.3 and B) Kv2.1/Kv9.3 with DTT. 
C) Current vs Voltage plot for Kv2.1/Kv9.3 and Kv2.1/Kv9.3/DTT. D) Normalized current vs Voltage 
plot for Kv2.1/Kv9.3 and Kv2.1/Kv9.3/DTT. Data were expressed as mean ± SEM. Two-way ANOVA 
with Bonferroni method to analyze the difference in current amplitude across all voltages did not reveal 
a statistically-significant difference between cells perfused without or with 5mM DTT. StudentÕs t-test 
with WelchÕs correction was used to analyze the difference between normalized current of 
Kv2.1/Kv9.3 and Kv2.1/Kv9.3/DTT at -30mV because the variances were unequal and it revealed that 




































The current traces in Figure 6.8 showed that the presence of DTT does not affect 
Kv2.1/Nox4. In the current vs voltage plot, DTT does not have any impact on 
Kv2.1/Nox4 current amplitude. Moreover, the activation threshold of Kv2.1/Nox4 




Figure 6.8: DTT does not reduce the Kv2.1/Nox4 current or shift the activation threshold. Cells were 
transfected with Kv2.1/Nox4 + GFP.  The standard voltage-step protocol was used to obtain recordings 
and cells were either perfused with external solution (Kv2.1/Nox4) or with 5mM DTT 
(Kv2.1/Nox4/DTT). Representative current traces for A) Kv2.1/Nox4 and B) Kv2.1/Nox4 with DTT.  
C) Current vs Voltage plot for Kv2.1/Nox4 and Kv2.1/Nox4/DTT. D) Normalized current vs Voltage 
plot for Kv2.1/Nox4 and Kv2.1/Nox4/DTT. Two-way ANOVA with Bonferroni method to analyze the 
difference in current amplitude across all voltages did not reveal a statistically-significant difference 
between cells perfused without or with 5mM DTT. StudentÕs t-test with WelchÕs correction was used to 
analyze the difference between normalized current of Kv2.1/Nox4 and Kv2.1/Nox4/DTT at -30mV 
because the variances were unequal and it revealed that there was no statistically-significant difference 































The co-expression of Nox4 with Kv2.1/Kv9.3 does not change the interaction of the 
Kv channels with DTT. Figure 6.9 showed that the current traces of 
Kv2.1/Kv9.3/Nox4 are similar despite the presence of DTT and the current vs voltage 
plot also revealed that DTT does not inhibit Kv2.1/Kv9.3/Nox4 current.  The 
normalized current vs voltage plot showed that DTT does not cause activation of 
Kv2.1/Kv9.3/Nox4 to occur earlier or later.  
 
	
Figure 6.9: DTT does not have an impact on Kv2.1/Kv9.3/Nox4 current amplitude and activation 
threshold. Cells were transfected with Kv2.1/Kv9.3/Nox4 + GFP.  The standard voltage-step protocol 
was used to obtain recordings and cells were either perfused with external solution 
(Kv2.1/Kv9.3/Nox4) or with 5mM DTT (Kv2.1/Kv9.3/Nox4/DTT). Representative current traces for 
A) Kv2.1/Kv9.3/Nox4 and B) Kv2.1/Kv9.3/Nox4 with DTT.  C) Current vs Voltage plot for 
Kv2.1/Kv9.3/Nox4 and Kv2.1/Kv9.3/Nox4/DTT. D) Normalized current vs Voltage plot for 
Kv2.1/Kv9.3/Nox4 and Kv2.1/Kv9.3/Nox4/DTT. Two-way ANOVA with Bonferroni method to 
analyze the difference in current amplitude across all voltages did not reveal a statistically-significant 
difference between cells perfused without or with 5mM DTT. StudentÕs t-test with WelchÕs correction 
was used to analyze the difference between normalized current of Kv2.1/Kv9.3/Nox4 and 
Kv2.1/Kv9.3/Nox4/DTT at -30mV because the variances were unequal and it revealed that there was 


































Effect of DTNB on current amplitude and activation threshold  
Cells were transfected with either Kv2.1, Kv2.1/Kv9.3, Kv2.1/Nox4, or 
Kv2.1/Kv9.3/Nox4 cDNAs and GFP cDNA was used as a reporter. Cells were either 
perfused with external solution or 2mM DTNB when recordings were obtained using 
the standard voltage-step protocol outlined in Chapter 2. Data were expressed as mean 
current amplitude ± SEM or mean normalized current ± SEM across all voltages. 
StudentÕs t-test with WelchÕs correction was used to analyze the difference between 
the normalized current of cells without and with 2mM DTNB as the variances were 
unequal. Multiple comparison test to compare differences in either current amplitude 
or normalized current across all voltages were done using two-way ANOVA and 
Bonferroni method. Since I was only comparing two populations (for example, Kv2.1 
cells without or with 2mM DTNB) at a time, Bonferroni method is recommended as it 
can compute confidence intervals and it does not assume independence. I have 
excluded the Sidak method even though it has a higher statistical power because this 
method requires samples to be independent, meaning cells that are used for reading 
without 2mM DTNB cannot be used for recordings with 2mM DTNB. Since the 
readings are paired in the experiments, Sidak method would not be appropriate.   
The oxidizing agent, DTNB does not have any impact on the current amplitude of 
Kv2.1 (Figure 6.10). In the normalized current vs voltage plot, the trends for Kv2.1 in 
the absence and presence of DTNB overlap, indicating that DTNB does not affect the 








Figure 6.10: DTNB does not alter the current amplitude and activation threshold of Kv2.1. Cells were 
transfected with Kv2.1 + GFP.  The standard voltage-step protocol was used to obtain recordings and 
cells were either perfused with external solution (Kv2.1) or with 2mM DTNB (Kv2.1/DTNB). 
Representative current traces for A) Kv2.1 and B) Kv2.1 with DTNB.  C) Current vs Voltage plot for 
Kv2.1 and Kv2.1/DTNB. D) Normalized current vs Voltage plot for Kv2.1 and Kv2.1/DTNB. Two-
way ANOVA with Bonferroni method to analyze the difference in current amplitude across all voltages 
did not reveal a statistically-significant difference between cells perfused without or with 2mM DTNB. 
StudentÕs t-test with WelchÕs correction was used to analyze the difference between normalized current 
of Kv2.1 and Kv2.1/DTNB at -30mV because the variances were unequal and it revealed that there was 
no statistically-significant difference between cells perfused with external solution and 2mM DTNB. 
 
DTNB also fails to exert any effect on Kv2.1/Kv9.3. The current amplitude of 
Kv2.1/Kv9.3 is not reduced in the presence of DTNB (Figure 6.11). The activation 

































Figure 6.11: DTNB does not affect the Kv2.1/Kv9.3 current and activation threshold. Cells were 
transfected with Kv2.1/Kv9.3 + GFP.  The standard voltage-step protocol was used to obtain 
recordings and cells were either perfused with external solution (Kv2.1/Kv9.3) or with 2mM DTNB 
(Kv2.1/Kv9.3/DTNB). Representative current traces for A) Kv2.1/Kv9.3 and B) Kv2.1/Kv9.3 with 
DTNB. C) Current vs Voltage plot for Kv2.1/Kv9.3 and Kv2.1/Kv9.3/DTNB. D) Normalized current 
vs Voltage plot for Kv2.1/Kv9.3 and Kv2.1/Kv9.3/DTNB. Two-way ANOVA with Bonferroni method 
to analyze the difference in current amplitude across all voltages did not reveal a statistically-
significant difference between cells perfused without or with 2mM DTNB. StudentÕs t-test with 
WelchÕs correction was used to analyze the difference between normalized current of Kv2.1/Kv9.3 and 
Kv2.1/Kv9.3/DTNB at -30mV because the variances were unequal and it revealed that there was no 
statistically-significant difference between cells perfused with external solution and 2mM DTNB. 
 
The presence of DTNB does not alter Kv2.1/Nox4 current amplitude (Figure 6.12). 
The activation threshold of Kv2.1/Nox4 in the presence of DTNB is identical to that 
in the absence of DTNB (Figure 6.12).  These results indicate that the presence of 




































Figure 6.12: DTNB does not affect Kv2.1/Nox4 current and has no impact on the activation threshold. 
Cells were transfected with Kv2.1/Nox4 + GFP.  The standard voltage-step protocol was used to obtain 
recordings and cells were either perfused with external solution (Kv2.1/Nox4) or with 2mM DTNB 
(Kv2.1/Nox4/DTNB). Representative current traces for A) Kv2.1/Nox4 and B) Kv2.1/Nox4 with 
DTNB. C) Current vs Voltage plot for Kv2.1/Nox4 and Kv2.1/ Nox4/DTNB. D) Normalized current vs 
Voltage plot for Kv2.1/Nox4 and Kv2.1/ Nox4/DTNB. Two-way ANOVA with Bonferroni method to 
analyze the difference in current amplitude across all voltages did not reveal a statistically-significant 
difference between cells perfused without or with 2mM DTNB. StudentÕs t-test with WelchÕs 
correction was used to analyze the difference between normalized current of Kv2.1/Nox4 and 
Kv2.1/Nox4/DTNB at -30mV because the variances were unequal and it revealed that there was no 
statistically-significant difference between cells perfused with external solution and 2mM DTNB. 
 
DTNB decreases the current amplitude of Kv2.1/Kv9.3/Nox4 (Figure 6.13) and the 
effect is statistically significant at 50mV. It is surprising that DTNB does not have 































when both Kv9.3 and Nox4 are co-expressed with Kv2.1. One of the hypotheses 
could be that the presence of both Kv9.3 and Nox4 somehow facilitates the 
interaction of DTNB on Kv2.1. However, the activation threshold of 
Kv2.1/Kv9.3/Nox4 in the presence of DTNB remains unchanged (Figure 6.13).  
 
 
Figure 6.13: DTNB significantly decreases Kv2.1/Kv9.3/Nox4 current but has no impact on the 
activation threshold. Cells were transfected with Kv2.1/Kv9.3/Nox4 + GFP.  The standard voltage-step 
protocol was used to obtain recordings and cells were either perfused with external solution 
(Kv2.1/Kv9.3/Nox4) or with 2mM DTNB (Kv2.1/Kv9.3/Nox4/DTNB). Representative current traces 
for A) Kv2.1/Kv9.3/Nox4 and B) Kv2.1/Kv9.3/Nox4/DTNB.  C) Current vs Voltage plot for 
Kv2.1/Kv9.3/Nox4 and Kv2.1/Kv9.3/Nox4/DTNB. The p-value for the current at V=50mV for the 
cells was calculated to be 0.0199 (* indicates p ≤ 0.05), indicating that the difference in current is 
significant. D) Normalized current vs Voltage plot for Kv2.1/Kv9.3/Nox4 and 
Kv2.1/Kv9.3/Nox4/DTNB. Two-way ANOVA with Bonferroni method revealed that there is no 
statistically-significant difference in the current amplitudes for all voltages, except at 50mV, where the 
p = 0.0315, so p ≤ 0.05 indicated by *. In terms of normalized current at -30mV, StudentÕs t-test with 
WelchÕs correction showed that there is no statistically-significant difference between cells perfused 





Effect of chloramine-T on current amplitude and activation threshold  
Recordings of transiently-transfected cells were done using standard voltage-step 
protocol. Data were expressed as mean ± SEM and the current amplitudes at 50mV 
were first analyzed using StudentÕs t-test with WelchÕs correction due to unequal 
variances. Two-way ANOVA was used to compare all readings of current amplitudes 
and normalized currents across all voltages. This is followed by Bonferroni procedure 
to examine whether they are differences between cells perfused with external solution 
and 1mM Ch-T.  
In contrast to the inhibitory effect of Ch-T on transient outward K+ current (Ito) or 
enhancing effect on sustained delayed rectifier K+ current (Idr) (Prasad and Goyal, 
2004), Ch-T does not affect the Kv2.1 current (Figure 6.14). This could probably 
suggest that Kv2.1 might not be an important delayed rectifier current contributor in 
the colon. Another reason for such discrepancy is that Kv2.1 has a different activation 
kinetic compared to mouse Kv4.1, mouse Kv4.2 and mouse Kv4.3, which were tested 
in the experiments of Prasad and Goyal, 2004. And it is also possible that the 
methionine residues on Kv2.1 are not susceptible to oxidation.  Agreeing with what 
has been reported by Prasad and Goyal, 2004, Ch-T does not alter the activation 








Figure 6.14: Chloramine-T does not have any effect on the current amplitude of Kv2.1 homomer and 
has a very moderate effect on the activation threshold. Cells were transfected with Kv2.1 + GFP.  The 
standard voltage-step protocol was used to obtain recordings and cells were perfused with external 
solution (Kv2.1) and then with 1mM Ch-T (Kv2.1/Ch-T). Representative traces for A) Kv2.1 and B) 
Kv2.1 with Ch-T.  C) Current vs Voltage plot for Kv2.1 and Kv2.1/Ch-T. D) Normalized current vs 
Voltage plot for Kv2.1 and Kv2.1/Ch-T. Two-way ANOVA with Bonferroni method to analyze the 
difference in current amplitude across all voltages did not reveal a statistically-significant difference 
between cells perfused without or with 1mM Ch-T. StudentÕs t-test with WelchÕs correction was used 
to analyze the difference between normalized current of Kv2.1 and Kv2.1/Ch-T at -30mV because the 
variances were unequal and it revealed that there was no statistically-significant difference between 
cells perfused with external solution and 1mM Ch-T. 
Similar to Kv2.1, Ch-T does not have any effect on Kv2.1/Kv9.3 current amplitude 
and activation threshold (Figure 6.15). This could indicate that neither 
































of the delayed rectifier current in the colon. The modulation effects of Kv9.3 on 




Figure 6.15: Chloramine-T does not alter the current amplitude and activation threshold of 
Kv2.1/Kv9.3. Cells were transfected with Kv2.1/Kv9.3 + GFP.  The standard voltage-step protocol was 
used to obtain recordings and cells were perfused with external solution (Kv2.1/Kv9.3) and then with 
1mM Ch-T (Kv2.1/Kv9.3/Ch-T). Representative traces for A) Kv2.1/Kv9.3 and B) Kv2.1/Kv9.3 with 
chloramine-T. C) Current vs Voltage plot for Kv2.1/Kv9.3 and Kv2.1/Kv9.3/Ch-T. D) Normalized 
current vs Voltage plot for Kv2.1/Kv9.3 and Kv2.1/Kv9.3/Ch-T.  Two-way ANOVA with Bonferroni 
method to analyze the difference in current amplitude across all voltages did not reveal a statistically-
significant difference between cells perfused without or with 1mM Ch-T. StudentÕs t-test with WelchÕs 
correction was used to analyze the difference between normalized current of Kv2.1/Kv9.3 and 
Kv2.1/Kv9.3/Ch-T at -30mV because the variances were unequal and it revealed that there was no 






























Effect of AMIGO proteins on the current amplitude and activation threshold of 
Kv2.1 
 
To assess the effect of AMIGO1, AMIGO2, and AMIGO3 proteins on Kv2.1 and 
Kv2.1/Kv9.3 cells, tsA-201 cells were transfected with the respective combination of 
cDNAs and electrophysiology recordings were obtained using the standard voltage 
step and repolarization protocols. During the patch clamp experiments, cells were 
perfused using external solution.  
 
While co-expression of AMIGO3 does not affect Kv2.1 current amplitude, AMIGO1 
decreases the current significantly from 0mV to 50mV, while AMIGO2 reduces 
current from 40mV to 50mV (Figure 6.16). This result could suggest that AMIGO1 is 
associated with Kv2.1 as it is modulating Kv2.1 function. However, this result is in 
contrast to the finding by Kuja-Panula et al, 2003, where the researchers found that 
AMIGO1 increased the Kv2.1 current at voltages from -40mV to +20mV. The effect 
of AMIGO1 was most significant at the threshold of activation (Peltola et al., 2011). 
Whether this could further suggest that another interacting partner besides AMIGO1 
needs to be present in order for us to observe the same effect as Kuja-Panula et al, 
2003Õs group awaits further experimentation. Another reason that could lead to such 
discrepancy could be that the other researchers used a mouse AMIGO1 while human 
AMIGO1 was used in our experiment. The difference in the repolarization protocol 
right after the voltage-step could also have contributed to the discrepancy in results.  
 
In terms of activation threshold, one-way ANOVA with DunnettÕs test was used to 
analyze the difference in normalized current of Kv2.1, Kv2.1/AMIGO1, 
Kv2.1/AMIGO2, and Kv2.1/AMIGO3 at -30mV. The voltage -30mV is chosen 
because this is the voltage used for comparison in Chapter 3. The analysis revealed 
that there is statistical significant difference between the normalized current of Kv2.1 
and Kv2.1/AMIGO2 at -30mV (Figure 6.16). Since the currents at different voltages 
were normalized to the current at 50mV resulting in all the normalized current to 
approach the value of 1.0, it will be inappropriate to analyze all the readings at every 




Figure 6.16: Effect of AMIGO proteins on current amplitude and activation threshold of Kv2.1. Current traces of A) Kv2.1, B) 
Kv2.1/AMIGO1, C) Kv2.1/AMIGO2, D) Kv2.1/AMIGO3. E) IV relationship of Kv2.1 in the presence of AMIGO1, AMIGO2, 
and AMIGO3 compared with Kv2.1 alone.  Two-way ANOVA followed by DunnettÕs test with Kv2.1 as control group showed 
that AMIGO1 reduces Kv2.1 current amplitude and this effect is statistically significant from 0mV to 50mV, with * indicating p 
≤ 0.05, ** indicating p ≤ 0.01, *** indicating p ≤ 0.001, **** indicating p < 0.0001. Current reduction effect due to coexpression 
of Kv2.1 with AMIGO2 is smaller, but is statistically significant at 40mV and 50mV, with * indicating p ≤ 0.05 and ** 
indicating p ≤ 0.01. F) Normalized current of Kv2.1 in the presence of AMIGO1, AMIGO2, and AMIGO3 compared with Kv2.1 
alone. One-way ANOVA followed by DunnettÕs test with Kv2.1 set as control group to analyze the difference in the normalized 










Effect of AMIGO proteins on the current amplitude and activation threshold of 
Kv2.1/Kv9.3 
 
Similar to the finding above, AMIGO1 has been found to reduce the current of the 
Kv2.1/Kv9.3 (Figure 6.17). Data were analyzed using two-way ANOVA followed by 
DunnettÕs test with Kv2.1/Kv9.3 as control group. The analysis showed that AMIGO1 
reduces Kv2.1/Kv9.3 current amplitude and this effect is statistically significant from 
-10mV to 50mV (Figure 6.17). Current reduction effect due to coexpression of 
Kv2.1/Kv9.3 with AMIGO2 is statistically significant from 0mV to 50mV (Figure 
6.17).  
 
It is interesting to note that co-expression of AMIGO1 with Kv2.1/Kv9.3 resulted in a 
lower current amplitude (4717.9±662 pA, n=25) compared with Kv2.1/AMIGO1 
(5604.6±4230 pA, n=35) at 50mV (Figure 6.16E and Figure 6.17E). This could 
indicate that the effect of AMIGO1 is enhanced when Kv2.1 is present together with 
Kv9.3 as the percentage of reduction of current amplitude is about 15.8%. While 
AMIGO2 significantly reduced Kv2.1 homomer current at 40mV and 50mV, 
AMIGO2 significantly reduced the current of Kv2.1/Kv9.3 heteromer (Figure 6.17) 
from 0mV onwards. This observation could signify that Kv9.3 is needed for the 
interaction of AMIGO2 with Kv2.1. On the other hand, co-expression of AMIGO3 
with Kv2.1/Kv9.3 displayed a similar I-V relationship to Kv2.1/Kv9.3, indicating that 
AMIGO3 does not affect the current amplitude (Figure 6.17).  
 
AMIGO2 also shifts the Kv2.1/Kv9.3 heteromerÕs activation threshold to a more 
depolarized potential (Figure 6.17). However, the extent of the effect is greater than 
on Kv2.1 homomer, judging by the p-value obtained from analyzing the current at -
30mV (Figure 6.17F vs Figure 6.16F). This observation is in agreement with the 






Figure 6.17: Effect of AMIGOs on current amplitude and activation threshold of Kv2.1/Kv9.3. AMIGO1 and AMIGO2 reduce 
the current amplitude of Kv2.1/Kv9.3. Current traces of A) Kv2.1/Kv9.3, B) Kv2.1/Kv9.3/AMIGO1, C) Kv2.1/Kv9.3/AMIGO2, 
D) Kv2.1/Kv9.3/AMIGO3. E) IV relationship of Kv2.1/Kv9.3 in the presence of AMIGO1, AMIGO2, and AMIGO3 compared 
with Kv2.1 alone. Two-way ANOVA followed by DunnettÕs test with Kv2.1/Kv9.3 as control group showed that AMIGO1 
reduces Kv2.1/Kv9.3 current amplitude and this effect is statistically significant from -10mV to 50mV, with ** indicating p ≤ 
0.01, *** indicating p ≤ 0.001, **** indicating p < 0.0001. Current reduction effect due to coexpression of Kv2.1/Kv9.3 with 
AMIGO2 is statistically significant from 0mV to 50mV, with * indicating p ≤ 0.05, ** indicating p ≤ 0.01, **** indicating p < 
0.0001. F) Normalized current of Kv2.1/Kv9.3 in the presence of AMIGO1, AMIGO2, and AMIGO3 compared with 
Kv2.1/Kv9.3 alone. One-way ANOVA followed by DunnettÕs test with Kv2.1/Kv9.3 as control group to analyze the difference 
in the normalized current at -30mV revealed that there is statistical significant difference between the Kv2.1/Kv9.3/AMIGO2 and 













AMIGO2 increases the tslow and tfast of Kv2.1 
 
AMIGO2 was found to have profound effects on both the slow and fast inactivation 
kinetics of Kv2.1, evident both in the current trace resulting from repolarization to -
50mV from +20mV and in the bar charts depicting the tslow and tfast (Figure 6.18). 
AMIGO2 delayed both the slow and fast components of the Kv2.1 deactivation time 
(Figure 6.18). When assessing the effects of AMIGO2 on current amplitude, the 
current reduction effect appeared at a hyperpolarized potential when AMIGO2 is 
coexpressed with Kv2.1/Kv9.3 than with Kv2.1 (starting at 10mV for 
Kv2.1/Kv9.3/AMIGO2 and at 40mV for Kv2.1/AMIGO2) (Figure 6.16E and Figure 
6.17E). Therefore, assessment of the deactivation kinetics might be a different method 
to characterize the presence of AMIGO2 protein. This observation could also suggest 
that AMIGO2 is causing the Kv2.1 channel to be inactivated for longer without 
affecting current amplitude or causing the channel to be activated earlier. Overall, this 
effect on delaying the deactivation kinetics will result in longer time for the next 
action potential to be transduced. This is because the channel has to recover from 
inactivation before the next action potential can be generated.  
 
Interestingly, AMIGO1 was shown to reduce Kv2.1 current amplitude (Figure 6.16) 
yet it does not have any effect on the deactivation kinetics (Figure 6.18). The reason 
as to why the AMIGO1 and AMIGO2 proteins have reversed effects, with the former 
affecting current amplitude yet does not affect the tslow and tfast of Kv2.1 and the 
latter reducing Kv2.1 current at a more depolarized potential yet have a profound 
effect in deactivation kinetics, is not known. AMIGO1 and AMIGO2 presumably 
interact with Kv2.1 in a different manner. On the other hand, AMIGO3 does not 







Figure 6.18: AMIGO2 increases the tslow and tfast of Kv2.1. A) Current traces resulting from the 
depolarization to -50mV from +20mV for Kv2.1, Kv2.1/AMIGO1, Kv2.1/AMIGO2, and 
Kv2.1/AMIGO3. Bar chart showing the B) slow deactivation kinetics (tslow) and C) fast deactivation 
kinetics (tfast) of Kv2.1, Kv2.1/AMIGO1, Kv2.1/AMIGO2, and Kv2.1/AMIGO3. One-way ANOVA 
with DunnettÕs test revealed that there is a statistically-significant difference between tslow and tfast of 








AMIGO2 increases the tslow of Kv2.1/Kv9.3 while AMIGO1 decreases the tfast 
of Kv2.1/Kv9.3 
 
Although AMIGO2 exerts its effect on the tslow of Kv2.1/Kv9.3, AMIGO2 has no 
effect on the tfast of Kv2.1/Kv9.3 (Figure 6.19). Surprisingly, AMIGO1 accelerates 
the fast component of inactivation kinetics of Kv2.1 when Kv9.3 is present (Figure 
6.19). The effect of AMIGO1 on the tfast of Kv2.1/Kv9.3 revealed that AMIGO1 
might interact with Kv9.3, although AMIGO1 does not affect the activation threshold 
of Kv2.1/Kv9.3 (Figure 8.6). The difference in inactivation times observed when 
different AMIGO proteins are co-expressed with the Kv2.1/Kv9.3 heteromer could 
prove that the characterization of different AMIGO proteins associated with 
Kv2.1/Kv9.3 based on calculation of inactivation times gave insights into how the 









Figure 6.19: AMIGO2 increases the tslow of Kv2.1/Kv9.3 while AMIGO1 decreases the tfast of 
Kv2.1/Kv9.3. A) Current traces resulting from the depolarization to -50mV from +20mV for 
Kv2.1/Kv9.3, Kv2.1/Kv9.3/AMIGO1, Kv2.1/Kv9.3/AMIGO2, and Kv2.1/ Kv9.3/AMIGO3. Bar chart 
showing the B) slow deactivation kinetics (tslow) and C) fast deactivation kinetics (tfast) of Kv2.1 
Kv9.3/, Kv2.1/Kv9.3/AMIGO1, Kv2.1/Kv9.3/AMIGO2, and Kv2.1/Kv9.3/AMIGO3. One-way 
ANOVA with DunnettÕs test revealed that there is a statistically-significant difference between tslow of 
Kv2.1/Kv9.3 and Kv2.1/Kv9.3 AMIGO2 and between tfast of Kv2.1/Kv9.3 and Kv2.1/Kv9.3 






Effect of H2O2 on the current amplitude and activation threshold of 
Kv2.1/AMIGO2  
 
As demonstrated above (Figure 6.16), AMIGO2 only affects the current amplitude of 
Kv2.1 at 40mV onwards. In line with the results where addition of H2O2 did not affect 
the current amplitude of Kv2.1 (Figure 6.1), the presence of this ROS agent when 
Kv2.1 is co-expressed with AMIGO2 (Kv2.1/AMIGO2/H2O2) reversed the current 
amplitude back to the level of Kv2.1 (Figure 6.20).  However, the effect of AMIGO2 
in shifting the activation threshold of Kv2.1 to a more polarized potential was 




Figure 6.20: H2O2 does not have any effect on the current amplitude of Kv2.1/AMIGO2 but abolished the activation threshold 
shift effect of AMIGO2 on Kv2.1. Representative current traces for A) Kv2.1, B) Kv2.1/AMIGO2, and C) 
Kv2.1/AMIGO2/H2O2. D) IV relationship of Kv2.1, Kv2.1/AMIGO2, and Kv2.1/AMIGO2 in the presence of H2O2; E) 
Normalized current of Kv2.1, Kv2.1/AMIGO2, and Kv2.1/AMIGO2/ H2O2. Two-way ANOVA with DunnettÕs test where Kv2.1 
is set as control group showed that there is no statistical significant difference between the absolute current of Kv2.1 and 
Kv2.1/AMIGO2/H2O2 whereas current amplitudes of Kv2.1/AMIGO2 were significantly smaller at 40mV and 50mV, with * 
indicating p ≤ 0.05 and ** indicating p ≤ 0.01. One-way ANOVA with DunnettÕs test revealed that there is no significant 











Effect of H2O2 on the current amplitude and activation threshold of 
Kv2.1/Kv9.3/AMIGO2  
 
As seen in Figure 6.17, co-expression of AMIGO2 reduced the current of 
Kv2.1/Kv9.3 (Kv2.1/Kv9.3/AMIGO2 5437±926 pA, n=19 vs Kv2.1/Kv9.3 
8246.7±488 pA, n=38) in normoxic condition. Surprisingly, the presence of H2O2 
restored the current amplitude of Kv2.1/Kv9.3/AMIGO2 to the level of Kv2.1/Kv9.3 
(9273.2±235, n=7) at 50mV (Figure 6.21). This observation could suggest that 
AMIGO2 is an interaction partner that needs to be present in order for Kv channels 
oxygen sensing to occur. H2O2 has yielded contradictory results, as to whether this 
ROS inhibits K+ channels thus causing vasoconstriction or activating K+  channels 
hence giving rise to vasodilation (Park et al., 2015b). This result particularly 
substantiates the latter, and perhaps also suggests that H2O2 mediates its effect via the 
oxygen-sensing capability of AMIGO2. It should be re-emphasized that Kv9.3 is 
needed for AMIGO2-Kv2.1 interaction, as it has been demonstrated earlier that the 
effect of AMIGO2 is enhanced when Kv9.3 is present (Figure 6.18). This could 
explain why the restoration effect is seen with Kv2.1/Kv9.3/AMIGO2, but not with 







Figure 6.21: Addition of H2O2 restored the current amplitude of Kv2.1/Kv9.3/AMIGO2 to the control 
level and shifted the activation threshold to the control level. Representative current traces for A) 
Kv2.1/Kv9.3, B) Kv2.1/Kv9.3/AMIGO2, and C) Kv2.1/Kv9.3/AMIGO2/H2O2. D) IV relationship of 
Kv2.1/Kv9.3, Kv2.1/Kv9.3/AMIGO2, and Kv2.1/Kv9.3/AMIGO2 in the presence of H2O2; E) 
Normalized current of Kv2.1/Kv9.3, Kv2.1/Kv9.3/AMIGO2, and Kv2.1/AMIGO2/Kv9.3/H2O2. Two-
way ANOVA with DunnettÕs test where Kv2.1/Kv9.3 is set as control group showed that there is no 
statistical significant difference between the absolute current of Kv2.1/Kv9.3 and 
Kv2.1/Kv9.3/AMIGO2/H2O2 whereas current amplitudes of Kv2.1/Kv9.3/AMIGO2 were significantly 
smaller than Kv2.1/Kv9.3 from 0mV to 50mV, with * indicating p ≤ 0.05, *** indicating p ≤ 0.001, 
and **** indicating p < 0.0001. One-way ANOVA with DunnettÕs test revealed that there is no 
significant difference between normalized current of Kv2.1/Kv9.3/AMIGO2/H2O2 compared with 
Kv2.1/Kv9.3 at -30mV.  
 
Effect of H2O2 on deactivation kinetics of Kv2.1/AMIGO2 
 
While the presence of H2O2 abolished the effect of AMIGO2 on the activation 
threshold of Kv2.1, it does not have any effect on the tslow of Kv2.1/AMIGO2 but 










analyzed with one-way ANOVA followed by TukeyÕs multiple comparison test as it 
would be interesting to know if tslow and tfast of Kv2.1/AMIGO2/H2O2 are 
significantly different than Kv2.1 and if the tslow and tfast of Kv2.1/AMIGO2/H2O2 
are significantly different than Kv2.1/AMIGO2. The effect of H2O2 on tslow of 
Kv2.1/AMIGO2 is inconclusive as from the current results H2O2 did not reduce the 
tslow of Kv2.1/AMIGO2 to the level of Kv2.1 yet the tslow was not significantly 
higher than that of Kv2.1 (Figure 6.22). Meanwhile, H2O2 significantly increases tfast 
of Kv2.1/AMIGO2 (Figure 6.22).  
 
 
Figure 6.22: H2O2 does not abolish the effect of AMIGO2 elongating the tslow and tfast of Kv2.1. Bar 
chart showing the A) slow deactivation kinetics (tslow) and B) fast deactivation kinetics (tfast) of   
Kv2.1, Kv2.1/AMIGO2, and Kv2.1/ AMIGO2/H2O2. One-way ANOVA followed by TukeyÕs multiple 
comparison test showed that H2O2 has an inconclusive effect on tslow of Kv2.1/AMIGO2 yet 
significantly increases the tfast of Kv2.1/AMIGO2, with * indicating p ≤ 0.05, ** indicating p ≤ 0.01, 








Effect of H2O2 on deactivation kinetics of Kv2.1/Kv9.3/AMIGO2 
  
It remains inconclusive as to whether the presence of H2O2 has any impact on the 
tslow and tfast of Kv2.1/Kv9.3 (Figure 6.2). In the experiment to probe the effect of 
H2O2 on the deactivation kinetics of Kv2.1/Kv9.3/AMIGO2, data were analyzed using 
one-way ANOVA followed by TukeyÕs test as we wanted to know if H2O2 reversed 
the effect of AMIGO2 in elongating the tslow of Kv2.1 to the level of Kv2.1.  In the 
case of tslow, it seems that the presence of H2O2 causes the tslow of 
Kv2.1/Kv9.3/AMIGO2 to have an intermediate value (160.5±30 ms, n=4) between 
Kv2.1/Kv9.3 (120.0±5 ms, n=15) and Kv2.1/Kv9.3/AMIGO2 cells (186.3±15 ms, 
n=9) as the difference between tslow of Kv2.1/Kv9.3/AMIGO2/H2O2 compared with 
both Kv2.1 and Kv2.1/Kv9.3/AMIGO2 was not significant (Figure 6.23). Meanwhile 
there is no statistical significant difference between the populations in terms of tfast 
(Figure 6.23). However, the large variability in the data, especially with the reading of 
tfast of Kv2.1/Kv9.3/AMIGO2/H2O2, restricting a conclusion from being drawn.  
 
Figure 6.23: H2O2 does not alter the effect of AMIGO2 on the tslow and tfast of Kv2.1/Kv9.3. Bar 
chart showing the A) slow deactivation kinetics (tslow) and B) fast deactivation kinetics (tfast) of   
Kv2.1, Kv2.1/AMIGO2, and Kv2.1/ AMIGO2/H2O2. One-way ANOVA followed by TukeyÕs multiple 
comparison test showed that H2O2 has an inconclusive effect on tslow and tfast of 
Kv2.1/Kv9.3/AMIGO2 with ns indicating that the effect is not significant.  
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6.3 Discussion  
 
The effect of H2O2 on Kv channels still remains elusive. A study performed in mice 
showed that mice expressing human catalase to breakdown H2O2 were reported to 
have a significant reduction in systolic blood pressure compared to transgene-negative 
littermates (Suvorava, 2005). This suggests that H2O2 acts as a vasoconstrictor 
(Suvorava, 2005). More importantly, Archer et al., 1998 have found that 
mitochondrial-derived H2O2 reduces the Kv current in ductus arteriosus smooth 
muscle cells (DASMC). This led to membrane depolarization and activation of the L-
type Ca2+ channels, resulting in vasoconstriction (Archer et al., 2004). There are two 
major candidates in the DASMC which could be the target of H2O2, these are Kv1.5 
and Kv2.1 (Archer et al., 2004). Hence, whether the overall effect is due to H2O2 
acting on Kv1.5 or Kv2.1 is still unknown. This gap in the literature review has 
piqued interest in the effect of H2O2 on Kv2.1.  
Studies performed to dissect the effect of H2O2 on coronary arteries showed that the 
putative target of this ROS is Kv1.5 as it is the major contributor of the Kv current 
there (Archer et al., 2004). H2O2 has been found to increase Kv1.5 current as long as 
the voltage is below +20mV (S. W. Park et al., 2015). In this case, activation of Kv1.5 
decreases membrane excitability and thus vasodilatory effect is produced (S. W. Park 
et al., 2015). However, at high depolarizing voltages, H2O2 inhibits the channels (S. 
W. Park et al., 2015). Accordingly, it is still uncertain whether H2O2 is a vasodilator. 
Another example illustrating the role of H2O2 as a vasodilator is the observation that 
H2O2 induces the activation of KATP and KCa, which leads to the same effect as 
opening of Kv channels (S. W. Park et al., 2015). 
Park et al., 2015b have provided strong evidence that H2O2 produces vasorelaxation 
effect in mesenteric arteries and H2O2 mediates its action on Kv channels, rather than 
on KCa channels. This is because they have found that the K+ current was blocked by 
the general Kv channel blocker, 4-aminopyridine (4-AP), but was not affected by 
inhibitors of large-conductance Ca2+-activated K+ channel and inward rectifier K+ 
channel (Kir). The Kv currents were enhanced in the presence of H2O2 in a 
concentration-dependent manner (S. W. Park et al., 2015). Furthermore, H2O2 also 
accelerates Kv channel activation and shifted steady state activation to polarizing 
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potentials (to the left) (S. W. Park et al., 2015). Collectively, these effects elicited a 
vasodilatory effect on the mesenteric arteries. Interestingly, these effects could be 
abolished by DTT (S. W. Park et al., 2015). 
Increase in H2O2 leads to several cellular modifications. Since glutathione (GSH) is 
the most abundant reducing equivalent of H2O2, it has been hypothesized that S-
glutathionylation, a process where H2O2 oxidizes the thiol groups of cysteine residues, 
allowing the protein to form disulfide bonds with GSH, is the most dominant process 
in the myocytes (S. W. Park et al., 2015). S-glutathionylation is an essential 
posttranslational modification process, which regulates protein structure and function. 
The streptavidin pull-down assays with biotinylated glutathione ethyl ester performed 
by Park et al., 2015b demonstrated the co-localization of glutathione (GSH) and Kv 
channel proteins in the presence of H2O2. Moreover, S-glutathionylation of Kv 
channels is the process responsible for causing smooth muscle relaxation in the rat 
mesenteric arteries (S. W. Park et al., 2015). 
With these observations, it was proposed that H2O2 could actually be beneficial as a 
signalling molecule that induce S-glutathionylation which ultimately leads to 
vasodilation rather than acting solely as a ROS to inhibit Kv channels (S. W. Park et 
al., 2015). However, increased oxidative stress within mesenteric arteries, possibly 
due to presence of other ROS or prolonged hypoxic condition, could mask the ability 
of H2O2 to stimulate Kv channels (S. W. Park et al., 2015). Even more interesting is 
that such condition could reverse the initial vasodilatory effect, causing the inhibitory 
effect of H2O2 on Kv channels to be revealed (S. W. Park et al., 2015). This could 
mean that whether H2O2 exerts an activating or inhibitory effect on Kv channels is 
dependent on the basal redox status of the cells (S. W. Park et al., 2015). 
Contrary to the observation of Park et al, 1997, who demonstrated that H2O2 induces 
vasorelaxation by enhancing Kv currents, results in this chapter showed that H2O2 
does not have any significant impact on the absolute current and activation threshold 
of Kv2.1, Kv2.1/Kv9.3, Kv2.1/Nox4, and Kv2.1, Kv9.3/Nox4. Researchers from the 
other group have sought to determine the effects of H2O2 on rat mesenteric arteries (S. 
W. Park et al., 2015). The lack of effect of H2O2 on Kv2.1 and Kv2.1/Kv9.3 could 
suggest that these channels are not the main contributors of the delayed rectifier 
current in the rat mesenteric arteries.  
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The deactivation kinetics of Kv2.1 and Kv2.1/Kv9.3 in the absence and presence of 
Nox4 were also studied in this chapter. Results have shown that H2O2 does not affect 
the slow and fast components of the time constant of deactivation, tslow and tfast 
respectively, of Kv2.1, Kv2.1/Kv9.3, Kv2.1/Nox4, and Kv2.1/Kv9.3/Nox4. Coherent 
with the results obtained in Chapter 3, the tslow of Kv2.1/Kv9.3 is significantly 
longer than that of Kv2.1. The presence of H2O2 did not shorten the tslow of 
Kv2.1/Kv9.3.  
 
It might be too early to draw the conclusion that Kv2.1 and Kv2.1/Kv9.3 are not the 
target Kv channels of H2O2. This is because the inability of H2O2 to affect Kv2.1 and 
Kv2.1/Kv9.3 channels could be explained by the absence of a regulatory protein that 
could mediate the effect of H2O2 on these channels. Several researchers have 
described the variation in the hypoxic response of Kv2.1, where Kv2.1 has been 
consistently reported to be sensitive to hypoxic inhibition in cDNA-transfected L 
cells, but only a subset of Kv2.1-transfected COS cells are shown to be sensitive to 
hypoxia and Kv2.1 mRNA-injected Xenopus oocytes are not sensitive to hypoxic 
inhibition (Conforti et al., 2000; Hulme et al., 1999; Patel et al., 1997; Patel and 
Honor, 2001). These observations could indicate that the hypoxic response of Kv2.1 
might be abolished due to the absence of certain regulatory factors in the heterologous 
expression system used.  
 
Since the presence of Nox4 does not make a difference, it is likely that Nox4 is not 
the regulatory protein in question. Aforementioned in Chapter 3, future experiments 
could investigate into the possible interaction of other Nox proteins such as Nox1 and 
Nox2 with these Kv channels.  
 
Park et al., 1997 demonstrated that DTT reduced the Kv current in rabbit PASMC. 
However, the result from this chapter showed that Kv2.1 current is not inhibited by 
DTT. This could indicate that Kv2.1 is not the main contributor to the delayed 
rectifier current in rabbit PASMC as there are many Kv channels expressed in 
PASMC (Evans et al., 1996; Moudgil et al., 2006). However, this argument should be 
taken with caution as Kv2.1 and Kv2.1/Kv9.3 are usually considered as good 
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candidates of O2-sensitive K+ current in the rabbit PASMC (Coppock et al., 2001). 
Another plausible reason which could explain the variation in result is that the variety 
of Kv b-subunit, that can be expressed with different Kv a-subunit, might confer 
different characteristics to the Kv channels. Another reason could be the different 
mediators or regulatory proteins that are present in the native system (rabbit PASMC) 
yet are absent in our heterologous expression system, tsA-201 cells. These mediators 
could be essential in the hypoxic response of Kv2.1 or Kv2.1/Kv9.3 to DTT.  Parallel 
to the findings of Park et al., 1997, DTT does not affect the steady-state activation of 
Kv2.1 current. Although Kv9.3 is a silent channel, it has been established that co-
expression of this subunit with Kv2.1 modulates the latter (Kerschensteiner et al., 
2005; Kerschensteiner and Stocker, 1999). Our findings here showed that Kv9.3 does 
not make a difference to Kv2.1 steady-state inactivation in the presence of DTT. In 
addition, DTT is also not effective in reducing Kv2.1/Nox4 and Kv2.1/Kv9.3/Nox4 
current amplitude or in modulating their steady-state activation.  
 
Results from experiments with DTNB are similar to that with DTT, with the 
exception that DTNB slightly increases the current amplitude of Kv2.1/Kv9.3/Nox4. 
Other than that, DTNB also does not have any effect on the activation threshold of the 
cells. Our results with regards to the lack of effect of DTNB on Kv2.1 and 
Kv2.1/Kv9.3 agree with that published by Park et al, 1997. They have shown that 
2,2Õ-dithiobis(5-nitropyridine) (DTNBP), which is a membrane-permeable oxidizing 
agent, increased the Kv current in rabbit PASMC but the membrane-impermeable 
DTNB has no effect on the Kv current. DTT, DTNBP, and DTNB are redox agents 
that target sulphydryl groups and these groups exist on both sides of the cell 
membrane Park et al., 1997. Our results with DTNB and those of Park et al, 1997 
could indicate that the sulphydryl groups that are susceptible to modification by these 
redox agents might be at the intracellular side of the membrane. However, more 
experiments should be done with DTT, especially when the appropriate regulatory 
factors which mediate the effect of DTT on Kv2.1 and Kv2.1/Kv9.3 are identified, 
before the conclusion that intracellular sulphydryl groups of these channels are the 
target of these redox agents can be made.   
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It was of interest to test whether Ch-T is one of the ROS that contributes to the 
inhibition of Kv2.1 and Kv2.1/Kv9.3 current because Ch-T has been shown to 
suppress transient outward K+ current (Ito) and sustained delayed rectifier K+ current 
(Idr) in mouse colonic myocytes (Prasad and Goyal, 2004). Moreover, suppression of 
Ito has been linked to arrhythmias in the heart (Tanaka et al., 1998). The difference 
between the results for Ch-T in this study with those from published literature could 
be attributable to the different characteristics of Kv channels studied. In the research 
of Prasad and Goyal, 2004, the Kv channels of interest are Kv4.1, Kv4.2 and Kv4.3 
which are prominent in the colonic tissues (Prasad and Goyal, 2004). The mainly 
colon-specific redox agents, Ch-T and NH2Cl, have an effect on the Kv4 channels 
studied (Duprat et al., 2005; Koh et al., 1999; Prasad and Goyal, 2004). However, this 
study showed that the effect of Ch-T on Kv2.1 channel is almost negligible. Ch-T is 
capable of oxidizing both methionine and cysteine residues (Prasad and Goyal, 2004). 
The effect of various oxidizing and reducing agents which target the cysteine residues 
such as H2O2, DTNB, and DTT have been explored in other parts of the project and it 
has been determined that these cysteine-specific agents have negligible or modest 
effect on Kv2.1. When it comes to Ch-T, the negligible effect of this agent on Kv2.1 
could demonstrate that the methionine residues on Kv2.1 are not susceptible to 
oxidation by Ch-T.  
 
Previously, conflicting results on the effect of Ch-T on various K+ channels have also 
been published, supporting the notion that different K+ channels can be differentially 
modulated by Ch-T. For example, Ciorba et al., 1999 have shown that Ch-T 
decelerate the inactivation kinetic of KCa channels expressed in Xenopus oocytes, 
which is indicative of the enhancement of Ito and that this effect is due to oxidation of 
both methionine and cysteine residues . In contrast, Prasad and Goyal, 2004 showed 
that Ch-T inhibits Ito, through the inhibition of Kv4. 
For a more complete analysis of the effect of Ch-T on Kv2.1 channel, the 
repolarization of the current to -50mV from various step voltages could also be 
analyzed in order to determine the deactivation kinetics. Such analysis have been 
performed by Tanaka et al., 1998, when they analyzed how the outward current from 
rabbit atrial cells are affected by Ch-T.  
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Auxiliary subunits or interacting partners of ion channels regulate the function of ion 
channels in several ways (Chen et al., 2012). They have an impact on the ion channel 
subunit assembly, transportation to the surface membrane or localization at certain 
compartments, protein stability, electrophysical and pharmacological properties (Chen 
et al., 2012). Cell adhesion molecules are commonly known for being auxiliary 
subunits for Na+ channels (Chen et al., 2012) and the demonstration of AMIGO1 as 
an interacting partner for Kv2.1 (Kuja-Panula et al., 2003; Peltola et al., 2016, 2011; 
Zhao et al., 2014) is an exciting discovery that K+ channels could also be target 
channels for these adhesion molecules.  
 
Kv9.3 is an established modulatory subunit of Kv2.1, capable of regulating the ion 
channelÕs biophysical and pharmacological properties (Kerschensteiner and Stocker, 
1999; Kerschensteiner et al., 2005; Patel and Honor, 2001; Patel et al., 1997, 1999). 
Interestingly, separate studies indicated that downregulation of Kv9.3 and AMIGO1 
are linked to altered complex behavioural traits that resemble schizophrenia and it is 
likely that such consequence resulted from disrupted regulation of Kv2.1 (Peltola et 
al., 2016). Thus, this study investigated into the effect of regulation of Kv2.1 when it 
is co-expressed with both Kv9.3 and AMIGO1.  
 
Contrary to the discovery of Peltola et al, 2011, where the group showed that 
AMIGO1 increases the current amplitude of Kv2.1, the present study showed that 
AMIGO1 actually decreases the current amplitude of Kv2.1 and Kv2.1/Kv9.3. Such 
contradiction in results could result from the difference in the electrophysiological 
protocol used, where the repolarization from each voltage step differs in our 
protocols. AMIGO1 does not have any effect on the deactivation kinetics of Kv2.1 
and Kv2.1/Kv9.3 apart from accelerating the tfast of Kv2.1/Kv9.3.  
 
This study also investigated into the potential of the other family members of this 
adhesion molecule, namely AMIGO2 and AMIGO3 as auxiliary subunits of Kv2.1 
and Kv2.1/Kv9.3. AMIGO2 reduces the Kv2.1 current amplitude at a more 
depolarized potential (from 40mV onwards) but reduces Kv2.1/Kv9.3 current starting 
from 0mV. While AMIGO2 shifts both Kv2.1 and Kv2.1/Kv9.3 activation threshold 
resulting in these channels being activated at a more hyperpolarized potential, the 
effect of the shift is greater when Kv9.3 is present. These observations made it 
	 195	
tempting to speculate that Kv9.3 is needed for the interaction of AMIGO2 with 
Kv2.1. However, AMIGO2 was found to increase both tslow and tfast of Kv2.1 but 
only prolongs tslow of Kv2.1/Kv9.3 and has no effect on tfast of Kv2.1/Kv9.3. It is 
unclear why AMIGO2 has a stronger effect on the current amplitude and activation 
threshold when Kv9.3 is present but posed a heavier influence on the deactivation 
kinetics when Kv9.3 is absent. Hossain et al, 2011 published that AMIGO2 is 
downregulated in hypoxia but overexpression of AMIGO2 could protect cells treated 
with 50mM of H2O2 for five days from cell death. In the experiments above, the 
presence of H2O2 restored (increased) the current amplitude of 
Kv2.1/Kv9.3/AMIGO2 to the level of Kv2.1/Kv9.3 and abolished the activation 
threshold shift of AMIGO2 on both Kv2.1 and Kv2.1/Kv9.3, even though H2O2 does 
not have any effect on Kv2.1 and Kv2.1/Kv9.3 when AMIGO2 is not present, as 
demonstrated earlier in this chapter. This could suggest that AMIGO2 is a regulatory 
protein modulating Kv2.1 and Kv9.3 channels and H2O2 manifests its effect on these 
channels when AMIGO2 is present. Surprisingly the presence of H2O2 does not affect 
the tslow and tfast of both Kv2.1/AMIGO2 and Kv2.1/Kv9.3/AMIGO2. This could 
mean AMIGO2 regulates the channels in other ways without affecting the 
deactivation kinetics in the presence of H2O2.   
 
It is inconclusive as to whether AMIGO2 confers protective effect by reducing 
Kv2.1/Kv9.3 current and causing the channels to open at a more polarized potential 
(earlier), and without affecting the time constant of inactivation. The result supporting 
the argument that AMIGO does confer protective effect might be seen in how 
AMIGO2 increases the time constant of inactivation of Kv2.1/Kv9.3 when H2O2 is 
absent. Conversely, when H2O2 is present, the time constants remained increased and 
does not get reduced back to the level of Kv2.1 or Kv2.1/Kv9.3. When time constants 
of inactivation are increased, the duration of action potential is prolonged, and this 
prevents the next action potential to be conducted, thus reducing the excitability of the 
cells.  
 
The observation that AMIGO2 significantly reduces the current amplitude of 
Kv2.1/Kv9.3 does not match the suggestion that AMIGO2 reduces the excitability of 
the cell. Another argument which highlight the negative impact of AMIGO2 
expression in the PASMC is that AMIGO2 promotes cell proliferation and might be 
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involved in hypoxia-induced vascular remodelling (Hossain et al., 2011; H. Park et 
al., 2015; Rabenau et al., 2004). Pulmonary vascular remodelling occurs when the 
balance of cell apoptosis and proliferation is tipped towards proliferation, resulting in 
uncontrollable cell growth occluding the lumen. Although, Hossain et al, 2011 and H. 
Park et al., 2015 have provided evidence that AMIGO2 is important for endothelial 
cells survival (Hossain et al., 2011; H. Park et al., 2015), it must be noted that 
endothelial cells also produce endothelin, (Tang et al., 2009) a well-known 
vasoconstriction factor produced by endothelial cells which also promotes vascular 
remodelling (Kim et al., 2000). H. Park et al., 2015 have demonstrated that PDK1 and 
Akt (protein kinase B) are involved in the AMIGO2-VEGF signalling pathway to 
control cell proliferation (H. Park et al., 2015). For detailed explanation of how 
AMIGO2 forms a scaffold on which PDK1 and Akt bind, please see Appendix. Akt 
serves as a downstream mediator of VEGF to promote endothelial cell survival, 
proliferation, migration, permeability, vascular tone and angiogenesis (Dimmeler and 
Zeiher, 2000; Liu et al., 2000) and AMIGO2 activates Akt (H. Park et al., 2015).  Akt 
inhibition has been correlated to reduce ovarian tumour growth, angiogenesis, 
endothelial cell tube formation, and morphogenesis. Endothelial cells which are 
cultured together with vascular smooth muscle cells have constitutively active Akt 
and are able to form non-functional vasculature (H. Park et al., 2015). However, 
partial inhibition of PI3K to suppress Akt1 will activate Erk1/2 (MAPK) pathway to 
promote arteriogenesis (H. Park et al., 2015). Therefore, vasculogenesis and 
angiogenesis can be regulated by more than one pathway (H. Park et al., 2015). 
Instead of relying on PI3K-Akt pathway alone, the process depends on the balance 
between this pathway with MAPK signalling (H. Park et al., 2015). In short, 
AMIGO2 silencing might only control part of the network and another compensatory 
pathway might be activated to contribute to cell proliferation.  
Promotion of cell apoptosis is generally accepted to be beneficial in remediating 
pulmonary vascular remodelling with the exception of endothelial cells. Nevertheless, 
the effect of AMIGO2 silencing which leads to the promotion of cell apoptosis seems 
contradictory to the findings that AMIGO2 expression in CA2/CA3 in the 
hippocampus might be neuroprotective	 (Laeremans et al., 2013).  Therefore, 
AMIGO2 expression might be beneficial or undesirable, depending on anatomy. 
Furthermore, it is not known whether the downregulation of AMIGO2 due to hypoxia 
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is simply a coping mechanism to reduce endothelial cells population, (thus avoiding 
vascular remodelling) or a detrimental consequence promoting apoptosis of the wrong 
cell population. In the future, AMIGO2-silenced rat model should be used to see the 
changes on PASMC and PAEC proliferation and inflammatory markers in hypoxic 
conditions.		 
 
In Rabenau et al, 2004Õs research, it is surprising how AMIGO2 silencing leads to 
chromosomal instability yet inhibits tumor growth in gastric adenocarcinoma cells. It 
has been documented that chromosomal instability does not necessarily drives 
tumorigenesis (Rabenau et al., 2004). Moreover, it has not been confirmed as to why 
downregulation of a cell adhesion molecule could lead to chromosomal instability. 
Rabenau et al, 2004 suggested that downregulation of AMIGO2 could have an effect 
on several currently unidentified pathways to eventually lead to chromosomal 
instability. This observation has been compared to the finding of human Ha-ras 
oncogene upregulation affecting several cellular pathways, which in turn activates the 
nucleolytic activity that compromises DNA repair mechanisms, to ultimately causing 
chromosomal aberration (Rabenau et al., 2004). Therefore, it is essential to have a 
thorough understanding into the pathways that are affected by AMIGO2 signal 
transduction before speculating the role of AMIGO2 in cell proliferation. In addition, 
the role of AMIGO2 in cell adhesion and/or chromosomal instability and in 
promoting tumourigenicity might be mutually exclusive (Rabenau et al., 2004). 
In parallel, an anti-tumor drug which is under clinical trials named perifosine has been 
postulated to inhibit Akt by targeting the lipid-binding PH domain to prevent 
recruitment of Akt to the plasma membrane (H. Park et al., 2015). Interestingly, 
Delgado-Ramirez et al, 2016 showed that this drug also inhibits Kv2.1 by decreasing 
current amplitude and accelerating closed-state inactivation (Delgado-Ramrez et al., 
2016). In the future, when more data supporting the hypothesis that AMIGO2 is an 
interacting partner of Kv2.1 are available, future work could probe into whether 
perifosine mediates its effect on Kv2.1 by inhibiting the transport of Akt to the plasma 
membrane, hence prohibiting Kv2.1 from associating with AMIGO2 (Delgado-
Ramrez et al., 2016; H. Park et al., 2015) 	
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Finally, AMIGO3 does not have any influence on Kv2.1 or Kv2.1/Kv9.3 in terms of 
current amplitude, activation threshold or deactivation kinetics. This could imply that 
AMIGO3 is not an interacting partner of Kv2.1 or Kv9.3. Although AMIGO3 has 
anti-oxidative effects (Ahn et al., 2015), it is possible that AMIGO3 does not confer 
these protective effective via Kv2.1 or Kv9.3.  
 
Another interesting point is that there is high expression of RAGE (a receptor for 
AMIGOs) in the lungs, while it is usually lowly expressed in other adult tissues. It is 
tempting to speculate that RAGE has a functionally regulated expression in the 
context of pulmonary hypertension. This hypothesis could perhaps be investigated in 
the future.  
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Chapter 7: Conclusion, Discussion, and Future Direction 
 
Although recent advances in PH research have allowed us to better categorize PH, the 
two primary mechanisms underlying PH in general are hypoxic pulmonary 
vasoconstriction (hypoxic pulmonary vasoconstriction) and pulmonary vascular 
remodelling (pulmonary vascular remodelling ) (Kuhr et al., 2012; Olschewski et al., 
2014; Ward and McMurtry, 2009). hypoxic pulmonary vasoconstriction is a 
physiological mechanism to divert oxygen to areas with low oxygen tension (hypoxia) 
(Archer et al., 1998). However, chronic hypoxia will cause PH (Morrell et al., 2009; 
Ward and McMurtry, 2009). Dysfunction or reduction of function of K+ channels 
have been linked in PH because failure of K+ channels to open will cause 
vasoconstriction and uncontrolled cell proliferation, which will worsen PH conditions 
(Kuhr et al., 2012). Kv1.5 and Kv2.1 are the two most studied K+ ion channels in PH 
(Archer et al., 2004, 1998; Lee et al., 2006). The reason we are focused on Kv2.1 is 
the interesting finding that it can heteromerize and be modulated by a silent channel, 
Kv9.3 (Kerschensteiner, 2003; Patel et al., 1999, 1997; Patel and Honor, 2001).  
The following paragraphs summarize the key findings resulting from this thesis and 
how the characteristics of Kv2.1 and Kv9.3 could be implicated in PH, the limitations 
of the experiments performed and the future directions that can be taken to fill the 




Kv2.1 is regulated by Kv9.3 
 
The biophysical and pharmacological regulation of Kv2.1 by Kv9.3 have been 
demonstrated by several authors (Patel et al, 1997, Patel et al, 1999, Kerschensteiner, 
2003, Zhong et al, 2010). The results in this thesis showed that Kv9.3 modulates 
Kv2.1 in terms of current amplitude, activation threshold, and deactivation kinetics.  
 
Kv9.3 increases the current amplitude of Kv2.1 at the activation voltage range 
(Kerschensteiner, 2003). This could mean that the K+ efflux is bigger when the Kv2.1 
channels are activated, bringing the cells back to resting membrane potential faster. 
This could have significant impact in the case of pulmonary hypertension. In addition, 
co-expression of Kv9.3 with Kv2.1 also causes Kv2.1 channels to be activated earlier 
(at a more negative/polarized voltage range). This could be important to prolong the 
action potential duration of firing so that more K+ ions can flow out of the cells 
(Kerschensteiner, 2003). Kv2.1/Kv9.3 also has a longer slow component of time 
constant of deactivation compared with Kv2.1 (Hristov et al., 2012; Zhong et al., 
2010). In order for the transduction of the next action potential (activation of Na+ 
channels to allow Na+ influx), K+ channels have to recover from deactivation (Hristov 
et al., 2012; Zhong et al., 2010). Therefore, a longer duration of deactivation could 
prevent the next action potential to be generated, thus reducing the membrane 
excitability which confers beneficial effects to the cells. On the other hand, if the 
function of Kv2.1/Kv9.3 is compromised, there will be reduced outward delayed 
rectifier current, which will cause the cells to remain in the depolarized state. 
Membrane surface expression of Kv9.3 is only detected when it is co-expressed with 
Kv2.1 as Kv9.3 proteins are usually retained in the cytoplasm (Shepard and Rae, 
1999). If Kv2.1 is expressed as homomers at the membrane surface without Kv9.3, 
the deactivation kinetics would be accelerated, allowing for faster transduction of 
action potential.  
 
As mentioned in the Introduction chapter, failure of K+ channels to open will cause 
the cells to remain in polarized state (more positive ions inside the cells as compared 
with outside), and the cell will enter cell cycle or undergo proliferation (Kuhr et al., 
2012; Moudgil et al., 2006). Lee et al., 2015 have demonstrated that Kv9.3 is pro-
proliferative. In this context, the presence of Kv9.3 might not be ideal in alleviating 
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PH. However, the study performed by Lee et al, 2015 stating that the silencing of 
Kv9.3 which leads to inhibition of human colon and lung cancer was performed on 
non-excitable cells and only investigated on the role of Kv9.3 in isolation from Kv2.1 
(i.e. only studied Kv9.3 homomers without comparing with Kv2.1/Kv9.3 heteromers). 
Thus, there is a gap in the literature as the effects of silencing of Kv2.1 and 
Kv2.1/Kv9.3 on cell proliferation are unknown and were not assessed in this thesis.  
 
 
Nox4 does not regulate Kv2.1 or Kv2.1/Kv9.3 
 
It is clearly shown in Chapter 3 that Nox4 does not regulate Kv2.1. It remains 
unknown as to why Kv2.1/Kv9.3/Nox4 shows dual mode of steady-state activation 
(Figure 3.8). In one series of experiment, it was found that Nox4 abolished the effect 
of Kv9.3 on the activation threshold of Kv2.1. In another series of experiment, 
Kv2.1/Kv9.3/Nox4 cells behaved more similarly to Kv2.1/Kv9.3 cells, indicating that 
Nox4 does not interfere with the Kv2.1/Kv9.3 heteromer. Since there is a larger 
number of cells which showed the lack of effect of Nox4 on Kv2.1/Kv9.3, we drew 
the conclusion that Nox4 does not modulate Kv2.1/Kv9.3. This means the presence of 
Kv9.3 does facilitate the interaction of Nox4 with Kv2.1. One of the reasons which 
we could propose to explain the dual mode of steady-state of activation is that the 
cells expressing Kv2.1/Kv9.3/Nox4 might have a regulatory component which 
modulates their behaviour to resemble that of Kv2.1 (meaning this regulatory 
component abolished the effect of Kv9.3 on Kv2.1), while the cells used  in the other 
series of experiment somehow do not express this regulatory component or the effect 
of this regulatory component is less prominent.  
 
The argument that Nox4 does not regulate Kv2.1 or Kv2.1/Kv9.3 is in line with the 
results of Mittal et al, 2012, where they demonstrated that Nox4 does not colocalize 
with Kv2.1, but colocalizes with Kv1.5 and TASK-1 instead. However, the idea of 
colocalization does not automatically translate to interaction between the two 
proteins. This can be seen in the case of colocalization of Kv1.5 and Nox4 (Lee et al., 
2006). While many authors agreed that these two proteins are colocalized, whether 
Nox4 modulates Kv1.5 is still under debate. Lee et al, 2006 showed that Nox4 does 
not modulate Kv1.5 but Mittal et al, 2012 argued otherwise. This discrepancy is 
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perhaps due to the experiment setup, where Mittal et al, 2012 used rats that have been 
subjected to chronic hypoxia for three weeks and Lee et al, 2006 performed the 
experiment in normoxia. This could mean that, in order for Nox4 to act as an oxygen 
sensor thereby modulating the function of Kv1.5, a stimulus must be present. And the 
stimulus in question might be hypoxia. This hypothesis fits into the speculations of 
other research groups, who proposed that Nox4 is hypoxia sensor (Brandes et al., 
2010; Lee et al., 2013; Nisimoto et al., 2014).  
 
While it was disappointing to draw the conclusion that Nox4 does not modulate 
Kv2.1, even in the presence of Kv9.3, the next question that arises from this study is 
whether other Nox proteins could be involved in regulating Kv2.1 and Kv2.1/Kv9.3. 
One of the candidates would be Nox2 (or gp91phox). Buttigieg et al, 2012 even 
proposed that Nox2 (or gp91phox) is the main oxygen sensor while Nox4 plays a 
minor role. On the other hand, Goyal et al., 2004 propounded that Nox1 plays a 
significant role too considering that Nox1 induces HIF-1a upregulation even in the 
absence of hypoxia.  
 
Future experiments could look into the colocalization of either Nox1 or Nox2 proteins 
with Kv2.1 using immunostaining or immunoprecipitation techniques, before looking 
into the functional implications of their colocalization using patch clamp 
electrophysiology. It is a well-known fact that Kv2.1 behaves differently in different 
heterologous expression systems (L cells, Xenopus oocytes, HEK cells) (Conforti et 
al., 2000; Hulme et al., 1999; Patel et al., 1997; Patel and Honor, 2001). Perhaps, it 
would be a good idea to analyze closely the regulatory proteins present in each 
expression system to shed some light on the candidate regulatory proteins that are 
present endogenously which could affect Kv2.1 biophysical properties. 
 
On the other hand, there are key cysteine residues on Kv2.1 which are prone to 
oxidation (Cotella et al., 2012; Yu et al., 2016)c. Identification of key cysteine 
residues might give clues as to how Kv9.3 mediates its effect on Kv2.1. Cotella et al., 
2012 reported an oxidation resistant Kv2.1 variant which has a mutation in the 
conserved cysteine residue, C73 to an alanine (C73A).  Yu et al., 2016 reported that 
dasatinib, a Food and Drug AdministrationÐapproved inhibitor of Src tyrosine kinases 
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significantly reduced the signs of typical lesions of brain injury such as inflammation 
(astrocytosis), neurodegeneration, and cell death in C73A transgenic mice. In motor 
(rotarod) and cognitive (Morris water maze) tests, both transgenic and WT mice 
demonstrated improvements when treated with dasatinib. While there is reported 
success of dasatinib in mouse model of traumatic brain injury, the same cannot be 
said in the case of pulmonary hypertension. Guignabert et al, 2016 reported that 
dasatinib causes lung vascular toxicity and increases tendency of pulmonary 
hypertension in humans and rodents. Instead of counteracting the effect of oxidized 
Kv2.1, dasatinib is said to cause endothelial cell dysfunction and vascular damage by 
inducing mitochondrial ROS  production, and this pathway of ROS  production is 
independent of Src family kinases (Guignabert et al., 2016). In short, studies to 
identify other cysteine residues in Kv2.1 might be important in elucidating the 
different ROS production pathways involved in PH and thereby improving the 
therapeutic options for PH patients.  
 
Animal experiments to dissect the role Kv2.1 have been well documented, but the role 
of Kv9.3 has not gained as much attention. Considering the hypothesis of Zhong et al, 
2010 stating that the delayed rectifier current in rat middle cerebral arteries is most 
likely contributed by Kv2.1/Kv9.3 instead of Kv2.1 alone, perhaps it would be a good 
idea to repeat the experiments outlined in this thesis on animal models. The 
characterization of Kv2.1 and Kv2.1/Kv9.3 currents in this thesis would allow us to 
differentiate between the two currents in native cells.  
 
 
Kv2.1 and Kv9.3 proteins are present in the rat lungs and heart 
 
Kv2.1 and Kv9.3 proteins are expressed in rat lungs and heart. The limitation in this 
chapter is that controls could have been included where staining with C31 which 
targets endothelial cells and sm22/alpha smooth muscle actin could which target 
smooth muscle cells to confirm that Kv2.1 and Kv9.3 target these cell types.  
 
Colocalization could be deciphered as co-occurring at the same place or as 
correlation, which means that the levels of distribution of the two proteins occurring 
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at the same place are also similar (Adler and Parmryd, 2012). For example, two 
proteins might spatially overlap but they are not distributed proportionally within the 
cells (Adler and Parmryd, 2012). Although the results from this experiment might 
suggest that Kv2.1 and Kv9.3 are present in the same location, double 
immunostaining using secondary antibodies conjugated with different Alexa Flour 
dyes to target primary Kv2.1 and Kv9.3 antibodies should be done to confirm that the 
two proteins overlap (Owen et al., 2009). The imaging of the cells using confocal 
micROS copy will allow us to determine whether there is an overlap of the two 
different fluorescent dyes excited at different wavelengths, which will indicate spatial 
colocalization (Owen et al., 2009). To analyse correlation, we could calculate the 
number of cells which express both of the proteins and cells which express either of 
the proteins to see if the relationship is proportional.  
 
Alternatively, Frster Resonance Energy Transfer (FRET) can be done to measure the 
distance of two fluorophores conjugated to Kv2.1 and Kv9.3 proteins, which will give 
us an idea of the proximity of the proteins to each other (Sekar and Periasamy, 2003). 
The advantage of FRET is that it can be precise up to 10nm proximity, which is a 
much higher resolution compared to light microscopy (250nm proximity) (Sekar and 




AMIGO1 and AMIGO2 regulates Kv2.1 and Kv2.1/Kv9.3 and the presence of 
H2O2 abolishes the effect of AMIGO2 on these channels 
 
This study showed that AMIGO1 inhibits Kv2.1 and Kv2.1/Kv9.3 current amplitude. 
This result does not agree with the results published by Peltola et al, 2011. The reason 
that such discrepancy arises could be due to the difference in the electrophysiological 
protocol used, where the repolarization from each voltage step differs in our protocols 
(Peltola et al., 2011). It could also be due to the difference in the species of the 
AMIGO proteins.  We have researched on the human AMIGO1 while the other group 
has used the mouse AMIGO1 and basic local alignment search tool (BLAST) result 
has shown that the sequences of the two variants are 84% identical.  
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Other new information provided by this study includes AMIGO1 does not have any 
effect on the deactivation kinetics of Kv2.1 and Kv2.1/Kv9.3 but accelerates the tfast 
of Kv2.1/Kv9.3.  
 
While AMIGO2 does not have any effect on Kv2.1 current amplitude, it reduces 
Kv2.1/Kv9.3 current. AMIGO2 also shifts the activation threshold of both Kv2.1 and 
Kv2.1/Kv9.3 to a more negative voltage range. In terms of time constant of 
inactivation, AMIGO2 increases both tslow and tfast of Kv2.1 and prolongs the tslow 
of Kv2.1/Kv9.3.  
 
Hossain et al, 2011 reported that the mRNA expression of AMIGO2 is reduced when 
the atmospheric O2 concentration decreased to 5% and 0% and overexpression of 
AMIGO2 can protect cells treated with 50mM of H2O2 for five days from apoptosis. 
Following from the suggestion that AMIGO2 plays a protective role in vascular 
remodelling induced by hypoxia, one of the aims in the thesis was to test the effects of 
H2O2 on Kv2.1/AMIGO2 and Kv2.1/Kv9.3/AMIGO2. AMIGO2 does not affect the 
Kv2.1 current amplitude but reduces the Kv2.1/Kv9.3 current amplitude. Although in 
Chapter 6 we have demonstrated that H2O2 does not have any effect on the current 
amplitude of Kv2.1 and Kv2.1/Kv9.3, here we found that the presence of H2O2 
restored the current amplitude of Kv2.1/Kv9.3/AMIGO2 to the level of Kv2.1/Kv9.3 
and abolished the activation threshold shift of AMIGO2 on both Kv2.1 and 
Kv2.1/Kv9.3.  
 
While it was postulated that AMIGO2 might have a beneficial effect in the case of PH 
as it protects cells from cell death, the results from this thesis argue that AMIGO2 has 
a role in vascular remodelling induced by hypoxia but whether the role is beneficial or 
not is yet to be determined. This is because it is contradictory as to why AMIGO2 
reduces Kv2.1/Kv9.3 current but causes the channels to open at a more 
hyperpolarized potential (earlier) and prolongs the tslow of Kv2.1/Kv9.3. While the 
two latter actions could lead to reduced cell excitability, the action of reducing K+ 
current does not elicit the same effect. Another reason is that the effect of H2O2 in 
PASMC still remains elusive, as several researchers are still divided as to whether 
H2O2 is a vasoconstrictor or vasodilator (S. W. Park et al., 2015). Results in Chapter 8 
demonstrated that H2O2 does not affect the tslow and tfast of both Kv2.1/AMIGO2 
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and Kv2.1/Kv9.3/AMIGO2. This could mean AMIGO2 regulates the channels in 
other ways without affecting the deactivation kinetics in the presence of H2O2.  
 
Similar to Kv9.3, AMIGO2 is also pro-proliferative (H. Park et al., 2015; Rabenau et 
al., 2004). Since Kv9.3 increases Kv2.1 current while AMIGO2 reduces the current 
amplitude of Kv2.1/Kv9.3, it is tempting to speculate that the pro-proliferative 
pathways induced by Kv9.3 and AMIGO2 are different.  
 
AMIGO3 does not modulate Kv2.1 or Kv2.1/Kv9.3, probably because AMIGO3 is 
not an interacting partner of these K+ channels in the first place. AMIGO3 has been 
proven to be anti-oxidative (Ahn et al., 2015), but it might confer these protective 
effective via pathways that do not involve Kv2.1 or Kv9.3.  
 
The colocalization of AMIGO1 and Kv2.1 has been demonstrated, but not with Kv9.3 
(Kuja-Panula et al, 2003). In addition, Kuja-Panula et al, 2003 have used mouse brain 
lysate, which is a positive control for a lot of proteins. Although they have 
demonstrated that AMIGO1 mRNA is also found in adult mouse lung and heart 
tissues, the differential expression of AMIGO1 in relation to Kv2.1 and Kv9.3 in 
these organs warrants further research. As mentioned above, results from this thesis 
have shown that Kv2.1 and Kv9.3 proteins are expressed in rat lungs and tissues. In 
the future, double or triple staining of these proteins together could be done to prove 
the colocalization of these proteins.  
It would be interesting to assess whether AMIGO2, Kv2.1, and Kv9.3 mRNA and 
protein levels are differentially expressed in rat PASMC. Since results from this study 
showed that AMIGO2 does regulate Kv2.1, it would be a good idea to visualize the 
colocalization of these proteins using immunofluorescence or FRET. In order to shed 
light on how the levels of protein expression change during hypoxia, Western blot can 
be performed on cells transfected with these proteins.  Although the mRNA level of 
AMIGO2 has been assessed in gastric adenocarcinoma patients (Rabenau et al., 
2004), gastric adenocarcinoma cell line (Rabenau et al., 2004), and in human 
umbilical cord endothelial cells (HUVEC) (H. Park et al., 2015), the level of 




Overall, the results of the thesis have elucidated not only the role of a well-studied K+ 
channel, Kv2.1 in PH, but also highlighted the importance of the silent Kv9.3 
channels in modulating Kv2.1 channels. Considering the speculation that 
Kv2.1/Kv9.3 might be the more dominant form of K+ channels in the pulmonary 
vasculature, this finding would prove valuable in optimize therapeutic approaches and 
in diagnosis of patients. The discovery of AMIGO proteins (specifically AMIGO1 
and AMIGO2) as interacting partners have also contributed to the understanding of 
the pathways that implicate Kv2.1. AMIGO proteins could very well have a role in 
PH and whether the role is beneficial or pathogenic still warrants further research.  
 
Figure 7.1: Schematic summary of the regulation of Kv2.1 and Kv2.1/Kv9.3 by H2O2 and AMIGO1 and AMIGO2. Starting from 
the left, Kv2.1/Kv9.3 has increased current amplitude compared with Kv2.1 alone regardless of absence or presence of H2O2. 
The presence of H2O2 restores the current amplitude of Kv2.1/Kv9.3/AMIGO2 to the Kv2.1/Kv9.3 level. Co-expression of 
AMIGO2 significantly reduces the current amplitude of Kv2.1/Kv9.3. Meanwhile, co-expression of AMIGO1 reduces Kv2.1 
amplitude. Kv2.1 homomers have smaller current amplitude compared with Kv2.1/Kv9.3.  Thickness of arrows represents the 
magnitude of current going through the channels. The results from this study suggested that Kv2.1/Kv9.3 and 
Kv2.1/Kv9.3/AMIGO2 in the presence of H2O2 lead to cell hyperpolarization, thus PASMC relaxation and vasodilation. On the 
other hand, Kv2.1, Kv2.1/AMIGO1, and Kv2.1/Kv9.3/AMIGO2 in the absence of H2O2 result in cell depolarization, PASMC 
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1) Subset of data supporting the notion that Kv2.1/Nox4 behaves similarly to 
Kv2.1 and Kv2.1/Kv9.3/Nox4 to Kv2.1/Kv9.3 
	
 
Figure 8.1: Absolute current of the cells without DTT (Left) and the normalized current for assessing 
the activation thresholds of cells without DTT (Right). The results are from cells that are perfused with 
external solution before being perfused with DTT.  
 






































Figure 8.2: Absolute current for the cells without DTNB (Left) and Activation thresholds of the cells 
without DTNB (Right). The results are from cells that are perfused with external solution before being 
perfused with DTNB. 
 
2) Relationship of AMIGO2 with PDK1 and Akt to control cell proliferation 
AMIGO2 is important in forming an extracellular matrix on the cell membrane, which 
then causes PDK1 to be recruited to the surface and docked on the matrix (H. Park et 
al., 2015). PDK1 then binds to the secondary messenger, PIP3, at its pleckstrin 
homology domain (H. Park et al., 2015). According to Gao and Harris, 2006, the 
autophosphorylation of PDK1 at serine 241 within the catalytic domain can be 
inhibited easily by the pleckstrin homology domain that is not bound to PIP3 (Gao 
and Harris, 2006). The PDK1-PIP3 interaction allows trans-phosphorylation of PDK1 
at threonine 513 within the PH domain which destabilizes the ÔautoinhibitionÕ 
conformation and thus permitting the protein to activate Akt. In endothelial cells 
where AMIGO2 is silenced, there has been reduced transportation of PDK1 to the cell 
membrane and hence reduced PDK1 and Akt phosphorylation (H. Park et al., 2015).  
By forming a scaffold, it is likely AMIGO2 brings PIP3-activated PDK1 nearer to 
PIP3-activated Akt (refer Figure 10.3) (H. Park et al., 2015). 





































The group also established that it is the protein transduction domain A-2 (PTD-A2), 
which contains the amino acid residues 465Ð474 (conserved residues in AMIGO1-3) 
located at the cytoplasmic domain of AMIGO2 that is responsible for interaction with 
PH domain of PDK1.  Astonishingly, addition of soluble PTD-A2 inhibited PDK1 
and Akt phosphorylation and was even effective in suppressing pathological 
angiogenesis in murine tumour and oxygen-induced retinopathy models (H. Park et 
al., 2015). This might be because soluble PTD-A2 compromises the formation of 
AMIGO2 scaffold, causing PDK1 to be retained in cytosol and so prevents PDK1 and 
Akt from being phosphorylated (H. Park et al., 2015). This could partially explain as 
to why addition of AMIGO1 extracellular domain in the culture medium inhibited the 
fasciculation of neuritis as compared to immobilizing AMIGO1 extracellular matrix 
on a well plate that has been reported by Kuja-Panula et al, 2003 (Kuja-Panula et al., 
2003; H. Park et al., 2015). The finding that soluble PTD-A2 has anti-tumour property 
is also testimony that disruption of AMIGO2 scaffold-forming process could be 
beneficial in preventing pathological angiogenesis in pulmonary vascular 
remodelling.  
 
Figure 8.3: Schematics of the relationship between AMIGO2, PDK1, and Akt. Adapted from H. Park et 
al, 2015.  
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The group has examined the AMIGO2-VEGF relationship more closely by assessing 
whether Akt activation is affected when AMIGO2 is absent in vitro and in vivo. In 
endothelial cells where AMIGO2 is silenced and cultured in normal growth media 
(without VEGF), Akt phosphorylation (threonine 308 and serine 473) was reduced 
(H. Park et al., 2015). In contrast, Akt phosphorylation was increased when AMIGO2 
was overexpressed (H. Park et al., 2015). AMIGO2-silenced mice also displayed 
decreased Akt phosphorylation in hyaloid vessels and retinas (H. Park et al., 2015). 
AMIGO2 knockdown endothelial cells treated with VEGF revealed that while VEGF 
receptor 2 (VEGF2) phosphorylation at tyrosine 1175 was not affected, Akt 
phosphorylation was inhibited (H. Park et al., 2015). This might indicate that 
AMIGO2 has a higher importance in controlling Akt activation (H. Park et al., 2015). 
Although Akt inhibition has been correlated to reduce ovarian tumour growth, 
angiogenesis, endothelial cell tube formation, and morphogenesis, capillary-like 
network formation was unaffected (H. Park et al., 2015). Endothelial cells which are 
cultured together with vascular smooth muscle cells have constitutively active Akt 
and are able to form non-functional vasculature (H. Park et al., 2015).  Partial 
inhibition of PI3K suppresses Akt1, in turn activates Erk1/2 (MAPK) pathway to 
promote arteriogenesis (H. Park et al., 2015). Therefore, vasculogenesis and 
angiogenesis can be regulated by more than one pathway (H. Park et al., 2015). 
Instead of relying on PI3K-Akt pathway alone, the process depends on the balance 
between this pathway with MAPK signalling (H. Park et al., 2015). 
 
 
	
 
